1 | A fixed-dose combination OF 95 MG clarithromycin, 45 MG rifabutin, and 10 MG clofazimine | - | - | - | - | 1件: 96 96 💬
|
2 | A natural remedy FOR rheumatoid arthritis VS. common drugs | - | - | - | - | 1件: 46 46 💬
|
3 | A novel synthetic, orally-administered, NON-peptide small molecule, which acts AS | - | - | - | - | 1件: 254 254 💬
|
4 | A plant based high fiber diet that mimics fasting (FMD) plus advanced therapy | - | - | - | - | 1件: 97 97 💬
|
5 | A simulated agent OF jitongning tablets | - | - | - | - | 1件: 271 271 💬
|
6 | A single blood sample FOR HLA typing | - | - | - | - | 3件: 35 35, 38, 162 💬
|
7 | A-1293543.74 | - | - | - | - | 1件: 96 96 💬
|
8 | A-319 | - | - | - | - | 1件: 49 49 💬
|
9 | A-623 | - | - | - | - | 1件: 49 49 💬
|
10 | A-623 or AMG 623 | - | - | - | - | 1件: 66 66 💬
|
11 | A-dopamine | - | - | - | - | 1件: 6 6 💬
|
12 | A-step | - | - | - | - | 1件: 299 299 💬
|
13 | A01ac02 | - | - | - | - | 1件: 28 28 💬
|
14 | A04ad10 | - | - | - | - | 1件: 298 298 💬
|
15 | A07da03 | - | - | - | - | 1件: 97 97 💬
|
16 | A07ea06 | - | - | - | - | 1件: 66 66 💬
|
17 | A10bk03 | - | - | - | - | 1件: 65 65 💬
|
18 | A11ha02 | - | - | - | - | 1件: 93 93 💬
|
19 | A16ax06 | - | - | - | - | 1件: 19 19 💬
|
20 | A16ax07 | - | - | - | - | 1件: 240 240 💬
|
21 | A4250 | - | - | - | - | 4件: 93 93, 296, 297, 338 💬
|
22 | A4250-015 | - | - | - | - | 1件: 297 297 💬
|
23 | A4I antagonist | - | - | - | - | 1件: 13 13 💬
|
24 | A: 1 dosis | - | - | - | - | 1件: 97 97 💬
|
25 | AAC hexal | - | - | - | - | 1件: 299 299 💬
|
26 | Aadipose-derived mesenchymal stem cells | - | - | - | - | 1件: 6 6 💬
|
27 | AAV BBP-631 | - | - | - | - | 1件: 81 81 💬
|
28 | AAV directed hldlr gene therapy | - | - | - | - | 1件: 79 79 💬
|
29 | AAV-GAD | - | - | - | - | 1件: 6 6 💬
|
30 | AAV-GAD dose 1 | - | - | - | - | 1件: 6 6 💬
|
31 | AAV-GAD dose 2 | - | - | - | - | 1件: 6 6 💬
|
32 | AAV-haadc-2 | - | - | - | - | 1件: 6 6 💬
|
33 | AAV1-gamma-sarcoglycan vector injection | - | - | - | - | 1件: 113 113 💬
|
34 | AAV2-gdnf | - | - | - | - | 1件: 6 6 💬
|
35 | AAV2-gdnf gene therapy | - | - | - | - | 2件: 6 6, 17 💬
|
36 | AAV2-REP1 | - | - | - | - | 1件: 90 90 💬
|
37 | AAV2/5-HPDE6B | - | - | - | - | 1件: 90 90 💬
|
38 | AAV2/5-hrkp.rpgr | - | - | - | - | 1件: 90 90 💬
|
39 | AAV2/5-rpgr | - | - | - | - | 1件: 90 90 💬
|
40 | AAV2/8.TBG.harsb | - | - | - | - | 1件: 19 19 💬
|
41 | AAV5-hrkp.rpgr | - | - | - | - | 1件: 90 90 💬
|
42 | AAV5-hrkp.rpgr intermediate dose | - | - | - | - | 1件: 90 90 💬
|
43 | AAV5-hrkp.rpgr LOW dose | - | - | - | - | 1件: 90 90 💬
|
44 | AAV8-rpgr | 1件: Cotoretigene toliparvovec Cotoretigene toliparvovec | - | - | - | 1件: 90 90 💬
|
45 | AAV8.TBG.hldlr | - | - | - | - | 1件: 79 79 💬
|
46 | AAV9 BBP-812 | - | - | - | - | 1件: 307 307 💬
|
47 | AAV9-CAG-COH-sgsh | - | - | - | - | 1件: 19 19 💬
|
48 | AAV9-GLB1 | - | - | - | - | 1件: 19 19 💬
|
49 | AAVB-081 | - | - | - | - | 2件: 90 90, 303 💬
|
50 | Aavlk03hotc | - | - | - | - | 1件: 251 251 💬
|
51 | Aavrh.10-hmpsiiia | - | - | - | - | 1件: 19 19 💬
|
52 | Aavrh.10cuarsa | - | - | - | - | 1件: 19 19 💬
|
53 | Aavrh.10cucln2 | - | - | - | - | 1件: 19 19 💬
|
54 | Aavrh.10cuhcln2 vector 2.85x10^11 genome copies | - | - | - | - | 1件: 19 19 💬
|
55 | Aavrh.10cuhcln2 vector 9.0x10^11 genome copies | - | - | - | - | 1件: 19 19 💬
|
56 | Aavrh.10hfxn, serotype RH.10 adeno-associated virus (AAV) gene transfer vector expressing THE cdna coding FOR human FXN | - | - | - | - | 1件: 18 18 💬
|
57 | Aavrh10.CAG.HCYP46a1 | - | - | - | - | 1件: 8 8 💬
|
58 | AB 1003 | - | - | - | - | 1件: 2 2 💬
|
59 | AB-1001 gene therapy | - | - | - | - | 1件: 8 8 💬
|
60 | AB-1003 dose level 1 | - | - | - | - | 1件: 113 113 💬
|
61 | AB-1003 dose level 2 | - | - | - | - | 1件: 113 113 💬
|
62 | AB-101 | - | - | - | - | 4件: 35 35, 44, 46, 49 💬
|
63 | AB1010 | - | - | - | - | 6件: 2 2, 5, 6, 13, 46, 96 💬
|
64 | ABA-101 | - | - | - | - | 1件: 13 13 💬
|
65 | Abacavir | 1件: Abacavir Abacavir | 2件: Abacavir sulfate
Abacavir sulfate
,
Abacavir
💬
| - | - | 4件: 2 2, 135, 265, 325 💬
|
66 | Abacavir 300MG twice daily | 1件: Abacavir Abacavir | 2件: Abacavir sulfate
Abacavir sulfate
,
Abacavir
💬
| - | - | 1件: 265 265 💬
|
67 | Abacavir sulfate | 1件: Abacavir Abacavir | 2件: Abacavir sulfate
Abacavir sulfate
,
Abacavir
💬
| - | - | 1件: 265 265 💬
|
68 | Abacavir sulfate, lamivudine and zidovudine | 1件: Abacavir Abacavir | 2件: Abacavir sulfate
Abacavir sulfate
,
Abacavir
💬
| - | - | 1件: 265 265 💬
|
69 | Abatacept | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 26件: 2 2, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
|
70 | Abatacept + csdmard | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
71 | Abatacept + vaccines | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
72 | Abatacept active treatment | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 50 50 💬
|
73 | Abatacept also known AS orencia also known AS CTLA4-IG | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 49 49 💬
|
74 | Abatacept delayed-onset treatment | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 50 50 💬
|
75 | Abatacept injection | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 3件: 11 11, 46, 107 💬
|
76 | Abatacept prefilled syringe | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
77 | Abatacept SC | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 53 53 💬
|
78 | Abatacept subcutaneous | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 50 50 💬
|
79 | Abatacept, rituximab or tocilizumab | 1件: Abatacept Abatacept | 1件: Abatacept
Abatacept
💬
| 2件: CD80 CD80, CD86 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | 1件: 46 46 💬
|
80 | ABBV-006 | - | - | - | - | 1件: 97 97 💬
|
81 | ABBV-066 | - | - | - | - | 2件: 96 96, 97 💬
|
82 | ABBV-0805 | - | - | - | - | 1件: 6 6 💬
|
83 | ABBV-105 | - | - | - | - | 2件: 46 46, 49 💬
|
84 | ABBV-105, A-1519938.0 | - | - | - | - | 1件: 46 46 💬
|
85 | ABBV-119 | - | - | - | - | 1件: 299 299 💬
|
86 | ABBV-154 | - | - | - | - | 2件: 46 46, 96 💬
|
87 | ABBV-2222 | - | - | - | - | 1件: 299 299 💬
|
88 | ABBV-257 | - | - | - | - | 1件: 46 46 💬
|
89 | ABBV-3067 | - | - | - | - | 1件: 299 299 💬
|
90 | ABBV-319 | - | - | - | - | 1件: 49 49 💬
|
91 | ABBV-323 | - | - | - | - | 2件: 53 53, 97 💬
|
92 | ABBV-323 dose A | - | - | - | - | 1件: 97 97 💬
|
93 | ABBV-323 dose B | - | - | - | - | 1件: 97 97 💬
|
94 | ABBV-3373 | - | - | - | - | 1件: 46 46 💬
|
95 | ABBV-382 | - | - | - | - | 1件: 96 96 💬
|
96 | ABBV-576 | - | - | - | - | 1件: 299 299 💬
|
97 | ABBV-668 | - | - | - | - | 1件: 97 97 💬
|
98 | ABBV-8e12 | - | - | - | - | 2件: 5 5, 7 💬
|
99 | ABBV-951 | - | - | - | - | 1件: 6 6 💬
|
100 | ABBV-CLS-628 | - | - | - | - | 1件: 67 67 💬
|
101 | ABBV-CLS-7262 | 1件: ABBV-CLS-7262 ABBV-CLS-7262 | - | - | - | 1件: 2 2 💬
|
102 | ABBV-CLS-7262 dose 1 | 1件: ABBV-CLS-7262 ABBV-CLS-7262 | - | - | - | 1件: 2 2 💬
|
103 | ABBV-CLS-7262 dose 2 | 1件: ABBV-CLS-7262 ABBV-CLS-7262 | - | - | - | 1件: 2 2 💬
|
104 | Abbvie care 2.0 | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
105 | ABC | - | - | - | - | 2件: 6 6, 325 💬
|
106 | ABC008 | - | - | - | - | 1件: 15 15 💬
|
107 | Abcertin | - | - | - | - | 1件: 19 19 💬
|
108 | Abdominal compression | - | - | - | - | 2件: 6 6, 17 💬
|
109 | Abdominal ultrasound | - | - | - | - | 2件: 19 19, 231 💬
|
110 | Abelcet | 1件: Amphotericin B Amphotericin B | 1件: Amphotericin B
Amphotericin B
💬
| - | - | 1件: 299 299 💬
|
111 | Abelmoschus manihot | - | - | - | - | 1件: 66 66 💬
|
112 | Abemaciclib | 1件: Abemaciclib Abemaciclib | 1件: Abemaciclib
Abemaciclib
💬
| 2件: CDK4 CDK4, CDK6 💬
| 28件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Breast cancer, Cell cycle, Cellular senescence, Chronic myeloid leukemia, Cushing syndrome, Epstein-Barr virus infection, Glioma, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Measles, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Small cell lung cancer, T cell receptor signaling pathway, Tight junction, Viral carcinogenesis, p53 signaling pathway 💬 | 1件: 34 34 💬
|
113 | Abetimus sodium | 1件: Abetimus Abetimus | 1件: Abetimus sodium
Abetimus sodium
💬
| - | - | 1件: 49 49 💬
|
114 | ABH001 | 1件: ABH001 ABH001 | - | - | - | 1件: 36 36 💬
|
115 | ABI-009 | - | - | - | - | 1件: 21 21 💬
|
116 | ABI-M201 | - | - | - | - | 1件: 97 97 💬
|
117 | Abiraterone acetate | 1件: Abiraterone Abiraterone | 1件: Abiraterone acetate
Abiraterone acetate
💬
| 1件: CYP17A CYP17A 💬
| 5件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | 2件: 75 75, 81 💬
|
118 | Abiraterone acetato | 1件: Abiraterone Abiraterone | 1件: Abiraterone acetate
Abiraterone acetate
💬
| 1件: CYP17A CYP17A 💬
| 5件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Ovarian steroidogenesis, Prolactin signaling pathway, Steroid hormone biosynthesis 💬 | 1件: 75 75 💬
|
119 | Abituzumab | 1件: Abituzumab Abituzumab | - | - | - | 1件: 51 51 💬
|
120 | Abituzumab 1500 MG | 1件: Abituzumab Abituzumab | - | - | - | 1件: 51 51 💬
|
121 | Abituzumab 500 MG | 1件: Abituzumab Abituzumab | - | - | - | 1件: 51 51 💬
|
122 | Ablation | - | - | - | - | 1件: 84 84 💬
|
123 | ABO-101 | - | - | - | - | 2件: 19 19, 234 💬
|
124 | ABO-102 | 1件: Rebisufligene etisparvovec Rebisufligene etisparvovec | - | - | - | 1件: 19 19 💬
|
125 | Abobotulinumtoxin A | - | - | - | - | 1件: 13 13 💬
|
126 | ABP 501 | - | - | - | - | 1件: 46 46 💬
|
127 | ABP 692 | - | - | - | - | 1件: 13 13 💬
|
128 | ABP 710 | - | - | - | - | 1件: 46 46 💬
|
129 | ABP 710 - biosimilar TO infliximab | 1件: Infliximab Infliximab | 1件: Infliximab
Infliximab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
130 | ABP 798 | - | - | - | - | 1件: 46 46 💬
|
131 | ABP 798 biosimilar TO rituximab | 1件: Rituximab Rituximab | 1件: Rituximab
Rituximab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 46 46 💬
|
132 | ABP 959 | - | - | - | - | 1件: 62 62 💬
|
133 | ABP 959 - biosimilar TO eculizumab | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
134 | ABP 959 - proposed biosimilar TO eculizumab | 1件: Eculizumab Eculizumab | 1件: Eculizumab
Eculizumab
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
135 | Abpc | 1件: Ampicillin Ampicillin | 3件: Ampicillin
Ampicillin
,
Ampicillin hydrate
,
Ampicillin sodium
💬
| - | - | 1件: 84 84 💬
|
136 | ABR-215062 | - | - | - | - | 1件: 13 13 💬
|
137 | ABR-215062 sodium salt | - | - | - | - | 2件: 13 13, 96 💬
|
138 | ABR-215757 | - | - | - | - | 2件: 49 49, 51 💬
|
139 | Abrilumab | 1件: Abrilumab Abrilumab | 1件: Abrilumab
Abrilumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 2件: 96 96, 97 💬
|
140 | Abrocitinib | 1件: Abrocitinib Abrocitinib | 1件: Abrocitinib
Abrocitinib
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 39 39 💬
|
141 | Abrocitinib 200 MG | 1件: Abrocitinib Abrocitinib | 1件: Abrocitinib
Abrocitinib
💬
| 1件: JAK1 JAK1 💬
| 27件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | 1件: 84 84 💬
|
142 | Absorptive clearance scan | - | - | - | - | 1件: 299 299 💬
|
143 | ABT 494 | - | - | - | - | 1件: 46 46 💬
|
144 | ABT 494 12MG | - | - | - | - | 2件: 46 46, 96 💬
|
145 | ABT 494 3MG | - | - | - | - | 2件: 46 46, 96 💬
|
146 | ABT humira | - | - | - | - | 1件: 96 96 💬
|
147 | ABT-122 | - | - | - | - | 1件: 46 46 💬
|
148 | ABT-199 | - | - | - | - | 1件: 49 49 💬
|
149 | ABT-494 | - | - | - | - | 7件: 41 41, 46, 49, 96, 97, 107, 271 💬
|
150 | ABT-494 15MG | - | - | - | - | 1件: 46 46 💬
|
151 | ABT-494 30MG | - | - | - | - | 1件: 46 46 💬
|
152 | ABT-555 | - | - | - | - | 1件: 13 13 💬
|
153 | ABT-874 | - | - | - | - | 1件: 96 96 💬
|
154 | ABT-874/human monoclonal antibody against IL-12 | - | - | - | - | 1件: 13 13 💬
|
155 | ABT-humira | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 97 💬
|
156 | ABT-SLV187 | - | - | - | - | 1件: 6 6 💬
|
157 | ABX-1431 HCL | 1件: ABX-1431 ABX-1431 | - | - | - | 1件: 13 13 💬
|
158 | ABX1100 injection FOR IV infusion | 1件: ABX1100 ABX1100 | - | - | - | 1件: 256 256 💬
|
159 | ABX464 | - | - | - | - | 3件: 46 46, 96, 97 💬
|
160 | ABX464 100MG | - | - | - | - | 2件: 46 46, 97 💬
|
161 | ABX464 25MG | - | - | - | - | 1件: 97 97 💬
|
162 | ABX464 50MG | - | - | - | - | 2件: 46 46, 97 💬
|
163 | ABY-035 | - | - | - | - | 1件: 271 271 💬
|
164 | AC-203 | - | - | - | - | 1件: 36 36 💬
|
165 | AC-203 1% topical ointment | - | - | - | - | 1件: 162 162 💬
|
166 | AC0058TA | - | - | - | - | 1件: 49 49 💬
|
167 | AC430 | - | - | - | - | 1件: 46 46 💬
|
168 | Acacia GUM | 1件: Acacia Acacia | 1件: Acacia
Acacia
💬
| - | - | 1件: 97 97 💬
|
169 | Acalabrutinib | 1件: Acalabrutinib Acalabrutinib | 2件: Acalabrutinib
Acalabrutinib
,
Acalabrutinib maleate hydrate
💬
| 1件: BTK BTK 💬
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 | 2件: 46 46, 61 💬
|
170 | Acamprosate | 1件: Acamprosate Acamprosate | 2件: Acamprosate calcium
Acamprosate calcium
,
Acamprosate
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 6 6, 206 💬
|
171 | Acarbose | 1件: Acarbose Acarbose | 1件: Acarbose
Acarbose
💬
| 5件: AMY AMY, AMY, GAA, GANC, MGAM 💬
| 6件: Carbohydrate digestion and absorption Carbohydrate digestion and absorption, Galactose metabolism, Lysosome, Pancreatic secretion, Salivary secretion, Starch and sucrose metabolism 💬 | 1件: 298 298 💬
|
172 | Acazicolcept | 1件: Acazicolcept Acazicolcept | 1件: Acazicolcept
Acazicolcept
💬
| 2件: CD28 CD28, ICOS 💬
| 13件: Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, Rheumatoid arthritis, Systemic lupus erythematosus, T cell receptor signaling pathway, Type I diabetes mellitus, Viral myocarditis 💬 | 1件: 49 49 💬
|
173 | ACC | - | - | - | - | 1件: 299 299 💬
|
174 | ACC600tabs | - | - | - | - | 1件: 299 299 💬
|
175 | Accelerated 1 HOUR-infusion | - | - | - | - | 2件: 96 96, 97 💬
|
176 | Accelerated 30 minutes-infusion | - | - | - | - | 2件: 96 96, 97 💬
|
177 | Accelerated HBV vaccine | - | - | - | - | 1件: 97 97 💬
|
178 | Accelerometer | - | - | - | - | 1件: 17 17 💬
|
179 | Accelerometry TO assess physical activity | - | - | - | - | 1件: 299 299 💬
|
180 | Acceptance and commitment therapy | - | - | - | - | 1件: 97 97 💬
|
181 | Access program - sildenafil citrate, viagra, revatio | - | - | - | - | 1件: 86 86 💬
|
182 | Accordion pill carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
183 | Accordion pill ¿ carbidopa/levodopa 50/400 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
184 | Accordion pill ¿ carbidopa/levodopa 50/500 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
185 | Accordion pill? carbidopa/levodopa 50/400 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
186 | Accordion pill? carbidopa/levodopa 50/500 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
187 | Accordion pill¿ carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
188 | Accordion pill™ carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
189 | Accordion pill™ carbidopa/levodopa 50/400 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
190 | Accordion pill™ carbidopa/levodopa 50/500 MG | 2件: Carbidopa Carbidopa, Levodopa | 2件: Levodopa
Levodopa
,
Carbidopa
💬
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬
| 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
191 | Accupro | - | - | - | - | 1件: 19 19 💬
|
192 | Accuretic | - | - | - | - | 1件: 19 19 💬
|
193 | Acded + modulen | - | - | - | - | 1件: 96 96 💬
|
194 | ACDN-01 | - | - | - | - | 2件: 90 90, 301 💬
|
195 | ACE I, ATA II and statins | - | - | - | - | 1件: 218 218 💬
|
196 | ACE inhibitor | - | - | - | - | 1件: 66 66 💬
|
197 | ACE inhibitor or angiotensin receptor antagonist | - | - | - | - | 1件: 66 66 💬
|
198 | ACE retino | - | - | - | - | 1件: 90 90 💬
|
199 | ACE-011 | - | - | - | - | 1件: 86 86 💬
|
200 | ACE-011 / ??-7962 | - | - | - | - | 1件: 86 86 💬
|
201 | ACE-011 / MK - 7962 | - | - | - | - | 1件: 86 86 💬
|
202 | ACE-011 / MK-7962 | - | - | - | - | 1件: 86 86 💬
|
203 | ACE-011/ MK-7962 | - | - | - | - | 1件: 86 86 💬
|
204 | ACE-031 0.5 MG/KG Q4WK | - | - | - | - | 1件: 113 113 💬
|
205 | ACE-031 1.0 MG/KG Q2WK | - | - | - | - | 1件: 113 113 💬
|
206 | ACE-083 | - | - | - | - | 2件: 10 10, 113 💬
|
207 | ACE-inhibitor | - | - | - | - | 1件: 218 218 💬
|
208 | ACE/ARB | - | - | - | - | 1件: 66 66 💬
|
209 | Acebilustat | 1件: Acebilustat Acebilustat | - | - | - | 1件: 299 299 💬
|
210 | Aceclofenac | 1件: Aceclofenac Aceclofenac | 1件: Aceclofenac
Aceclofenac
💬
| 3件: PTGES PTGES, PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
211 | Acei | - | - | - | - | 2件: 66 66, 224 💬
|
212 | Acei / angiotensin converting enzyme inhibitor | - | - | - | - | 1件: 234 234 💬
|
213 | Acei/ARB and corticosteroids | - | - | - | - | 1件: 66 66 💬
|
214 | Acei/ARB+ finerenone | - | - | - | - | 1件: 222 222 💬
|
215 | Acellbia | - | - | - | - | 1件: 46 46 💬
|
216 | Aceneuramic acid | 1件: Aceneuramic acid Aceneuramic acid | 1件: Aceneuramic acid
Aceneuramic acid
💬
| - | - | 1件: 30 30 💬
|
217 | Aceneuramic acid extended-release | 1件: Aceneuramic acid Aceneuramic acid | 1件: Aceneuramic acid
Aceneuramic acid
💬
| - | - | 1件: 30 30 💬
|
218 | Aceneuramic acid extended-release tablets | 1件: Aceneuramic acid Aceneuramic acid | 1件: Aceneuramic acid
Aceneuramic acid
💬
| - | - | 1件: 30 30 💬
|
219 | ACER-002 (celiprolol) 200 MG BID | - | - | - | - | 1件: 168 168 💬
|
220 | Acetamide | 1件: Acetamide Acetamide | - | - | - | 1件: 65 65 💬
|
221 | Acetaminophen | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 14件: 11 11, 19, 34, 46, 49, 51, 70, 77, 86, 96, 222, 256, 300, 337 💬
|
222 | Acetaminophen tablet 650MG | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 💬
|
223 | Acetaminophen tablets | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
224 | Acetaminophen/paracetamol | 1件: Acetaminophen Acetaminophen | 1件: Acetaminophen
Acetaminophen
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 35 35, 49 💬
|
225 | Acetate | 1件: Acetate Acetate | - | - | - | 14件: 11 11, 46, 49, 51, 70, 71, 73, 76, 89, 97, 158, 235, 265, 299 💬
|
226 | Acetato DE octreótida | - | - | - | - | 1件: 77 77 💬
|
227 | Acetato DI ammonio | - | - | - | - | 1件: 97 97 💬
|
228 | Acetazolamide | 1件: Acetazolamide Acetazolamide | 2件: Acetazolamide
Acetazolamide
,
Acetazolamide sodium
💬
| 13件: CA CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA2, CA4 💬
| 6件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 5件: 13 13, 90, 115, 155, 230 💬
|
229 | Acetazolamide sandoz 250 | 1件: Acetazolamide Acetazolamide | 2件: Acetazolamide
Acetazolamide
,
Acetazolamide sodium
💬
| 13件: CA CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA, CA2, CA4 💬
| 6件: Bile secretion Bile secretion, Collecting duct acid secretion, Gastric acid secretion, Nitrogen metabolism, Pancreatic secretion, Proximal tubule bicarbonate reclamation 💬 | 1件: 225 225 💬
|
230 | Acetic acid | 1件: Acetic acid Acetic acid | 1件: Acetic acid, glacial
Acetic acid, glacial
💬
| - | - | 2件: 97 97, 296 💬
|
231 | Acetohydroxamic acid | 1件: Acetohydroxamic acid Acetohydroxamic acid | 1件: Acetohydroxamic acid
Acetohydroxamic acid
💬
| - | - | 1件: 251 251 💬
|
232 | Acetominophen | - | - | - | - | 1件: 63 63 💬
|
233 | Acetyl- L- carnitine | - | - | - | - | 1件: 265 265 💬
|
234 | Acetyl-L-carnitine | 1件: Acetylcarnitine Acetylcarnitine | - | - | - | 1件: 2 2 💬
|
235 | Acetyl-L-carnitine 1000MG 2X PER DAY FOR 3 months | 1件: Acetylcarnitine Acetylcarnitine | - | - | - | 1件: 298 298 💬
|
236 | Acetylcarnitine | 1件: Acetylcarnitine Acetylcarnitine | - | - | - | 3件: 2 2, 97, 265 💬
|
237 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬
| - | - | 10件: 34 34, 51, 53, 85, 94, 97, 193, 233, 298, 299 💬
|
238 | Acetylcysteine sodium | 1件: Acetylcysteine Acetylcysteine | 1件: Acetylcysteine
Acetylcysteine
💬
| - | - | 1件: 299 299 💬
|
239 | Acetylsalicylic acid | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 4件: 13 13, 46, 51, 210 💬
|
240 | ACH-0144471 | 1件: Danicopan Danicopan | 1件: Danicopan
Danicopan
💬
| 1件: CFD CFD 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 2件: 62 62, 222 💬
|
241 | ACH-0144471 compresse | 1件: Danicopan Danicopan | 1件: Danicopan
Danicopan
💬
| 1件: CFD CFD 💬
| 3件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬 | 1件: 222 222 💬
|
242 | ACH-0145228 | - | - | - | - | 1件: 62 62 💬
|
243 | ACH0144471 compresse | - | - | - | - | 1件: 222 222 💬
|
244 | Achim | - | - | - | - | 1件: 51 51 💬
|
245 | Achim capsules | - | - | - | - | 1件: 51 51 💬
|
246 | ACI-7104.056 AT dose A | - | - | - | - | 1件: 6 6 💬
|
247 | Aciclin | - | - | - | - | 1件: 28 28 💬
|
248 | Aciclovir | 1件: Acyclovir Acyclovir | 2件: Acyclovir
Acyclovir
,
Acyclovir sodium
💬
| - | - | 3件: 13 13, 28, 60 💬
|
249 | Acide folique | 1件: Folic acid Folic acid | 2件: Folic acid
Folic acid
,
Folate sodium
💬
| - | - | 1件: 46 46 💬
|
250 | Acide tranexamique mylan 0,5 G/ 5 ML, solution injectable | - | - | - | - | 1件: 299 299 💬
|
251 | Acido ascorbico | - | - | - | - | 1件: 10 10 💬
|
252 | Acido deossicolico | - | - | - | - | 1件: 94 94 💬
|
253 | Acido fusidico/idrocortisone acetato | 1件: Fusidic acid Fusidic acid | 2件: Fusidic acid
Fusidic acid
,
Fusidic acid hemihydrate
💬
| - | - | 1件: 272 272 💬
|
254 | Acido micofenolico | 1件: Mycophenolic acid Mycophenolic acid | 2件: Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| 2件: IMPDH IMPDH, IMPDH 💬
| 2件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | 2件: 49 49, 51 💬
|
255 | Acido obeticolico | - | - | - | - | 3件: 93 93, 94, 296 💬
|
256 | Acido tauroursodesossicolico | - | - | - | - | 1件: 2 2 💬
|
257 | Acido ursodessicolico | - | - | - | - | 1件: 93 93 💬
|
258 | Acidophilus | 1件: Lactobacillus acidophilus Lactobacillus acidophilus | 1件: Lactomin
Lactomin
💬
| - | - | 1件: 97 97 💬
|
259 | Acidum ascorbicum D6 | 1件: Ascorbic acid Ascorbic acid | 1件: Ascorbic acid
Ascorbic acid
💬
| - | - | 1件: 206 206 💬
|
260 | Acipimox | 1件: Acipimox Acipimox | 1件: Acipimox
Acipimox
💬
| - | - | 2件: 78 78, 265 💬
|
261 | Acitretin | 1件: Acitretin Acitretin | 1件: Acitretin
Acitretin
💬
| 5件: RARA RARA, RARB, RXRA, RXRB, RXRG 💬
| 20件: Acute myeloid leukemia Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Efferocytosis, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | 1件: 37 37 💬
|
262 | Aclasta | 1件: Zoledronic acid Zoledronic acid | 5件: Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 3件: 97 97, 271, 274 💬
|
263 | Aclasta 5 MG infusionslösung | 1件: Zoledronic acid Zoledronic acid | 5件: Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 13 13 💬
|
264 | Aclasta 5MG solution FOR infusion | - | - | - | - | 1件: 13 13 💬
|
265 | ACM | - | - | - | - | 1件: 49 49 💬
|
266 | ACN00177 | - | - | - | - | 1件: 337 337 💬
|
267 | Acomplia 20 MG FILM-coated tablets | - | - | - | - | 1件: 193 193 💬
|
268 | Acoramidis | 1件: Acoramidis Acoramidis | 1件: Acoramidis
Acoramidis
💬
| 1件: TTR TTR 💬
| 1件: Thyroid hormone synthesis Thyroid hormone synthesis 💬 | 1件: 28 28 💬
|
269 | Acotiamide | 1件: Acotiamide Acotiamide | - | - | - | 2件: 11 11, 51 💬
|
270 | ACP-103 | - | - | - | - | 1件: 6 6 💬
|
271 | ACR16 | - | - | - | - | 1件: 8 8 💬
|
272 | ACR16 10 MG | - | - | - | - | 1件: 8 8 💬
|
273 | ACR16 22.5 MG | - | - | - | - | 1件: 8 8 💬
|
274 | ACR16 45 MG | - | - | - | - | 1件: 8 8 💬
|
275 | ACR16 hydrochloride, ASP2314 hydrochloride, FR310826 | - | - | - | - | 1件: 8 8 💬
|
276 | ACR325 | 1件: ACR325 ACR325 | - | - | - | 1件: 6 6 💬
|
277 | ACT | - | - | - | - | 1件: 13 13 💬
|
278 | ACT - 064992 | - | - | - | - | 1件: 86 86 💬
|
279 | ACT-050089 | - | - | - | - | 1件: 86 86 💬
|
280 | ACT-064992 | - | - | - | - | 5件: 51 51, 85, 86, 88, 210 💬
|
281 | ACT-064992 / JNJ-67896062 | - | - | - | - | 1件: 86 86 💬
|
282 | ACT-064992/ JNJ-67896062 | - | - | - | - | 1件: 86 86 💬
|
283 | ACT-064992D | - | - | - | - | 1件: 86 86 💬
|
284 | ACT-1 | - | - | - | - | 1件: 13 13 💬
|
285 | ACT-128800 | - | - | - | - | 1件: 13 13 💬
|
286 | ACT-128800 dose 1 | - | - | - | - | 1件: 13 13 💬
|
287 | ACT-128800 dose 2 | - | - | - | - | 1件: 13 13 💬
|
288 | ACT-128800 dose 3 | - | - | - | - | 1件: 13 13 💬
|
289 | ACT-178418 | - | - | - | - | 1件: 86 86 💬
|
290 | ACT-293987 | - | - | - | - | 3件: 51 51, 86, 88 💬
|
291 | ACT-293987 / JNJ-67896049 | - | - | - | - | 1件: 84 84 💬
|
292 | ACT-334441 | - | - | - | - | 1件: 49 49 💬
|
293 | ACT-385781A | - | - | - | - | 1件: 86 86 💬
|
294 | ACT-434964 | - | - | - | - | 1件: 19 19 💬
|
295 | ACT-HIB | - | - | - | - | 3件: 14 14, 62, 222 💬
|
296 | ACT-HIB polvere E solvente PER soluzione iniettabile IN siringa preriempita 0,5 ML | - | - | - | - | 2件: 61 61, 62 💬
|
297 | Actavis ferrous sulphate tablets BP 200MG | - | - | - | - | 1件: 97 97 💬
|
298 | Actemra | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 2件: 46 46, 107 💬
|
299 | Actemra +MTX | - | - | - | - | 1件: 46 46 💬
|
300 | Actemra, MRA | 1件: Tocilizumab Tocilizumab | 1件: Tocilizumab
Tocilizumab
💬
| 1件: IL6R IL6R 💬
| 11件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 107 107 💬
|
301 | Acth | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 3件: 13 13, 145, 222 💬
|
302 | Acth (acthar) GEL | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 66 66 💬
|
303 | Acth/oral steroids | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 145 145 💬
|
304 | Acthar | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 6件: 2 2, 13, 46, 49, 50, 222 💬
|
305 | Acthar 80 unit injection | - | - | - | - | 1件: 66 66 💬
|
306 | Acthar GEL | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 5件: 13 13, 46, 49, 84, 222 💬
|
307 | Acthar GEL 40 units twice weekly | - | - | - | - | 1件: 84 84 💬
|
308 | Acthar injectable product | - | - | - | - | 1件: 46 46 💬
|
309 | Acthib - polvere E solvente PER soluzione iniettabile 1 flaconcino polvere+1 siringa preriempita solvente 0.5 ML | - | - | - | - | 2件: 62 62, 66 💬
|
310 | Acthrel | - | - | - | - | 1件: 75 75 💬
|
311 | Actimmune | - | - | - | - | 1件: 326 326 💬
|
312 | Actimmune registry | - | - | - | - | 1件: 326 326 💬
|
313 | Actimyo recording | - | - | - | - | 1件: 6 6 💬
|
314 | Activated charcoal | 1件: Activated charcoal Activated charcoal | 1件: Charcoal, activated
Charcoal, activated
💬
| - | - | 2件: 13 13, 85 💬
|
315 | Activated prothrombin complex concentrate | 1件: Anti-inhibitor coagulant complex Anti-inhibitor coagulant complex | 1件: Human blood-coagulation factor eight inhibitor bypassing activity complex, dried
Human blood-coagulation factor eight inhibitor bypassing activity complex, dried
💬
| - | - | 1件: 288 288 💬
|
316 | Active comparator | - | - | - | - | 5件: 6 6, 43, 44, 46, 96 💬
|
317 | Active control | - | - | - | - | 1件: 13 13 💬
|
318 | Active investigational treatment ENT-01 | - | - | - | - | 1件: 6 6 💬
|
319 | Active stimulation | - | - | - | - | 1件: 46 46 💬
|
320 | Active tdcs | - | - | - | - | 1件: 6 6 💬
|
321 | Active topical NS2 1% dermatologic cream | - | - | - | - | 1件: 160 160 💬
|
322 | Active tpcs | - | - | - | - | 1件: 6 6 💬
|
323 | Active transcranial direct current stimulation | - | - | - | - | 1件: 6 6 💬
|
324 | Active treatment group 7% hypertonic saline | - | - | - | - | 1件: 299 299 💬
|
325 | Active treatment with dual therapy | - | - | - | - | 1件: 2 2 💬
|
326 | Activematrix | - | - | - | - | 1件: 70 70 💬
|
327 | Activity monitor | - | - | - | - | 1件: 113 113 💬
|
328 | Actonel 5MG film coated tablets | 1件: Risedronic acid Risedronic acid | 3件: Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬
|
329 | Actonel once A week 35 MG FILM-coated tablets | 1件: Risedronic acid Risedronic acid | 3件: Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬
|
330 | Actonel once A week 35MG | - | - | - | - | 1件: 97 97 💬
|
331 | Actonel once A week 5MG film coated tablets | 1件: Risedronic acid Risedronic acid | 3件: Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 113 113 💬
|
332 | Actonel/optinate 5MG FILM-coated tablets | 1件: Risedronic acid Risedronic acid | 3件: Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 1件: 274 274 💬
|
333 | Actos 15 MG | 1件: Pioglitazone Pioglitazone | 2件: Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 2 2 💬
|
334 | Actos 30 MG | 1件: Pioglitazone Pioglitazone | 2件: Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 2 2 💬
|
335 | Actos 45 MG | 1件: Pioglitazone Pioglitazone | 2件: Pioglitazone hydrochloride
Pioglitazone hydrochloride
,
Pioglitazone
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 2 2 💬
|
336 | Actrapid 100 IU/ML, solution FOR injection IN A vial | - | - | - | - | 1件: 299 299 💬
|
337 | Actrapid penfill 100UI/ML | - | - | - | - | 1件: 299 299 💬
|
338 | Actriia-IGG1FC | - | - | - | - | 1件: 86 86 💬
|
339 | Actus-101 | 1件: ACTUS-101 ACTUS-101 | - | - | - | 1件: 256 256 💬
|
340 | ACU-4429 | - | - | - | - | 1件: 301 301 💬
|
341 | Acupuncture | - | - | - | - | 2件: 46 46, 70 💬
|
342 | Acupuncture combined with oral hydroxychloroquine sulfate tablets | - | - | - | - | 1件: 53 53 💬
|
343 | Acupuncture GB20 or GB20 plus BL2 | - | - | - | - | 1件: 53 53 💬
|
344 | Acute antioxidant | - | - | - | - | 1件: 299 299 💬
|
345 | Acycloguanosine | 1件: Acyclovir Acyclovir | 2件: Acyclovir
Acyclovir
,
Acyclovir sodium
💬
| - | - | 2件: 46 46, 53 💬
|
346 | Acyclovir | 1件: Acyclovir Acyclovir | 2件: Acyclovir
Acyclovir
,
Acyclovir sodium
💬
| - | - | 2件: 13 13, 28 💬
|
347 | Acylated and unacylated ghrelin dosages | - | - | - | - | 3件: 193 193, 201, 202 💬
|
348 | ACZ885 | - | - | - | - | 7件: 46 46, 84, 106, 107, 108, 266, 267 💬
|
349 | ACZ885 drug substance | - | - | - | - | 3件: 46 46, 106, 107 💬
|
350 | ACZ885, 150MG/1.0ML | - | - | - | - | 2件: 266 266, 267 💬
|
351 | ACZ885D | - | - | - | - | 1件: 108 108 💬
|
352 | ACZ885G | - | - | - | - | 1件: 107 107 💬
|
353 | AD 452 | - | - | - | - | 1件: 46 46 💬
|
354 | AD 452 18 MG tablet | - | - | - | - | 1件: 46 46 💬
|
355 | AD 452 4.5 MG tablet | - | - | - | - | 1件: 46 46 💬
|
356 | AD 452 9 MG tablet | - | - | - | - | 1件: 46 46 💬
|
357 | AD libitum water intake | - | - | - | - | 1件: 67 67 💬
|
358 | AD26.COV2-S.02 | - | - | - | - | 1件: 299 299 💬
|
359 | AD26.COV2.S | - | - | - | - | 7件: 13 13, 35, 46, 49, 50, 51, 107 💬
|
360 | AD5-CB-cftr | - | - | - | - | 1件: 299 299 💬
|
361 | AD981 | - | - | - | - | 1件: 230 230 💬
|
362 | Adagen | - | - | - | - | 1件: 65 65 💬
|
363 | Adalimuab, etanercept, tocilizumab, or abatacept | - | - | - | - | 1件: 46 46 💬
|
364 | Adalimumab | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 18件: 19 19, 37, 40, 41, 46, 55, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 💬
|
365 | Adalimumab - GP2017 | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
366 | Adalimumab - US licensed humira | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
367 | Adalimumab 40 MG | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
368 | Adalimumab 40 MG EOW or EW | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
369 | Adalimumab 40 MG SC every other week | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 💬
|
370 | Adalimumab 40MG | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
371 | Adalimumab 40MG Q2W | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
372 | Adalimumab 80 MG | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
373 | Adalimumab AB | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 💬
|
374 | Adalimumab and infliximab | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
375 | Adalimumab and ITS biosimilars | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 💬
|
376 | Adalimumab biosimilare | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 107 107 💬
|
377 | Adalimumab delivered IN current autoinjector | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
378 | Adalimumab delivered IN current syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
379 | Adalimumab delivered IN physiolis autoinjector | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
380 | Adalimumab delivered IN physiolis syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
381 | Adalimumab humira | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
382 | Adalimumab injection | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 5件: 38 38, 40, 46, 96, 162 💬
|
383 | Adalimumab PFS and PEN | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
384 | Adalimumab PRN | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 96 96 💬
|
385 | Adalimumab serum trough concentration | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
386 | Adalimumab treatment | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 151 151 💬
|
387 | Adalimumab trough concentration | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
388 | Adalimumab with methotrexate | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
389 | Adalimumab, current formulation | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
390 | Adalimumab, etanercept, golimumab or infliximab | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 271 271 💬
|
391 | Adalimumab, NEW formulation | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
392 | Adalimumab, plus prednisone | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
393 | Adalimumab, solution FOR injection 40 MG/ (0.8 ML) PRE-filled syringe | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
394 | Adalimumab-680LT | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
395 | Adalimumab-800CW | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 46 46, 97 💬
|
396 | Adalimumab-EU | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
397 | Adalimumab-pfizer | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 46 46 💬
|
398 | Adalimummab | - | - | - | - | 1件: 46 46 💬
|
399 | Adaptor: hakko adaptor | - | - | - | - | 1件: 6 6 💬
|
400 | Adcirca | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
401 | Adcirca 20 MG FILM-coated tablets | 1件: Tadalafil Tadalafil | 1件: Tadalafil
Tadalafil
💬
| 1件: PDE5 PDE5 💬
| 2件: Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
402 | Adderall XR | - | - | - | - | 1件: 13 13 💬
|
403 | Adderall XR 10 MG | - | - | - | - | 1件: 13 13 💬
|
404 | Adderall XR 5MG | - | - | - | - | 1件: 13 13 💬
|
405 | Addition OF rituximab IF recurrence | - | - | - | - | 1件: 11 11 💬
|
406 | Additional blood samples | - | - | - | - | 1件: 41 41 💬
|
407 | Additional health questionnaire | - | - | - | - | 1件: 299 299 💬
|
408 | Additional therapies | - | - | - | - | 1件: 97 97 💬
|
409 | Adefovir | 1件: Adefovir Adefovir | 1件: Adefovir
Adefovir
💬
| - | - | 1件: 46 46 💬
|
410 | Adempas | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 5件: 51 51, 86, 88, 225, 299 💬
|
411 | Adempas 0.125 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 299 299 💬
|
412 | Adempas 0.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 💬
|
413 | Adempas 1 MG film coated tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
414 | Adempas 1.0 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 💬
|
415 | Adempas 1.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
416 | Adempas 1.5 MG film coated tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
417 | Adempas 2 MG film coated tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
418 | Adempas 2.0 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 86 86, 299 💬
|
419 | Adempas 2.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
420 | Adempas 2.5 MG film coated tablet | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
421 | Adempas filmtabletten | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
422 | Adempas® 0.5 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
423 | Adempas® 1.0 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
424 | Adempas® 1.5 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
425 | Adempas® 2.0 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
426 | Adempas® 2.5 MG FILM-coated tablets | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
427 | Adempas¿ 0.5 MG compressa rivestita CON film | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
428 | Adempas¿ 1.0 | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
429 | Adempas¿ 1.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
430 | Adempas¿ 2.0 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
431 | Adempas¿ 2.5 MG | 1件: Riociguat Riociguat | 1件: Riociguat
Riociguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
432 | Adeno-associated viral (AAV) serotype 8 (AAV2/8) vector with liver-specific thyroxine-binding globulin (TBG) promoter, driving THE expression OF THE human arsb gene | - | - | - | - | 1件: 19 19 💬
|
433 | Adeno-associated viral vector serotype 3B encoding shortened human ATP7B | - | - | - | - | 1件: 171 171 💬
|
434 | Adeno-associated viral vector serotype 8 containing THE human MD1 gene | - | - | - | - | 1件: 113 113 💬
|
435 | Adeno-associated viral vector serotype 9 containing THE human MINI-dystrophin gene | - | - | - | - | 1件: 113 113 💬
|
436 | Adeno-associated viral vector serotype 9 containing THE human N-acetyl-alpha-glucosaminidase gene | - | - | - | - | 1件: 19 19 💬
|
437 | Adeno-associated viral vector serotype 9 encoding human ATP7B | - | - | - | - | 1件: 171 171 💬
|
438 | Adeno-associated viral vector serotype 9 expressing codon-optimized human GRN gene | - | - | - | - | 1件: 127 127 💬
|
439 | Adeno-associated viral vector serotype RH10 containing THE human cholesterol 24-hydroxylase gene | - | - | - | - | 1件: 8 8 💬
|
440 | Adeno-associated virus serotype 2/6 encoding human alpha-galactosidase A cdna | - | - | - | - | 1件: 19 19 💬
|
441 | Adeno-associated virus serotype 2/6 encoding human iduronate 2-sulfatase (hids) gene donor vector, SB-A6P-HNT donor vector | - | - | - | - | 1件: 19 19 💬
|
442 | Adeno-associated virus serotype 2/6 encoding left SIDE-zinc finger nuclease (ZFN1), SB-A6P-zleft vector | - | - | - | - | 1件: 19 19 💬
|
443 | Adeno-associated virus serotype 2/6 encoding right SIDE-zinc finger nuclease (ZFN2), SB-A6P-zright vector | - | - | - | - | 1件: 19 19 💬
|
444 | Adeno-associated virus serotype 5 encoding A microrna targeted TO human huntingtin gene | - | - | - | - | 1件: 8 8 💬
|
445 | Adeno-associated virus serotype 9 carrying THE human fukutin-related protein and target sequence OF THE MIR-208A | - | - | - | - | 1件: 113 113 💬
|
446 | Adeno-associated virus serotype HU68 containing THE human galc gene | - | - | - | - | 1件: 19 19 💬
|
447 | Adeno-associated virus serotype RH.10 expressing BETA-galactosidase | - | - | - | - | 1件: 19 19 💬
|
448 | Adeno-associated virus serotype RH74 containing THE human delandistrogene moxeparvovec dystrophin gene | 1件: Delandistrogene moxeparvovec Delandistrogene moxeparvovec | 1件: Delandistrogene moxeparvovec
Delandistrogene moxeparvovec
💬
| 1件: DMD DMD 💬
| 5件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬 | 1件: 113 113 💬
|
449 | Adeno-associated virus serotype RH74 containing THE human micro- dystrophin gene | - | - | - | - | 1件: 113 113 💬
|
450 | Adeno-associated virus serotype RH74 containing THE human micro-dystrophin gene | - | - | - | - | 1件: 113 113 💬
|
451 | Adeno-associated virus type 2 vector encoding RAB escort protein 1 | - | - | - | - | 1件: 90 90 💬
|
452 | Adeno-associated virus-cftr vector | - | - | - | - | 1件: 299 299 💬
|
453 | Adenosine | 1件: Adenosine Adenosine | 1件: Adenosine
Adenosine
💬
| 4件: ADORA1 ADORA1, ADORA2A, ADORA2B, ADORA3 💬
| 13件: Alcoholism Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 13 13, 58, 65 💬
|
454 | Adenoviral vector-mediated gene transfer | - | - | - | - | 1件: 251 251 💬
|
455 | Adezunap | - | - | - | - | 1件: 13 13 💬
|
456 | Adherence counseling | - | - | - | - | 1件: 13 13 💬
|
457 | ADI-001 | - | - | - | - | 2件: 49 49, 51 💬
|
458 | Adipose derived mesenchymal stem cell | - | - | - | - | 1件: 3 3 💬
|
459 | Adipose derived mesenchymal stem cells | - | - | - | - | 1件: 86 86 💬
|
460 | Adipose derived stromal cells intravenously injected | - | - | - | - | 1件: 39 39 💬
|
461 | Adipose derived, autologous mesenchymal stem cells | - | - | - | - | 1件: 97 97 💬
|
462 | Adipose tissue biopsy | - | - | - | - | 1件: 77 77 💬
|
463 | Adipose tissue-derived mesenchymal stem cells | - | - | - | - | 1件: 97 97 💬
|
464 | Adipose tissue-derived mesenchymal stromal cells | - | - | - | - | 1件: 13 13 💬
|
465 | Adipose-derived stromal vascular fraction cells | - | - | - | - | 1件: 6 6 💬
|
466 | Adjunctive analgesics | - | - | - | - | 1件: 70 70 💬
|
467 | Adjunctive ANTI-depressants | - | - | - | - | 1件: 70 70 💬
|
468 | Adjuvant IM therapy | - | - | - | - | 1件: 19 19 💬
|
469 | Adjuvant immunomodulatory (IM) therapy | - | - | - | - | 1件: 19 19 💬
|
470 | Adjuvant without active component | - | - | - | - | 2件: 6 6, 17 💬
|
471 | ADL5859 | 1件: ADL5859 ADL5859 | - | - | - | 1件: 46 46 💬
|
472 | Administration KIT | - | - | - | - | 1件: 19 19 💬
|
473 | Administration OF A high dose OF desipramine | - | - | - | - | 1件: 156 156 💬
|
474 | Administration OF A LOW dose OF desipramine | - | - | - | - | 1件: 156 156 💬
|
475 | Administration OF AN ACE-inhibitor or NOT | - | - | - | - | 1件: 210 210 💬
|
476 | Administration OF carbidopa/levodopa | - | - | - | - | 2件: 6 6, 17 💬
|
477 | Administration OF drug (interferon-gamma 1-B) subcutaneously | - | - | - | - | 1件: 65 65 💬
|
478 | Administration OF methylprednisolone + prednisone + mycophenolate mofetil | - | - | - | - | 1件: 49 49 💬
|
479 | Administration OF methylprednisolone, paracetamol and dexchlorpheniramine | - | - | - | - | 1件: 49 49 💬
|
480 | Administration OF rituximab and methylprednisolone | - | - | - | - | 1件: 51 51 💬
|
481 | Admsc | 1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - | - | 2件: 51 51, 96 💬
|
482 | Adoport | - | - | - | - | 1件: 222 222 💬
|
483 | Adrabetadex | 1件: Adrabetadex Adrabetadex | - | - | - | 1件: 19 19 💬
|
484 | Adrenal aldosterone synthase (CYP11b2) staining | - | - | - | - | 1件: 75 75 💬
|
485 | Adrenal cortical hormone | - | - | - | - | 1件: 224 224 💬
|
486 | Adrenal cortisol synthase (CYP11b1) staining | - | - | - | - | 1件: 75 75 💬
|
487 | Adrenalina | - | - | - | - | 1件: 299 299 💬
|
488 | Adrenocorticotrophic hormone acth | - | - | - | - | 1件: 222 222 💬
|
489 | Adrenocorticotropic hormone | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 13 13, 84 💬
|
490 | Adrenocorticotropic hormone GEL | 1件: Corticotropin Corticotropin | 2件: Corticotropin
Corticotropin
,
Corticotropin, repository
💬
| 1件: MC2R MC2R 💬
| 6件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 50 50 💬
|
491 | Adrenocorticotropin hormone | - | - | - | - | 1件: 145 145 💬
|
492 | Adrenomedullin | 1件: Adrenomedullin Adrenomedullin | - | - | - | 3件: 96 96, 97, 124 💬
|
493 | Adrulipase | - | - | - | - | 1件: 299 299 💬
|
494 | ADS-001 | - | - | - | - | 1件: 231 231 💬
|
495 | ADS-5102 | - | - | - | - | 2件: 6 6, 13 💬
|
496 | ADS-5102, 137 MG | - | - | - | - | 1件: 13 13 💬
|
497 | ADS-5102, 274 MG | - | - | - | - | 1件: 13 13 💬
|
498 | Adsvf | - | - | - | - | 2件: 15 15, 96 💬
|
499 | Adsvf application IN THE right hand | - | - | - | - | 1件: 51 51 💬
|
500 | Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells | - | - | - | - | 1件: 47 47 💬
|
501 | Adult human mesenchymal stem cells | 1件: Remestemcel-L Remestemcel-L | 1件: Remestemcel-L
Remestemcel-L
💬
| - | - | 2件: 85 85, 96 💬
|
502 | Advagraf 0,5MG | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬
|
503 | Advagraf 1MG | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬
|
504 | Advagraf 5MG | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬
|
505 | Advagraf prolonged-release hard capsules | 1件: Tacrolimus Tacrolimus | 2件: Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 299 299 💬
|
506 | Advanced therapy | - | - | - | - | 1件: 97 97 💬
|
507 | Advanced therapy only without dietary intervention | - | - | - | - | 1件: 97 97 💬
|
508 | Advancement plasty | - | - | - | - | 1件: 96 96 💬
|
509 | Advate | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: Octocog alfa
Octocog alfa
💬
| 1件: F8 F8 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 💬
|
510 | Advate 1000 IU | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: Octocog alfa
Octocog alfa
💬
| 1件: F8 F8 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 💬
|
511 | Advate 1000 IU powder and solvent FOR solution FOR injection | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: Octocog alfa
Octocog alfa
💬
| 1件: F8 F8 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 💬
|
512 | Advate 1000IU powder and solvent FOR solution FOR injection | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: Octocog alfa
Octocog alfa
💬
| 1件: F8 F8 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 💬
|
513 | Advate 500 IU powder and solvent FOR solution FOR injection | 1件: Antihemophilic factor, human recombinant Antihemophilic factor, human recombinant | 1件: Octocog alfa
Octocog alfa
💬
| 1件: F8 F8 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 288 288 💬
|
514 | Adverse reactions OF gammagard subcutaneously AT week 12 | - | - | - | - | 1件: 65 65 💬
|
515 | Adverse reactions OF gammagard subcutaneously AT week 24 | - | - | - | - | 1件: 65 65 💬
|
516 | Adverse reactions OF gammagard subcutaneously AT week 36 | - | - | - | - | 1件: 65 65 💬
|
517 | Adverse reactions OF gammagard subdermally AT week 12 | - | - | - | - | 1件: 65 65 💬
|
518 | Adverse reactions OF gammagard subdermally AT week 24 | - | - | - | - | 1件: 65 65 💬
|
519 | Adverse reactions OF gammagard subdermally AT week 36 | - | - | - | - | 1件: 65 65 💬
|
520 | ADVM-043 | - | - | - | - | 1件: 231 231 💬
|
521 | ADX-038 | - | - | - | - | 1件: 62 62 💬
|
522 | ADX-097 | - | - | - | - | 1件: 66 66 💬
|
523 | ADX-2191 | - | - | - | - | 1件: 90 90 💬
|
524 | ADX-324 | - | - | - | - | 1件: 65 65 💬
|
525 | ADX-629 | - | - | - | - | 1件: 160 160 💬
|
526 | ADX48621 | - | - | - | - | 1件: 6 6 💬
|
527 | AEB071 | - | - | - | - | 1件: 97 97 💬
|
528 | AEB071A | - | - | - | - | 1件: 97 97 💬
|
529 | AED | - | - | - | - | 1件: 158 158 💬
|
530 | AEGR-733 | - | - | - | - | 1件: 79 79 💬
|
531 | AER-901 solution FOR nebulization | - | - | - | - | 1件: 86 86 💬
|
532 | AER002 | - | - | - | - | 1件: 299 299 💬
|
533 | AERO-RED 100 MG/ML gotas orales EN solucióN | - | - | - | - | 2件: 96 96, 97 💬
|
534 | Aerobic exercise | - | - | - | - | 2件: 46 46, 299 💬
|
535 | Aerobic exercises | - | - | - | - | 1件: 49 49 💬
|
536 | Aerobic training | - | - | - | - | 1件: 13 13 💬
|
537 | Aerolised liposomal ciclosporin A | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 💬
|
538 | Aerolised liposomal ciclosporin A 10MG | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 💬
|
539 | Aerolised liposomal ciclosporin A 5MG | 1件: Cyclosporine Cyclosporine | 1件: Cyclosporine
Cyclosporine
💬
| 5件: PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 228 228 💬
|
540 | Aeroquin | - | - | - | - | 1件: 299 299 💬
|
541 | Aerosol interferon-gamma | - | - | - | - | 1件: 85 85 💬
|
542 | Aerosolized human alpha-1 antitrypsin | - | - | - | - | 1件: 231 231 💬
|
543 | Aerosolized iloprost | - | - | - | - | 1件: 86 86 💬
|
544 | Aerosolized, human, plasma-derived alpha-1 antitrypsin | - | - | - | - | 1件: 299 299 💬
|
545 | Aerosoltherapy | - | - | - | - | 1件: 299 299 💬
|
546 | Aerovanc | - | - | - | - | 1件: 299 299 💬
|
547 | Aert, (R)-baclofen | - | - | - | - | 1件: 13 13 💬
|
548 | Aesculus hippocastanum / horse chestnut | - | - | - | - | 1件: 210 210 💬
|
549 | AF056 | - | - | - | - | 1件: 206 206 💬
|
550 | AF37702 injection | - | - | - | - | 1件: 283 283 💬
|
551 | AF37702, hematide | 1件: Peginesatide Peginesatide | 2件: Peginesatide
Peginesatide
,
Peginesatide acetate
💬
| 1件: EPOR EPOR 💬
| 7件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Efferocytosis, Hematopoietic cell lineage, Hormone signaling, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 283 283 💬
|
552 | Afamelanotide | 1件: Afamelanotide Afamelanotide | 2件: Afamelanotide
Afamelanotide
,
Afamelanotide acetate
💬
| 1件: MC1R MC1R 💬
| 3件: Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 2件: 159 159, 254 💬
|
553 | Afamelanotide 16 MG | 1件: Afamelanotide Afamelanotide | 2件: Afamelanotide
Afamelanotide
,
Afamelanotide acetate
💬
| 1件: MC1R MC1R 💬
| 3件: Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 1件: 254 254 💬
|
554 | Afamelanotide 16MG implant | 1件: Afamelanotide Afamelanotide | 2件: Afamelanotide
Afamelanotide
,
Afamelanotide acetate
💬
| 1件: MC1R MC1R 💬
| 3件: Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 1件: 254 254 💬
|
555 | Afamelanotide implant | 1件: Afamelanotide Afamelanotide | 2件: Afamelanotide
Afamelanotide
,
Afamelanotide acetate
💬
| 1件: MC1R MC1R 💬
| 3件: Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | 1件: 254 254 💬
|
556 | Afatinib | 1件: Afatinib Afatinib | 2件: Afatinib
Afatinib
,
Afatinib dimaleate
💬
| 3件: EGFR EGFR, ERBB2, ERBB4 💬
| 49件: Adherens junction Adherens junction, Amyotrophic lateral sclerosis, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction, Virion - Hepatitis viruses 💬 | 1件: 285 285 💬
|
557 | Afegostat tartrate | 1件: Afegostat Afegostat | 2件: Afegostat
Afegostat
,
Afegostat tartrate
💬
| - | - | 1件: 19 19 💬
|
558 | Affitope® PD01A | - | - | - | - | 1件: 6 6 💬
|
559 | Affitope® PD01A + adjuvant | - | - | - | - | 2件: 6 6, 17 💬
|
560 | Affitope® PD03A + adjuvant | - | - | - | - | 1件: 17 17 💬
|
561 | Aficamten | 1件: Aficamten Aficamten | 1件: Aficamten
Aficamten
💬
| 5件: MYH6_7 MYH6_7, MYH6_7, MYL2, MYL3, MYL4 💬
| 17件: Adherens junction Adherens junction, Adrenergic signaling in cardiomyocytes, Apelin signaling pathway, Cardiac muscle contraction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Focal adhesion, Hypertrophic cardiomyopathy, Leukocyte transendothelial migration, Motor proteins, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Viral myocarditis, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
562 | Afimetoran | 1件: Afimetoran Afimetoran | 1件: Afimetoran
Afimetoran
💬
| - | - | 1件: 49 49 💬
|
563 | Afinitor | 1件: Everolimus Everolimus | 1件: Everolimus
Everolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 3件: 34 34, 89, 158 💬
|
564 | Afinitor 5MG tablets | 1件: Everolimus Everolimus | 1件: Everolimus
Everolimus
💬
| 1件: MTOR MTOR 💬
| 49件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 2件: 89 89, 158 💬
|
565 | Aflibercept | 1件: Aflibercept Aflibercept | 1件: Aflibercept
Aflibercept
💬
| 3件: PGF PGF, VEGFA, VEGFB 💬
| 23件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 2件: 90 90, 166 💬
|
566 | AFQ056 | - | - | - | - | 3件: 6 6, 8, 206 💬
|
567 | AFQ056 with L-dopa | - | - | - | - | 1件: 6 6 💬
|
568 | AFQ065 | - | - | - | - | 1件: 6 6 💬
|
569 | After surgery FOR crohn'S disease, eligible patients will BE randomized 1:1 TO receive oral EXL01 | - | - | - | - | 1件: 96 96 💬
|
570 | Afucosylated IGG1 kappa monoclonal antibody | - | - | - | - | 1件: 300 300 💬
|
571 | AG011 | - | - | - | - | 1件: 97 97 💬
|
572 | AG011 - capsules | - | - | - | - | 1件: 97 97 💬
|
573 | AG011 - enema | - | - | - | - | 1件: 97 97 💬
|
574 | AG10 | - | - | - | - | 1件: 28 28 💬
|
575 | AG10 HCL | - | - | - | - | 1件: 28 28 💬
|
576 | AGA2115 | 1件: AGA2115 AGA2115 | - | - | - | 1件: 274 274 💬
|
577 | Agalsidase | - | - | - | - | 1件: 19 19 💬
|
578 | Agalsidase alfa | 1件: Agalsidase alfa Agalsidase alfa | 1件: Agalsidase alfa
Agalsidase alfa
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
579 | Agalsidase alpha | 1件: Agalsidase alfa Agalsidase alfa | 1件: Agalsidase alfa
Agalsidase alfa
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
580 | Agalsidase beta | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
581 | Agalsidase beta from biosidus 1 MG/KG | 1件: Agalsidase beta Agalsidase beta | 1件: Agalsidase beta
Agalsidase beta
💬
| 1件: GLA GLA 💬
| 5件: Galactose metabolism Galactose metabolism, Glycerolipid metabolism, Glycosphingolipid biosynthesis - globo and isoglobo series, Lysosome, Sphingolipid metabolism 💬 | 1件: 19 19 💬
|
582 | Agalsidasi alfa | - | - | - | - | 1件: 19 19 💬
|
583 | Agalsidasi beta | - | - | - | - | 1件: 19 19 💬
|
584 | Agamree | 1件: Vamorolone Vamorolone | 1件: Vamorolone
Vamorolone
💬
| 1件: NR3C1 NR3C1 💬
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 113 113 💬
|
585 | AGB101 | - | - | - | - | 1件: 6 6 💬
|
586 | Agee cream | - | - | - | - | 1件: 13 13 💬
|
587 | Agle 102 | - | - | - | - | 1件: 36 36 💬
|
588 | AGM 719 | - | - | - | - | 1件: 46 46 💬
|
589 | AGMB-129 | - | - | - | - | 1件: 96 96 💬
|
590 | AGMB-447 | - | - | - | - | 1件: 85 85 💬
|
591 | AGN 203818 | - | - | - | - | 1件: 226 226 💬
|
592 | Agomelatine or piacebo | 1件: Agomelatine Agomelatine | 1件: Agomelatine
Agomelatine
💬
| 3件: HTR2 HTR2, MTNR1A, MTNR1B 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 💬
|
593 | AGS-009 | - | - | - | - | 1件: 49 49 💬
|
594 | AGT-181 | - | - | - | - | 1件: 19 19 💬
|
595 | AGT-182 | 1件: AGT-182 AGT-182 | - | - | - | 1件: 19 19 💬
|
596 | AGTC-501 | 1件: Laruparetigene zovaparvovec Laruparetigene zovaparvovec | - | - | - | 1件: 90 90 💬
|
597 | Ahsc | - | - | - | - | 1件: 13 13 💬
|
598 | AI-1000 G2 | - | - | - | - | 1件: 46 46 💬
|
599 | Aidai score | - | - | - | - | 1件: 106 106 💬
|
600 | Aidsvax® B/E | - | - | - | - | 1件: 49 49 💬
|
601 | Aimspro | - | - | - | - | 2件: 13 13, 51 💬
|
602 | AIN | - | - | - | - | 1件: 13 13 💬
|
603 | AIN457 | - | - | - | - | 9件: 13 13, 37, 41, 46, 56, 96, 97, 107, 271 💬
|
604 | AIN457 150 MG | - | - | - | - | 1件: 271 271 💬
|
605 | AIN457, 150 MG | - | - | - | - | 1件: 271 271 💬
|
606 | AIN457, 150MG | - | - | - | - | 1件: 37 37 💬
|
607 | AIN457, 75 MG | - | - | - | - | 1件: 271 271 💬
|
608 | AIN457A | - | - | - | - | 1件: 271 271 💬
|
609 | AIN457F | - | - | - | - | 3件: 46 46, 107, 271 💬
|
610 | AIR | - | - | - | - | 2件: 85 85, 97 💬
|
611 | AIR - oxygen | 1件: Oxygen Oxygen | 1件: Oxygen
Oxygen
💬
| - | - | 1件: 299 299 💬
|
612 | AIR dnase | - | - | - | - | 1件: 299 299 💬
|
613 | AIR insufflation insertion | - | - | - | - | 1件: 97 97 💬
|
614 | AIR venous plethysmography | - | - | - | - | 1件: 58 58 💬
|
615 | AIR001 | - | - | - | - | 1件: 86 86 💬
|
616 | AIR001 inhalation solution | - | - | - | - | 1件: 86 86 💬
|
617 | AIRE-2 portable breath analyzer | - | - | - | - | 1件: 97 97 💬
|
618 | Airway clearance technique | - | - | - | - | 1件: 299 299 💬
|
619 | AJ201 | - | - | - | - | 1件: 1 1 💬
|
620 | AJM300 | - | - | - | - | 1件: 97 97 💬
|
621 | AK002 | - | - | - | - | 1件: 98 98 💬
|
622 | AK101 IV/AK101 SC | - | - | - | - | 1件: 97 97 💬
|
623 | AK102 | - | - | - | - | 1件: 79 79 💬
|
624 | AK106-001616 | 1件: AK106-001616 AK106-001616 | - | - | - | 1件: 46 46 💬
|
625 | AK111 | - | - | - | - | 1件: 271 271 💬
|
626 | AK1320 MS | - | - | - | - | 1件: 70 70 💬
|
627 | AKBM-3031 | - | - | - | - | 1件: 49 49 💬
|
628 | Akcea-angptl3-LRX | - | - | - | - | 2件: 79 79, 265 💬
|
629 | Aknemin 50 | - | - | - | - | 1件: 201 201 💬
|
630 | AKR-501, YM-477 | - | - | - | - | 1件: 63 63 💬
|
631 | AKST4290 | - | - | - | - | 2件: 6 6, 162 💬
|
632 | AL-108 | - | - | - | - | 3件: 5 5, 7, 127 💬
|
633 | AL001 | 1件: Latozinemab Latozinemab | 1件: Latozinemab
Latozinemab
💬
| 1件: SORT1 SORT1 💬
| 3件: Cholesterol metabolism Cholesterol metabolism, Lysosome, Neurotrophin signaling pathway 💬 | 2件: 2 2, 127 💬
|
634 | AL01211 | - | - | - | - | 2件: 19 19, 67 💬
|
635 | AL2846 capsules | - | - | - | - | 1件: 34 34 💬
|
636 | ALA | - | - | - | - | 1件: 286 286 💬
|
637 | Alac, inulin, FOS, and sodium butyrate | 1件: Butyric Acid Butyric Acid | 1件: Sodium butyrate
Sodium butyrate
💬
| - | - | 1件: 156 156 💬
|
638 | Alanine | 1件: Alanine Alanine | 1件: Alanine
Alanine
💬
| - | - | 3件: 70 70, 94, 298 💬
|
639 | Albendazole | 1件: Albendazole Albendazole | 1件: Albendazole
Albendazole
💬
| - | - | 1件: 96 96 💬
|
640 | Albumin | - | - | - | - | 3件: 2 2, 20, 51 💬
|
641 | Albumin solution | - | - | - | - | 1件: 20 20 💬
|
642 | Albumine humaine | - | - | - | - | 1件: 96 96 💬
|
643 | Albuterol | 1件: Albuterol Albuterol | 2件: Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 12 12, 13, 86, 113, 231, 256, 299, 340 💬
|
644 | Albuterol inhaler | 1件: Albuterol Albuterol | 2件: Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 89 89 💬
|
645 | Albuterol nebulizer | 1件: Albuterol Albuterol | 2件: Albuterol sulfate
Albuterol sulfate
,
Albuterol
💬
| 1件: ADRB2 ADRB2 💬
| 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 89 89 💬
|
646 | ALBúmina humana | - | - | - | - | 1件: 2 2 💬
|
647 | Alcohol | 1件: Ethanol Ethanol | 3件: Alcohol
Alcohol
,
Isopropanol and methylated alcohol
,
Ethanol
💬
| - | - | 1件: 285 285 💬
|
648 | Alcohol intake | 1件: Ethanol Ethanol | 3件: Alcohol
Alcohol
,
Isopropanol and methylated alcohol
,
Ethanol
💬
| - | - | 1件: 46 46 💬
|
649 | Alcohol septal ablation | 1件: Ethanol Ethanol | 3件: Alcohol
Alcohol
,
Isopropanol and methylated alcohol
,
Ethanol
💬
| - | - | 1件: 58 58 💬
|
650 | Alcohol wipes VS. NO alcohol wipes | 1件: Ethanol Ethanol | 3件: Alcohol
Alcohol
,
Isopropanol and methylated alcohol
,
Ethanol
💬
| - | - | 1件: 13 13 💬
|
651 | Alcoholic drink | - | - | - | - | 1件: 6 6 💬
|
652 | ALD518 | - | - | - | - | 1件: 46 46 💬
|
653 | Aldafermin | 1件: Aldafermin Aldafermin | 1件: Aldafermin
Aldafermin
💬
| 1件: FGF19 FGF19 💬
| 10件: Breast cancer Breast cancer, Calcium signaling pathway, Gastric cancer, MAPK signaling pathway, Melanoma, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton 💬 | 1件: 94 94 💬
|
654 | Aldesleuchina | - | - | - | - | 1件: 49 49 💬
|
655 | Aldesleukin | 1件: Aldesleukin Aldesleukin | 1件: Aldesleukin
Aldesleukin
💬
| 3件: IL2RA IL2RA, IL2RB, IL2RG 💬
| 14件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 5件: 2 2, 49, 65, 96, 97 💬
|
656 | Aldosterone | 1件: Aldosterone Aldosterone | 1件: Aldosterone
Aldosterone
💬
| 1件: NR3C2 NR3C2 💬
| 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 1件: 222 222 💬
|
657 | Aldurazyme | 1件: Laronidase Laronidase | 1件: Laronidase
Laronidase
💬
| 1件: IDUA IDUA 💬
| 2件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome 💬 | 2件: 19 19, 256 💬
|
658 | Aldurazyme*infus 1FL 5ML 500U | 1件: Laronidase Laronidase | 1件: Laronidase
Laronidase
💬
| 1件: IDUA IDUA 💬
| 2件: Glycosaminoglycan degradation Glycosaminoglycan degradation, Lysosome 💬 | 1件: 19 19 💬
|
659 | ALE.F02 | - | - | - | - | 1件: 220 220 💬
|
660 | Aleeto | - | - | - | - | 2件: 2 2, 17 💬
|
661 | Alefacept | 1件: Alefacept Alefacept | 1件: Alefacept
Alefacept
💬
| 1件: CD58 CD58 💬
| 2件: Cell adhesion molecules Cell adhesion molecules, Epstein-Barr virus infection 💬 | 6件: 37 37, 60, 65, 164, 284, 285 💬
|
662 | Alemtuzumab | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 18件: 13 13, 15, 19, 20, 36, 43, 44, 46, 51, 60, 65, 85, 96, 107, 283, 284, 285, 326 💬
|
663 | Alemtuzumab (already received BY alemtuzumab cohort between 1991 and 1994 | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 46 46 💬
|
664 | Alemtuzumab 0.2 MG | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 2件: 65 65, 164 💬
|
665 | Alemtuzumab 0.3 MG | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 2件: 65 65, 164 💬
|
666 | Alemtuzumab 12 MG | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
667 | Alemtuzumab 24 MG | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
668 | Alemtuzumab and rituximab | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 60 60 💬
|
669 | Alemtuzumab GZ402673 | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
670 | Alemtuzumab immunotherapy | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
671 | Alemtuzumab injection | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 13 13 💬
|
672 | Alemtuzumab, rituximab | 1件: Alemtuzumab Alemtuzumab | 1件: Alemtuzumab
Alemtuzumab
💬
| - | - | 1件: 63 63 💬
|
673 | Alendronat teva | - | - | - | - | 1件: 46 46 💬
|
674 | Alendronate | 1件: Alendronic acid Alendronic acid | 2件: Alendronate sodium
Alendronate sodium
,
Alendronic acid
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 6件: 41 41, 46, 50, 271, 274, 299 💬
|
675 | Alendronate sodium | 1件: Alendronic acid Alendronic acid | 2件: Alendronate sodium
Alendronate sodium
,
Alendronic acid
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 2件: 19 19, 299 💬
|
676 | Alendronic acid | 1件: Alendronic acid Alendronic acid | 2件: Alendronate sodium
Alendronate sodium
,
Alendronic acid
💬
| 1件: FDPS FDPS 💬
| 3件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | 2件: 46 46, 274 💬
|
677 | Alequel | - | - | - | - | 2件: 96 96, 97 💬
|
678 | Alesse | - | - | - | - | 1件: 77 77 💬
|
679 | ALFA-manosidadas humana recombinante | - | - | - | - | 1件: 19 19 💬
|
680 | ALFA-tocotrienolo chinone | - | - | - | - | 1件: 21 21 💬
|
681 | Alfacalcidol | 1件: Alfacalcidol Alfacalcidol | 1件: Alfacalcidol
Alfacalcidol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 7件: 41 41, 46, 50, 96, 107, 235, 238 💬
|
682 | Alfacalcidol 2 micrograms/ML | 1件: Alfacalcidol Alfacalcidol | 1件: Alfacalcidol
Alfacalcidol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 2件: 50 50, 107 💬
|
683 | Alfacalcidol tablets | 1件: Alfacalcidol Alfacalcidol | 1件: Alfacalcidol
Alfacalcidol
💬
| 1件: VDR VDR 💬
| 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 46 46 💬
|
684 | Alfuzosin | 1件: Alfuzosin Alfuzosin | 2件: Alfuzosin hydrochloride
Alfuzosin hydrochloride
,
Alfuzosin
💬
| 1件: ADRA1A ADRA1A 💬
| 9件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 13 13 💬
|
685 | Alga dunaliella bardawil | - | - | - | - | 1件: 90 90 💬
|
686 | Alga dunaliella bardawil powder | - | - | - | - | 1件: 90 90 💬
|
687 | Alga dunaliella bardawill | - | - | - | - | 1件: 90 90 💬
|
688 | Algin | 1件: Alginic acid Alginic acid | 2件: Alginic acid
Alginic acid
,
Sodium alginate
💬
| - | - | 1件: 97 97 💬
|
689 | Alginate | 1件: Alginic acid Alginic acid | 2件: Alginic acid
Alginic acid
,
Sodium alginate
💬
| - | - | 1件: 53 53 💬
|
690 | Alginate oligosaccharide | 1件: Alginic acid Alginic acid | 2件: Alginic acid
Alginic acid
,
Sodium alginate
💬
| - | - | 1件: 299 299 💬
|
691 | Alginic acid | 1件: Alginic acid Alginic acid | 2件: Alginic acid
Alginic acid
,
Sodium alginate
💬
| - | - | 1件: 51 51 💬
|
692 | Alglucosidase alfa | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
693 | Alglucosidase alfa GZ419829 | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
694 | Alglucosidase alfa or avalglucosidase alfa | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
695 | Alglucosidase alpha | - | - | - | - | 1件: 256 256 💬
|
696 | Alglucosidasi alfa umana ricombinante | - | - | - | - | 1件: 256 256 💬
|
697 | Algucosidase alfa 20 MG/KG once every 4 weeks instead OF once every 2 weeks | - | - | - | - | 1件: 256 256 💬
|
698 | Alicaforsen | 1件: Alicaforsen Alicaforsen | 1件: Alicaforsen sodium
Alicaforsen sodium
💬
| 1件: ICAM1 ICAM1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Cell adhesion molecules, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, Human T-cell leukemia virus 1 infection, Influenza A, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Rheumatoid arthritis, Staphylococcus aureus infection, TNF signaling pathway, Viral myocarditis 💬 | 2件: 96 96, 97 💬
|
699 | Alirocumab | 1件: Alirocumab Alirocumab | 1件: Alirocumab
Alirocumab
💬
| 1件: PCSK9 PCSK9 💬
| 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 💬
|
700 | Aliskiren | 1件: Aliskiren Aliskiren | 2件: Aliskiren
Aliskiren
,
Aliskiren fumarate
💬
| 1件: REN REN 💬
| 3件: Diabetic cardiomyopathy Diabetic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | 3件: 66 66, 167, 222 💬
|
701 | Alitretinoin | 1件: Alitretinoin Alitretinoin | 1件: Alitretinoin
Alitretinoin
💬
| 5件: RARA RARA, RARB, RXRA, RXRB, RXRG 💬
| 20件: Acute myeloid leukemia Acute myeloid leukemia, Adipocytokine signaling pathway, Bile secretion, Chemical carcinogenesis - receptor activation, Efferocytosis, Estrogen signaling pathway, Gastric cancer, Hepatitis C, Lipid and atherosclerosis, Non-alcoholic fatty liver disease, Non-small cell lung cancer, PI3K-Akt signaling pathway, PPAR signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thyroid cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer 💬 | 1件: 49 49 💬
|
702 | Alivecor kardiamobile 6-lead ECG | - | - | - | - | 1件: 58 58 💬
|
703 | ALK-001 | - | - | - | - | 1件: 301 301 💬
|
704 | Alkaline phosphatase | 1件: Alkaline Phosphatase Alkaline Phosphatase | - | - | - | 3件: 46 46, 93, 97 💬
|
705 | Alkalinized lidocaine-heparin | - | - | - | - | 1件: 226 226 💬
|
706 | Alkeran | 1件: Melphalan Melphalan | 2件: Melphalan
Melphalan
,
Melphalan hydrochloride
💬
| - | - | 2件: 28 28, 60 💬
|
707 | Alks 8700 | - | - | - | - | 1件: 13 13 💬
|
708 | Alks 8700 delayed release (DR) capsule | - | - | - | - | 1件: 13 13 💬
|
709 | ALL patients IN THE study will BE treated with ocrelizumab | - | - | - | - | 1件: 13 13 💬
|
710 | ALL subjects will receive maraviroc 300MG orally twice A DAY FOR 6 weeks | - | - | - | - | 1件: 84 84 💬
|
711 | ALL-P-AMBO-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-P-thioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidine | - | - | - | - | 1件: 2 2 💬
|
712 | ALL-trans retinoic acid | 1件: Tretinoin Tretinoin | 1件: Tretinoin
Tretinoin
💬
| 3件: PML PML, RARA, RARB 💬
| 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 94 94 💬
|
713 | ALL-trans-retinoid acid | - | - | - | - | 1件: 63 63 💬
|
714 | Allantoin | 1件: Allantoin Allantoin | 1件: Allantoin
Allantoin
💬
| - | - | 1件: 36 36 💬
|
715 | Allantoina | - | - | - | - | 1件: 36 36 💬
|
716 | ALLN-177 | - | - | - | - | 1件: 234 234 💬
|
717 | Allo BMT | - | - | - | - | 1件: 65 65 💬
|
718 | ALLO-APZ2-EB | 1件: Skin-derived ABCB5-positive Mesenchymal Stem cells Skin-derived ABCB5-positive Mesenchymal Stem cells | - | - | - | 1件: 36 36 💬
|
719 | ALLO-APZ2-OTS | - | - | - | - | 1件: 36 36 💬
|
720 | ALLO-ASC | - | - | - | - | 1件: 96 96 💬
|
721 | ALLO-ASC-CD | - | - | - | - | 1件: 96 96 💬
|
722 | ALLO-ASC-DFU | - | - | - | - | 1件: 36 36 💬
|
723 | ALLO-ASC-sheet | - | - | - | - | 1件: 36 36 💬
|
724 | ALLO-hmscs | - | - | - | - | 2件: 211 211, 299 💬
|
725 | ALLO-hsct | - | - | - | - | 1件: 20 20 💬
|
726 | Alloex | - | - | - | - | 1件: 6 6 💬
|
727 | Allogen-LI | - | - | - | - | 1件: 70 70 💬
|
728 | Allogeneic adipose tissue-derived mesenchymal stem cells | - | - | - | - | 1件: 97 97 💬
|
729 | Allogeneic adipose tissue-derived mesenchymal stem cells expanded | - | - | - | - | 3件: 38 38, 96, 162 💬
|
730 | Allogeneic adipose tissue-derived MSC | - | - | - | - | 1件: 36 36 💬
|
731 | Allogeneic bone marrow derived human mesenchymal stem cells | 1件: Allogenic bone marrow-derived mesenchymal stem cells Allogenic bone marrow-derived mesenchymal stem cells | - | - | - | 1件: 96 96 💬
|
732 | Allogeneic bone marrow transplant | - | - | - | - | 1件: 49 49 💬
|
733 | Allogeneic bone marrow transplantation | - | - | - | - | 8件: 60 60, 62, 65, 96, 164, 284, 285, 286 💬
|
734 | Allogeneic bone marrow-derived mesenchymal stem cells | - | - | - | - | 1件: 6 6 💬
|
735 | Allogeneic bone marrow-derived mesenchymal stromal cells | 1件: Allogenic bone marrow-derived mesenchymal stem cells Allogenic bone marrow-derived mesenchymal stem cells | - | - | - | 1件: 97 97 💬
|
736 | Allogeneic cardiosphere-derived cells | 1件: Allogeneic Cardiosphere-Derived Cells Allogeneic Cardiosphere-Derived Cells | - | - | - | 1件: 113 113 💬
|
737 | Allogeneic donor derived B-lymphocytes | - | - | - | - | 1件: 60 60 💬
|
738 | Allogeneic embryonic stem CELL-derived ventral midbrain dopaminergic progenitor cells | - | - | - | - | 1件: 6 6 💬
|
739 | Allogeneic fecal microbiota | - | - | - | - | 1件: 13 13 💬
|
740 | Allogeneic hematopoietic stem cell transplantation | - | - | - | - | 8件: 28 28, 51, 60, 62, 65, 164, 284, 285 💬
|
741 | Allogeneic hematopoietic stem cell transplantation stem cell source only bone marrow | - | - | - | - | 1件: 60 60 💬
|
742 | Allogeneic hope biosciences adipose-derived mesenchymal stem cells | - | - | - | - | 1件: 107 107 💬
|
743 | Allogeneic HSC | - | - | - | - | 1件: 65 65 💬
|
744 | Allogeneic hsct | - | - | - | - | 1件: 65 65 💬
|
745 | Allogeneic human cardiosphere-derived stem cells | - | - | - | - | 1件: 86 86 💬
|
746 | Allogeneic human umbilical cord tissue-derived mesenchymal stem cells | - | - | - | - | 1件: 13 13 💬
|
747 | Allogeneic mesenchymal precursor cells | - | - | - | - | 1件: 46 46 💬
|
748 | Allogeneic mesenchymal stem cell transplantation | - | - | - | - | 1件: 171 171 💬
|
749 | Allogeneic mesenchymal stem cells | - | - | - | - | 1件: 47 47 💬
|
750 | Allogeneic mesenchymal stromal cells | - | - | - | - | 1件: 36 36 💬
|
751 | Allogeneic mesenchymal stromal cells derived from THE umbilical cord | - | - | - | - | 1件: 49 49 💬
|
752 | Allogeneic neural retina-derived human neural retinal progenitor cells EX vivo expanded | - | - | - | - | 1件: 90 90 💬
|
753 | Allogeneic peripheral blood stem cell | - | - | - | - | 1件: 65 65 💬
|
754 | Allogeneic SKIN-derived ABCB5-positive mesenchymal stem cells | 1件: Skin-derived ABCB5-positive Mesenchymal Stem cells Skin-derived ABCB5-positive Mesenchymal Stem cells | - | - | - | 1件: 36 36 💬
|
755 | Allogeneic stem cell therapy | - | - | - | - | 1件: 96 96 💬
|
756 | Allogeneic stem cell transplant | - | - | - | - | 3件: 53 53, 56, 60 💬
|
757 | Allogeneic stem cell transplantation | - | - | - | - | 5件: 19 19, 20, 49, 62, 84 💬
|
758 | Allogeneic umbilical cord mesenchymal stem cell and adipose secretome implantation | - | - | - | - | 1件: 17 17 💬
|
759 | Allogeneic umbilical cord mesenchymal stem cell implantation | - | - | - | - | 1件: 17 17 💬
|
760 | Allogeneic umbilical cord mesenchymal stem cells | 1件: Allogeneic umbilical cord mesenchymal stem cells Allogeneic umbilical cord mesenchymal stem cells | - | - | - | 1件: 13 13 💬
|
761 | Allogenic eascs 5 milion cells/ML suspension FOR injection. CX601 | - | - | - | - | 1件: 96 96 💬
|
762 | Allogenic eascs 5 million cells/ML suspension FOR injection CX601 | - | - | - | - | 1件: 96 96 💬
|
763 | Allogenic eascs 5 million cells/ML suspension FOR injection. CX601 | - | - | - | - | 1件: 96 96 💬
|
764 | Allogenic embryonic stem CELL-derived A9 dopamine progenitor cell (A9-DPC) high dose | - | - | - | - | 1件: 6 6 💬
|
765 | Allogenic embryonic stem CELL-derived A9 dopamine progenitor cell (A9-DPC) LOW dose | - | - | - | - | 1件: 6 6 💬
|
766 | Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_high dose | - | - | - | - | 1件: 6 6 💬
|
767 | Allogenic embryonic stem cellderived A9 dopamine progenitor cell (A9-DPC)_low dose | - | - | - | - | 1件: 6 6 💬
|
768 | Allogenic human heterologous liver cells | - | - | - | - | 1件: 251 251 💬
|
769 | Allogenic mesenchymal stem cell isolated from adipose tissue | - | - | - | - | 3件: 38 38, 96, 162 💬
|
770 | Allogenic mesenchymal stromal cells | - | - | - | - | 1件: 36 36 💬
|
771 | Allogenic parathyroid cells | - | - | - | - | 1件: 235 235 💬
|
772 | Allogenic placenta derived mesenchymal stem cells | - | - | - | - | 1件: 13 13 💬
|
773 | Allogenic stem cell transplantation | - | - | - | - | 1件: 60 60 💬
|
774 | Allograft | - | - | - | - | 1件: 70 70 💬
|
775 | Allopregnanolone | 1件: Brexanolone Brexanolone | 1件: Brexanolone
Brexanolone
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 6 6, 205 💬
|
776 | Allopurinol | 1件: Allopurinol Allopurinol | 2件: Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 7件: 6 6, 46, 57, 60, 66, 96, 97 💬
|
777 | Allopurinol sandoz 100 MG, tabletten | 1件: Allopurinol Allopurinol | 2件: Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 1件: 96 96 💬
|
778 | Allopurinol sodium | 1件: Allopurinol Allopurinol | 2件: Allopurinol
Allopurinol
,
Allopurinol sodium
💬
| 1件: XDH XDH 💬
| 4件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Peroxisome, Purine metabolism 💬 | 2件: 96 96, 97 💬
|
779 | Allorx | - | - | - | - | 8件: 2 2, 13, 46, 51, 85, 90, 97, 226 💬
|
780 | ALN-51547 | - | - | - | - | 1件: 28 28 💬
|
781 | ALN-60212 | - | - | - | - | 1件: 79 79 💬
|
782 | ALN-60519 | - | - | - | - | 1件: 254 254 💬
|
783 | ALN-61444 | - | - | - | - | 1件: 231 231 💬
|
784 | ALN-62643 | - | - | - | - | 1件: 62 62 💬
|
785 | ALN-65492 | - | - | - | - | 1件: 28 28 💬
|
786 | ALN-65585 | - | - | - | - | 1件: 234 234 💬
|
787 | ALN-77412 | - | - | - | - | 1件: 231 231 💬
|
788 | ALN-AAT | - | - | - | - | 1件: 231 231 💬
|
789 | ALN-AAT02 | - | - | - | - | 1件: 231 231 💬
|
790 | ALN-AS1 | - | - | - | - | 1件: 254 254 💬
|
791 | ALN-CC5 | - | - | - | - | 4件: 11 11, 62, 66, 109 💬
|
792 | ALN-GO1 | - | - | - | - | 1件: 234 234 💬
|
793 | ALN-HTT02 | - | - | - | - | 1件: 8 8 💬
|
794 | ALN-pcssc | 1件: Inclisiran Inclisiran | 2件: Inclisiran
Inclisiran
,
Inclisiran sodium
💬
| 1件: PCSK9 PCSK9 💬
| 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 💬
|
795 | ALN-SOD | - | - | - | - | 1件: 2 2 💬
|
796 | ALN-TTR02 | - | - | - | - | 1件: 28 28 💬
|
797 | ALN-ttrsc | - | - | - | - | 1件: 28 28 💬
|
798 | ALN-ttrsc02 | - | - | - | - | 1件: 28 28 💬
|
799 | Aloasc | - | - | - | - | 1件: 97 97 💬
|
800 | Aloe barbadensis miller | 1件: Aloe vera leaf Aloe vera leaf | 1件: Aloe
Aloe
💬
| - | - | 1件: 97 97 💬
|
801 | Aloe vera GEL | 1件: Aloe vera leaf Aloe vera leaf | 1件: Aloe
Aloe
💬
| - | - | 1件: 97 97 💬
|
802 | Alofisel | 1件: Darvadstrocel Darvadstrocel | 1件: Darvadstrocel
Darvadstrocel
💬
| - | - | 1件: 96 96 💬
|
803 | Alogabat | 1件: Alogabat Alogabat | 1件: Alogabat
Alogabat
💬
| 1件: GABRA GABRA 💬
| 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Taste transduction 💬 | 1件: 201 201 💬
|
804 | Alovudine | 1件: Alovudine Alovudine | 1件: Alovudine
Alovudine
💬
| - | - | 1件: 6 6 💬
|
805 | Alpelisib | 1件: Alpelisib Alpelisib | 1件: Alpelisib
Alpelisib
💬
| 1件: PIK3CA_B_D PIK3CA_B_D 💬
| 103件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬 | 4件: 138 138, 278, 279, 280 💬
|
806 | Alpha 1-antitrypsin | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | 1件: alpha 1-Antitrypsin
alpha 1-Antitrypsin
💬
| 1件: SERPINA1 SERPINA1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 231 231, 298 💬
|
807 | Alpha 1-proteinase inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | 1件: alpha 1-Antitrypsin
alpha 1-Antitrypsin
💬
| 1件: SERPINA1 SERPINA1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 231 231 💬
|
808 | Alpha beta depletion | - | - | - | - | 2件: 60 60, 284 💬
|
809 | Alpha interferon | - | - | - | - | 1件: 56 56 💬
|
810 | Alpha lipoic acid | - | - | - | - | 1件: 13 13 💬
|
811 | Alpha-1 antitrypsin (AAT) | - | - | - | - | 1件: 231 231 💬
|
812 | Alpha-1 HC 100 MG | - | - | - | - | 1件: 299 299 💬
|
813 | Alpha-1 HC 200 MG | - | - | - | - | 1件: 299 299 💬
|
814 | Alpha-1 MP | - | - | - | - | 1件: 231 231 💬
|
815 | Alpha-1-antitrypsin | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | 1件: alpha 1-Antitrypsin
alpha 1-Antitrypsin
💬
| 1件: SERPINA1 SERPINA1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 231 231 💬
|
816 | Alpha-2C AR antagonist | - | - | - | - | 1件: 51 51 💬
|
817 | Alpha-ethylchenodeoxycholic acid (6-edca), OCA, INT-747 | - | - | - | - | 1件: 93 93 💬
|
818 | Alpha-glucosidase | 1件: Alglucosidase alfa Alglucosidase alfa | 1件: Alglucosidase alfa
Alglucosidase alfa
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
819 | Alpha-lipoic acid | - | - | - | - | 2件: 2 2, 13 💬
|
820 | Alpha-lipoic acid and L-acetyl carnitine | - | - | - | - | 1件: 5 5 💬
|
821 | Alpha-proteinase inhibitor | - | - | - | - | 1件: 98 98 💬
|
822 | Alpha-tocopherol | 1件: Vitamin E Vitamin E | 1件: Vitamin E
Vitamin E
💬
| - | - | 2件: 49 49, 206 💬
|
823 | Alpha-tocotrienol quinone | 1件: Vatiquinone Vatiquinone | 1件: Vatiquinone
Vatiquinone
💬
| - | - | 3件: 18 18, 21, 156 💬
|
824 | Alpha-tocotrienolquinone | - | - | - | - | 1件: 18 18 💬
|
825 | Alpha1-antitrypsin | - | - | - | - | 1件: 13 13 💬
|
826 | Alpha1-proteinase inhibitor | 1件: Alpha-1-proteinase inhibitor Alpha-1-proteinase inhibitor | 1件: alpha 1-Antitrypsin
alpha 1-Antitrypsin
💬
| 1件: SERPINA1 SERPINA1 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 231 231, 299 💬
|
827 | Alphanate | 3件: Antihemophilic factor human Antihemophilic factor human, Beroctocog alfa, Von Willebrand factor human | - | - | - | 1件: 288 288 💬
|
828 | Alphanate SD/HT | - | - | - | - | 1件: 288 288 💬
|
829 | Alphanate*INF 1F 1000UI+F 10ML | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 💬
|
830 | Alphanate*INF 1F 1500UI+F 10ML | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 💬
|
831 | Alphanate*INF 1F 250UI+F 5ML | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 💬
|
832 | Alphanate*INF 1F 500UI+F 5ML | 1件: Beroctocog alfa Beroctocog alfa | - | - | - | 1件: 288 288 💬
|
833 | ALPN-101 | - | - | - | - | 1件: 49 49 💬
|
834 | Alprazolam | 1件: Alprazolam Alprazolam | 1件: Alprazolam
Alprazolam
💬
| 16件: GABRA GABRA, GABRA, GABRA, GABRA, GABRA, GABRA, GABRB, GABRB, GABRB, GABRD, GABRE, GABRG, GABRG, GABRG, GABRP, GABRQ 💬
| 8件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 2件: 8 8, 75 💬
|
835 | Alprostadil | 1件: Alprostadil Alprostadil | 1件: Alprostadil
Alprostadil
💬
| 1件: PTGER1 PTGER1 💬
| 4件: Calcium signaling pathway Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬 | 2件: 51 51, 70 💬
|
836 | ALS patients epidemiological caracterization | - | - | - | - | 1件: 2 2 💬
|
837 | ALS patients genetic characterization | - | - | - | - | 1件: 2 2 💬
|
838 | Also referred TO AS 'MEDI2070' | - | - | - | - | 1件: 97 97 💬
|
839 | Also referred TO AS MED2070 | - | - | - | - | 1件: 96 96 💬
|
840 | Also referred TO AS MEDI2070 | - | - | - | - | 2件: 96 96, 97 💬
|
841 | ALTB-168 | - | - | - | - | 1件: 97 97 💬
|
842 | ALTB-268 | - | - | - | - | 1件: 97 97 💬
|
843 | Alternating, 10 SEC HIGH-frequency, 10 SEC LOW-frequency stimulation | - | - | - | - | 1件: 6 6 💬
|
844 | Alternating, 10 SEC HIGH-frequency, 50 SEC LOW-frequency stimulation | - | - | - | - | 1件: 6 6 💬
|
845 | Alternating, 50 SEC HIGH-frequency, 10 SEC LOW-frequency stimulation | - | - | - | - | 1件: 6 6 💬
|
846 | Alternating, 50 SEC HIGH-frequency, 50 SEC LOW-frequency stimulation | - | - | - | - | 1件: 6 6 💬
|
847 | Alternative osteoporosis medications | - | - | - | - | 1件: 274 274 💬
|
848 | ALTH12-1:4 | - | - | - | - | 1件: 97 97 💬
|
849 | ALTH12-2:4 | - | - | - | - | 1件: 97 97 💬
|
850 | Altri farmaci DEL sistema nervoso | - | - | - | - | 1件: 13 13 💬
|
851 | Altropane | 1件: Altropane Altropane | - | - | - | 1件: 6 6 💬
|
852 | Altropane (123I) injection | 1件: Altropane Altropane | - | - | - | 1件: 6 6 💬
|
853 | ALTU-135 | 1件: ALTU-135 ALTU-135 | - | - | - | 1件: 299 299 💬
|
854 | Altus-135 | - | - | - | - | 1件: 299 299 💬
|
855 | Alvarez 2 | - | - | - | - | 1件: 37 37 💬
|
856 | Alvelestat | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 💬
|
857 | Alvelestat oral tablet - dose 1 | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 💬
|
858 | Alvelestat oral tablet - dose 2 | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 💬
|
859 | Alvelestat tosylate | 1件: Alvelestat Alvelestat | - | - | - | 1件: 231 231 💬
|
860 | Alwextin cream | - | - | - | - | 1件: 36 36 💬
|
861 | ALX-0061 | - | - | - | - | 2件: 46 46, 49 💬
|
862 | ALX-0061 150 MG/ML | - | - | - | - | 1件: 49 49 💬
|
863 | ALX-0061 nanobody | - | - | - | - | 1件: 46 46 💬
|
864 | ALX-0081 | - | - | - | - | 1件: 64 64 💬
|
865 | ALX-009 | 1件: ALX-009 ALX-009 | - | - | - | 1件: 299 299 💬
|
866 | ALX-0600 | - | - | - | - | 1件: 96 96 💬
|
867 | ALX0081 | - | - | - | - | 1件: 64 64 💬
|
868 | ALXN1102 | - | - | - | - | 1件: 62 62 💬
|
869 | ALXN1103 | - | - | - | - | 1件: 62 62 💬
|
870 | ALXN1210 | - | - | - | - | 7件: 2 2, 11, 13, 50, 62, 66, 109 💬
|
871 | ALXN1720 | - | - | - | - | 1件: 11 11 💬
|
872 | ALXN1830 | - | - | - | - | 3件: 11 11, 35, 61 💬
|
873 | ALXN1840 | - | - | - | - | 1件: 171 171 💬
|
874 | ALXN1850 | - | - | - | - | 1件: 172 172 💬
|
875 | ALXN2040 | - | - | - | - | 1件: 62 62 💬
|
876 | ALXN2050 | - | - | - | - | 3件: 11 11, 62, 66 💬
|
877 | AM-01 | - | - | - | - | 1件: 51 51 💬
|
878 | Amantadin-ratiopharm 100MG | - | - | - | - | 1件: 6 6 💬
|
879 | Amantadine | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 4件: 6 6, 8, 13, 127 💬
|
880 | Amantadine 300 MG | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
881 | Amantadine HCL ER | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
882 | Amantadine HCL extended release | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
883 | Amantadine HCL extended release capsule | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
884 | Amantadine hydrochloride | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 6 6, 13 💬
|
885 | Amantadine hydrochloride 100 MG (milligrams) oral capsule | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
886 | Amantadine hydrochloride oral solution | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 2 2 💬
|
887 | Amantadine level | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
888 | Amantadine sulfate | 1件: Amantadine Amantadine | 2件: Amantadine hydrochloride
Amantadine hydrochloride
,
Amantadine
💬
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬
| 21件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
889 | AMB-05X | - | - | - | - | 1件: 85 85 💬
|
890 | Ambirix | - | - | - | - | 1件: 107 107 💬
|
891 | Ambrisentan | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 8件: 51 51, 66, 84, 85, 86, 88, 210, 211 💬
|
892 | Ambrisentan - high dose | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
893 | Ambrisentan - LOW dose | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
894 | Ambrisentan 5 MG | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 88 88 💬
|
895 | Ambrisentan 5 MG FILM-coated tablets | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
896 | Ambrisentan mimic | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
897 | Ambrisentan plus spironolactone | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
898 | Ambrisentan tablet | 1件: Ambrisentan Ambrisentan | 1件: Ambrisentan
Ambrisentan
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 86 86 💬
|
899 | Ambrosan 60MG tablets | - | - | - | - | 1件: 6 6 💬
|
900 | Ambroxol | 1件: Ambroxol Ambroxol | 2件: Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | 3件: 2 2, 6, 19 💬
|
901 | Ambroxol cloridrato | 1件: Ambroxol Ambroxol | 2件: Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | 1件: 6 6 💬
|
902 | Ambroxol hydrochloride | 1件: Ambroxol Ambroxol | 2件: Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | 2件: 6 6, 19 💬
|
903 | Ambroxol hydrochloride 30 MG tablet - 18 MG/KG/DAY | 1件: Ambroxol Ambroxol | 2件: Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | 1件: 19 19 💬
|
904 | Ambroxol hydrochloride 30 MG tablet - 27 MG/KG/DAY | 1件: Ambroxol Ambroxol | 2件: Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | 1件: 19 19 💬
|
905 | Ambroxol hydrochloride 30 MG tablet - 9 MG/KG/DAY | 1件: Ambroxol Ambroxol | 2件: Ambroxol hydrochloride
Ambroxol hydrochloride
,
Ambroxol
💬
| - | - | 1件: 19 19 💬
|
906 | Amcell clinimacs | - | - | - | - | 1件: 285 285 💬
|
907 | AMD3100 | - | - | - | - | 1件: 285 285 💬
|
908 | AMDX2011P | - | - | - | - | 2件: 2 2, 6 💬
|
909 | American ginseng extract HT-1001 | 1件: Panax quinquefolius whole Panax quinquefolius whole | - | - | - | 1件: 13 13 💬
|
910 | AMG 108 | 1件: AMG 108 AMG 108 | - | - | - | 1件: 46 46 💬
|
911 | AMG 139 | - | - | - | - | 1件: 96 96 💬
|
912 | AMG 145 | - | - | - | - | 1件: 79 79 💬
|
913 | AMG 157 | 1件: Tezepelumab Tezepelumab | 1件: Tezepelumab
Tezepelumab
💬
| 1件: TSLP TSLP 💬
| 2件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | 1件: 98 98 💬
|
914 | AMG 162 | - | - | - | - | 1件: 274 274 💬
|
915 | AMG 181 | - | - | - | - | 2件: 96 96, 97 💬
|
916 | AMG 357 | - | - | - | - | 1件: 46 46 💬
|
917 | AMG 407 | - | - | - | - | 2件: 56 56, 107 💬
|
918 | AMG 531 | - | - | - | - | 1件: 63 63 💬
|
919 | AMG 557 | - | - | - | - | 1件: 49 49 💬
|
920 | AMG 557/MEDI5872 | - | - | - | - | 1件: 53 53 💬
|
921 | AMG 570 | - | - | - | - | 1件: 49 49 💬
|
922 | AMG 592 | - | - | - | - | 3件: 46 46, 49, 97 💬
|
923 | AMG 623 | - | - | - | - | 1件: 49 49 💬
|
924 | AMG 714 | - | - | - | - | 1件: 46 46 💬
|
925 | AMG 719 | - | - | - | - | 1件: 46 46 💬
|
926 | AMG 785 | - | - | - | - | 1件: 274 274 💬
|
927 | AMG 811 | - | - | - | - | 1件: 49 49 💬
|
928 | AMG 827 | - | - | - | - | 2件: 46 46, 96 💬
|
929 | AMG 827 140 MG | - | - | - | - | 1件: 46 46 💬
|
930 | AMG 827 210 MG | - | - | - | - | 2件: 46 46, 96 💬
|
931 | AMG 827 350 MG | - | - | - | - | 1件: 96 96 💬
|
932 | AMG 827 70 MG | - | - | - | - | 1件: 46 46 💬
|
933 | AMG 827 700 MG | - | - | - | - | 1件: 96 96 💬
|
934 | AMG-407 | - | - | - | - | 2件: 56 56, 107 💬
|
935 | AMG145 | - | - | - | - | 1件: 79 79 💬
|
936 | AMG157 | - | - | - | - | 1件: 98 98 💬
|
937 | AMG181 | - | - | - | - | 1件: 97 97 💬
|
938 | AMG407 | - | - | - | - | 2件: 56 56, 107 💬
|
939 | AMG531 | - | - | - | - | 2件: 60 60, 63 💬
|
940 | AMG592 | - | - | - | - | 2件: 46 46, 49 💬
|
941 | AMG811 | - | - | - | - | 1件: 49 49 💬
|
942 | Amgevita | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
943 | Amgevita 40 MG injektionslösung IM fertigpen | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
944 | Amgevita 40 MG injektionslösung IN einer fertigspritze | 1件: Adalimumab Adalimumab | 1件: Adalimumab
Adalimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 2件: 96 96, 97 💬
|
945 | Amgevita 40MG solution FOR injection | - | - | - | - | 2件: 96 96, 97 💬
|
946 | Amias | - | - | - | - | 1件: 67 67 💬
|
947 | Amifampridina | - | - | - | - | 1件: 11 11 💬
|
948 | Amifampridina fosfato | - | - | - | - | 2件: 3 3, 11 💬
|
949 | Amifampridine | 1件: Amifampridine Amifampridine | 2件: Amifampridine
Amifampridine
,
Amifampridine phosphate
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 11 11 💬
|
950 | Amifampridine (base) with modified release | 1件: Amifampridine Amifampridine | 2件: Amifampridine
Amifampridine
,
Amifampridine phosphate
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 11 11 💬
|
951 | Amifampridine phosphate | 1件: Amifampridine Amifampridine | 2件: Amifampridine
Amifampridine
,
Amifampridine phosphate
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 3件: 3 3, 11, 12 💬
|
952 | Amifampridine phosphate 10 MG oral tablet | 1件: Amifampridine Amifampridine | 2件: Amifampridine
Amifampridine
,
Amifampridine phosphate
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 3 3 💬
|
953 | Amifostine | 1件: Amifostine Amifostine | 1件: Amifostine
Amifostine
💬
| - | - | 1件: 63 63 💬
|
954 | Amifostine trihydrate | 1件: Amifostine Amifostine | 1件: Amifostine
Amifostine
💬
| - | - | 1件: 28 28 💬
|
955 | Amikacin | 1件: Amikacin Amikacin | 2件: Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | 2件: 60 60, 299 💬
|
956 | Amikacin nebulization | 1件: Amikacin Amikacin | 2件: Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | 1件: 299 299 💬
|
957 | Amikacin sulfate | 1件: Amikacin Amikacin | 2件: Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | 1件: 299 299 💬
|
958 | Amikacine nebulization | 1件: Amikacin Amikacin | 2件: Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | 1件: 299 299 💬
|
959 | Amikin, amiklin, amicacin, BB-K8, biklin, fabianol, kaminax, mikavir, novamin, pierami | 1件: Amikacin Amikacin | 2件: Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | 1件: 299 299 💬
|
960 | Amikin®, amiklin, amicacin, BB-K8, biklin®, fabianol®, kaminax, mikavir, novamin®, pierami | 1件: Amikacin Amikacin | 2件: Amikacin sulfate
Amikacin sulfate
,
Amikacin
💬
| - | - | 1件: 299 299 💬
|
961 | Amilasa | - | - | - | - | 1件: 299 299 💬
|
962 | Amiloride | 1件: Amiloride Amiloride | 2件: Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬
| 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 4件: 13 13, 67, 225, 299 💬
|
963 | Amiloride HCL | 1件: Amiloride Amiloride | 2件: Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬
| 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 299 299 💬
|
964 | Amiloride HCL 5MG TAB | 1件: Amiloride Amiloride | 2件: Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬
| 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 67 67 💬
|
965 | Amiloride hydrochloride | 1件: Amiloride Amiloride | 2件: Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬
| 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 13 13 💬
|
966 | Amiloride hydrochloride, 2 H2O | 1件: Amiloride Amiloride | 2件: Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬
| 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 13 13 💬
|
967 | Amiloride solution FOR inhalation | 1件: Amiloride Amiloride | 2件: Amiloride hydrochloride
Amiloride hydrochloride
,
Amiloride
💬
| 3件: SCNN1A SCNN1A, SCNN1B, SCNN1G 💬
| 2件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption, Taste transduction 💬 | 1件: 299 299 💬
|
968 | Amilostad HCT tablets | - | - | - | - | 1件: 13 13 💬
|
969 | Amino acid intake | - | - | - | - | 1件: 113 113 💬
|
970 | Amino acid mixture beverage | - | - | - | - | 1件: 97 97 💬
|
971 | Amino acid supplement | - | - | - | - | 2件: 6 6, 46 💬
|
972 | Amino acids | 1件: Amino acids Amino acids | - | - | - | 4件: 6 6, 70, 90, 298 💬
|
973 | Amino salicylic acid | - | - | - | - | 1件: 97 97 💬
|
974 | Aminoacid, alanine-infusion | - | - | - | - | 1件: 251 251 💬
|
975 | Aminocaproic acid | 1件: Aminocaproic acid Aminocaproic acid | 1件: Aminocaproic acid
Aminocaproic acid
💬
| 2件: PLAT PLAT, PLG 💬
| 8件: Apelin signaling pathway Apelin signaling pathway, Complement and coagulation cascades, Fluid shear stress and atherosclerosis, Influenza A, Neuroactive ligand-receptor interaction, Prostate cancer, Staphylococcus aureus infection, Transcriptional misregulation in cancer 💬 | 1件: 70 70 💬
|
976 | Aminoglycoside | - | - | - | - | 1件: 299 299 💬
|
977 | Aminohippurate | 1件: Aminohippuric acid Aminohippuric acid | 2件: Aminohippurate sodium
Aminohippurate sodium
,
Aminohippuric acid
💬
| - | - | 1件: 67 67 💬
|
978 | Aminolevulinic acid | 1件: Aminolevulinic acid Aminolevulinic acid | 2件: Aminolevulinic acid hydrochloride
Aminolevulinic acid hydrochloride
,
Aminolevulinic acid
💬
| - | - | 4件: 34 34, 54, 180, 286 💬
|
979 | Aminophylline | 1件: Aminophylline Aminophylline | 2件: Aminophylline
Aminophylline
,
Aminophylline dihydrate
💬
| 18件: ADORA1 ADORA1, ADORA2B, PDE1, PDE1, PDE1, PDE10, PDE11, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE7, PDE7, PDE8, PDE8 💬
| 23件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Cortisol synthesis and secretion, Cushing syndrome, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 63 63 💬
|
980 | Aminosalicylic acid | 1件: Aminosalicylic acid Aminosalicylic acid | 1件: Aminosalicylic acid
Aminosalicylic acid
💬
| - | - | 2件: 96 96, 97 💬
|
981 | Amiodarone | 1件: Amiodarone Amiodarone | 2件: Amiodarone hydrochloride
Amiodarone hydrochloride
,
Amiodarone
💬
| 16件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12_18, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬
| 34件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Hormone signaling, Insulin secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 127 127 💬
|
982 | Amiselimod | 1件: Amiselimod Amiselimod | 1件: Amiselimod
Amiselimod
💬
| 5件: S1PR1 S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬
| 4件: Efferocytosis Efferocytosis, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway 💬 | 1件: 97 97 💬
|
983 | Amitriptylin-CT | 1件: Amitriptyline Amitriptyline | 2件: Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 299 299 💬
|
984 | Amitriptylin-CT tabletten | 1件: Amitriptyline Amitriptyline | 2件: Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 299 299 💬
|
985 | Amitriptyline | 1件: Amitriptyline Amitriptyline | 2件: Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 226 226, 299 💬
|
986 | Amitriptyline hydrochloride | 1件: Amitriptyline Amitriptyline | 2件: Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 97 97 💬
|
987 | Amitriptyline/gabapentin | 1件: Amitriptyline Amitriptyline | 2件: Amitriptyline hydrochloride
Amitriptyline hydrochloride
,
Amitriptyline
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 226 226 💬
|
988 | Amivita | - | - | - | - | 1件: 2 2 💬
|
989 | Amlitelimab | 1件: Amlitelimab Amlitelimab | 1件: Amlitelimab
Amlitelimab
💬
| 1件: TNFSF4 TNFSF4 💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 51 51 💬
|
990 | Amlodipine | 1件: Amlodipine Amlodipine | 4件: Amlodipine besylate
Amlodipine besylate
,
Amlodipine maleate
,
Amlodipine
,
Amlodipine benzoate
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 67 67, 298 💬
|
991 | Amlodipine GEL | 1件: Amlodipine Amlodipine | 4件: Amlodipine besylate
Amlodipine besylate
,
Amlodipine maleate
,
Amlodipine
,
Amlodipine benzoate
💬
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
992 | Ammonia | 1件: Ammonia Ammonia | 1件: Ammonia solution, strong
Ammonia solution, strong
💬
| - | - | 3件: 88 88, 251, 296 💬
|
993 | Ammonium (15N) chloride | - | - | - | - | 1件: 251 251 💬
|
994 | Ammonium chloride | 1件: Ammonium chloride Ammonium chloride | 1件: Ammonium chloride
Ammonium chloride
💬
| - | - | 1件: 251 251 💬
|
995 | AMN107 | - | - | - | - | 2件: 34 34, 86 💬
|
996 | Amniotic epithelial cells | 1件: Amniotic Epithelial Cells Amniotic Epithelial Cells | - | - | - | 1件: 26 26 💬
|
997 | Amniotic fluid allograft | - | - | - | - | 1件: 70 70 💬
|
998 | Amniotic fluid or placental CD117 stem cells | - | - | - | - | 1件: 13 13 💬
|
999 | Amondys 45 | - | - | - | - | 1件: 113 113 💬
|
1000 | AMOR-1 | - | - | - | - | 1件: 235 235 💬
|
1001 | Amorphous calcium carbonate | - | - | - | - | 1件: 235 235 💬
|
1002 | Amoxapine & dipyridamole | 1件: Amoxapine Amoxapine | 1件: Amoxapine
Amoxapine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 46 46 💬
|
1003 | Amoxicilina | 1件: Amoxicillin Amoxicillin | 3件: Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | 1件: 46 46 💬
|
1004 | Amoxicillin | 2件: Amoxicillin Amoxicillin, Clavulanic acid | 5件: Amoxicillin
Amoxicillin
,
Clavulanate potassium
,
Amoxicillin sodium
,
Amoxicillin
,
Clavulanic acid
💬
| - | - | 5件: 46 46, 63, 96, 97, 299 💬
|
1005 | Amoxicillin and clavulanic acid | 2件: Amoxicillin Amoxicillin, Clavulanic acid | 5件: Amoxicillin
Amoxicillin
,
Clavulanate potassium
,
Amoxicillin sodium
,
Amoxicillin
,
Clavulanic acid
💬
| - | - | 1件: 299 299 💬
|
1006 | Amoxicillin and doxycyclin | 1件: Amoxicillin Amoxicillin | 3件: Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | 1件: 97 97 💬
|
1007 | Amoxicillin hydrate | 1件: Amoxicillin Amoxicillin | 3件: Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | 1件: 63 63 💬
|
1008 | Amoxicillin, metronidazole and doxycycline | 1件: Amoxicillin Amoxicillin | 3件: Amoxicillin
Amoxicillin
,
Amoxicillin sodium
,
Amoxicillin
💬
| - | - | 1件: 97 97 💬
|
1009 | AMP-110 | - | - | - | - | 1件: 46 46 💬
|
1010 | Ampc | 1件: Cyclic adenosine monophosphate Cyclic adenosine monophosphate | - | - | - | 1件: 84 84 💬
|
1011 | Amphotericin B | 1件: Amphotericin B Amphotericin B | 1件: Amphotericin B
Amphotericin B
💬
| - | - | 1件: 299 299 💬
|
1012 | Amphotericine B, liposome | - | - | - | - | 1件: 60 60 💬
|
1013 | Amplification BY PCR and direct sequencing ON THE entire coding sequence and intron-exons boundaries OF THE candidate gene | - | - | - | - | 1件: 265 265 💬
|
1014 | Ampreloxetine | 1件: Ampreloxetine Ampreloxetine | 1件: Ampreloxetine
Ampreloxetine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 💬
|
1015 | Ampreloxetine chydrochloride | 1件: Ampreloxetine Ampreloxetine | 1件: Ampreloxetine
Ampreloxetine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 💬
|
1016 | Ampreloxetine hydrochloride | 1件: Ampreloxetine Ampreloxetine | 1件: Ampreloxetine
Ampreloxetine
💬
| 2件: SLC6A2 SLC6A2, SLC6A4 💬
| 3件: Neuroactive ligand signaling Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 💬
|
1017 | Amprenavir | 1件: Amprenavir Amprenavir | 1件: Amprenavir
Amprenavir
💬
| - | - | 1件: 265 265 💬
|
1018 | Ampyra | 1件: Dalfampridine Dalfampridine | 1件: Dalfampridine
Dalfampridine
💬
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬
| 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 13 13 💬
|
1019 | Amsc | - | - | - | - | 1件: 2 2 💬
|
1020 | AMT-101 | 1件: AMT-101 AMT-101 | - | - | - | 2件: 46 46, 97 💬
|
1021 | AMT-130 | 1件: AMT-130 AMT-130 | - | - | - | 1件: 8 8 💬
|
1022 | AMT-162 | 1件: AMT-162 AMT-162 | - | - | - | 1件: 2 2 💬
|
1023 | AMT-191 | - | - | - | - | 1件: 19 19 💬
|
1024 | AMX0035 | - | - | - | - | 3件: 2 2, 5, 233 💬
|
1025 | AMX0114 | - | - | - | - | 1件: 2 2 💬
|
1026 | Amyl nitrite inhalation | 1件: Amyl Nitrite Amyl Nitrite | 1件: Amyl nitrite
Amyl nitrite
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 58 58 💬
|
1027 | Amylase | - | - | - | - | 1件: 299 299 💬
|
1028 | Amyotrophic lateral sclerosis functional rating scale-revised | - | - | - | - | 1件: 2 2 💬
|
1029 | Amyvid | - | - | - | - | 1件: 127 127 💬
|
1030 | Amyvid radiopharmaceutical | - | - | - | - | 1件: 13 13 💬
|
1031 | AMZ002 | 1件: AMZ002 AMZ002 | - | - | - | 1件: 145 145 💬
|
1032 | AN100226 | - | - | - | - | 2件: 13 13, 96 💬
|
1033 | AN100226, BG00002 | - | - | - | - | 1件: 13 13 💬
|
1034 | Anacetrapib | 1件: Anacetrapib Anacetrapib | 1件: Anacetrapib
Anacetrapib
💬
| 1件: CETP CETP 💬
| 1件: Cholesterol metabolism Cholesterol metabolism 💬 | 1件: 79 79 💬
|
1035 | Anaerobically cultivated human intestinal microbiota | - | - | - | - | 1件: 51 51 💬
|
1036 | Anaerobically cultivated medium | - | - | - | - | 1件: 51 51 💬
|
1037 | Anakinra | 1件: Anakinra Anakinra | 1件: Anakinra
Anakinra
💬
| 2件: IL1R1 IL1R1, IL1R2 💬
| 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 19件: 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 84, 86, 97, 106, 107, 266, 299 💬
|
1038 | Anakinra / kineret | 1件: Anakinra Anakinra | 1件: Anakinra
Anakinra
💬
| 2件: IL1R1 IL1R1, IL1R2 💬
| 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 107 107 💬
|
1039 | Anakinra and PEG STNF-R1 | 1件: Anakinra Anakinra | 1件: Anakinra
Anakinra
💬
| 2件: IL1R1 IL1R1, IL1R2 💬
| 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 1件: 46 46 💬
|
1040 | Anal dilation | - | - | - | - | 1件: 291 291 💬
|
1041 | Analgesics | - | - | - | - | 1件: 298 298 💬
|
1042 | Analysis OF gamma globulin | - | - | - | - | 1件: 84 84 💬
|
1043 | Anastrozole | 1件: Anastrozole Anastrozole | 1件: Anastrozole
Anastrozole
💬
| 1件: CYP19A CYP19A 💬
| 2件: Ovarian steroidogenesis Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | 3件: 78 78, 86, 193 💬
|
1044 | Anatomical landmark-guided suprascapular nerve block | - | - | - | - | 1件: 149 149 💬
|
1045 | Anavex2-73 | 1件: Blarcamesine Blarcamesine | 2件: Blarcamesine
Blarcamesine
,
Blarcamesine hydrochloride
💬
| 6件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SIGMAR1 💬
| 15件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 156 💬
|
1046 | Anavex2-73 oral liquid | 1件: Blarcamesine Blarcamesine | 2件: Blarcamesine
Blarcamesine
,
Blarcamesine hydrochloride
💬
| 6件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5, SIGMAR1 💬
| 15件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 156 156 💬
|
1047 | ANB-004, dose 1 | - | - | - | - | 1件: 3 3 💬
|
1048 | ANB-004, dose 2 | - | - | - | - | 1件: 3 3 💬
|
1049 | ANB-004, dose 3 | - | - | - | - | 1件: 3 3 💬
|
1050 | ANB019 | - | - | - | - | 1件: 37 37 💬
|
1051 | Andecaliximab | 1件: Andecaliximab Andecaliximab | 1件: Andecaliximab
Andecaliximab
💬
| 1件: MMP9 MMP9 💬
| 15件: Bladder cancer Bladder cancer, Diabetic cardiomyopathy, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Hepatitis B, IL-17 signaling pathway, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Pathways in cancer, Prostate cancer, Proteoglycans in cancer, Relaxin signaling pathway, TNF signaling pathway, Transcriptional misregulation in cancer 💬 | 5件: 46 46, 96, 97, 272, 299 💬
|
1052 | Andosan | - | - | - | - | 2件: 96 96, 97 💬
|
1053 | Androgel 1 % topical GEL | - | - | - | - | 1件: 13 13 💬
|
1054 | Androgel 10 grams OF GEL containing 100 MG OF testosterone | 1件: Testosterone Testosterone | 1件: Testosterone
Testosterone
💬
| 1件: AR AR 💬
| 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 1件: 13 13 💬
|
1055 | Androgens | - | - | - | - | 1件: 60 60 💬
|
1056 | Andrographis paniculata | - | - | - | - | 1件: 97 97 💬
|
1057 | Andrographolide | 1件: Andrographolide Andrographolide | - | - | - | 1件: 97 97 💬
|
1058 | Andrographolides | - | - | - | - | 1件: 13 13 💬
|
1059 | Anesthetic topical adhesive synera | - | - | - | - | 1件: 13 13 💬
|
1060 | Anfibatide | 1件: Anfibatide Anfibatide | - | - | - | 1件: 64 64 💬
|
1061 | ANG-3070 | - | - | - | - | 1件: 85 85 💬
|
1062 | ANG003 | - | - | - | - | 1件: 299 299 💬
|
1063 | Angio-optical coherence tomography | - | - | - | - | 1件: 41 41 💬
|
1064 | Angiotensin | 1件: Angiotensin II Angiotensin II | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 5件: 17 17, 66, 218, 222, 224 💬
|
1065 | Angiotensin blockade | 1件: Angiotensin II Angiotensin II | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬
|
1066 | Angiotensin converting enzyme test | 1件: Angiotensin II Angiotensin II | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 49 49 💬
|
1067 | Angiotensin II | 1件: Angiotensin II Angiotensin II | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 2件: 66 66, 222 💬
|
1068 | Angiotensin receptor blockers | 1件: Angiotensin II Angiotensin II | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 46 46 💬
|
1069 | Angiotensin-converting enzyme (ACE) inhibitor | 1件: Angiotensin II Angiotensin II | 3件: Angiotensin II
Angiotensin II
,
Angiotensin II
,
Angiotensin II acetate
💬
| 2件: AGTR1 AGTR1, AGTR2 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 224 224 💬
|
1070 | Anhidrous sodium sulfate | 1件: Sodium sulfate Sodium sulfate | 2件: Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | 1件: 97 97 💬
|
1071 | Anhydrous amiloride hydrochloride | - | - | - | - | 1件: 225 225 💬
|
1072 | Anhydrous carbidopa | 1件: Carbidopa Carbidopa | 1件: Carbidopa
Carbidopa
💬
| 1件: DDC DDC 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 💬
|
1073 | Anhydrous sodium sulfate | 1件: Sodium sulfate Sodium sulfate | 2件: Anhydous sodium sulfate
Anhydous sodium sulfate
,
Sodium sulfate
💬
| - | - | 1件: 97 97 💬
|
1074 | ANI (analgesia/nociception index) monitoring | - | - | - | - | 1件: 22 22 💬
|
1075 | Anifrolumab | 1件: Anifrolumab Anifrolumab | 1件: Anifrolumab
Anifrolumab
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 5件: 46 46, 49, 50, 51, 53 💬
|
1076 | Anifrolumab 1000 MG | 1件: Anifrolumab Anifrolumab | 1件: Anifrolumab
Anifrolumab
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 49 49 💬
|
1077 | Anifrolumab 300 MG | 1件: Anifrolumab Anifrolumab | 1件: Anifrolumab
Anifrolumab
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 49 49 💬
|
1078 | Animal tissue extracts | - | - | - | - | 1件: 60 60 💬
|
1079 | Anit human granulocyt-macrophage colony-stimulating factor (GM-CSF)monoclonal | - | - | - | - | 1件: 46 46 💬
|
1080 | Anito-CEL | 1件: Anitocabtagene autoleucel Anitocabtagene autoleucel | - | - | - | 1件: 11 11 💬
|
1081 | ANK-700 | - | - | - | - | 1件: 13 13 💬
|
1082 | ANLE138B | - | - | - | - | 1件: 6 6 💬
|
1083 | Anlotinib | 1件: Anlotinib Anlotinib | 1件: Catequentinib
Catequentinib
💬
| 10件: FGFR1 FGFR1, FGFR2, FGFR3, FGFR4, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬
| 36件: Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 85 85 💬
|
1084 | ANPD001 | - | - | - | - | 1件: 6 6 💬
|
1085 | Anrukinzumab | 1件: Anrukinzumab Anrukinzumab | 1件: Anrukinzumab
Anrukinzumab
💬
| 1件: IL13 IL13 💬
| 8件: Asthma Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬 | 1件: 97 97 💬
|
1086 | Anthropometric measurements | - | - | - | - | 1件: 299 299 💬
|
1087 | Anti BETA7 | - | - | - | - | 1件: 97 97 💬
|
1088 | Anti CD19 CAR NK cells | - | - | - | - | 1件: 46 46 💬
|
1089 | Anti CD3 monoclonal antibody | - | - | - | - | 1件: 97 97 💬
|
1090 | Anti haemophilus influeanze vaccination | - | - | - | - | 1件: 62 62 💬
|
1091 | Anti human granulocyte-macrophage colo | - | - | - | - | 1件: 46 46 💬
|
1092 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal | - | - | - | - | 1件: 46 46 💬
|
1093 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal antibody | - | - | - | - | 1件: 46 46 💬
|
1094 | Anti human granulocyte-macrophage colony-stimulating factor (GM-CSF)monoclonal | - | - | - | - | 1件: 46 46 💬
|
1095 | Anti IL 6 MAB | - | - | - | - | 1件: 46 46 💬
|
1096 | Anti IL-1ß antibody, subclass IGG4 | - | - | - | - | 1件: 46 46 💬
|
1097 | Anti LP40 antibody, subclass IGG4 | - | - | - | - | 1件: 49 49 💬
|
1098 | Anti LP40 antibody, subclass IGG4 LA294 | - | - | - | - | 2件: 13 13, 46 💬
|
1099 | Anti LP40 anticuerpo, subclase IGG4 | - | - | - | - | 1件: 49 49 💬
|
1100 | Anti lymphotoxin alpha | - | - | - | - | 1件: 46 46 💬
|
1101 | Anti phospholipid marker | - | - | - | - | 1件: 49 49 💬
|
1102 | Anti thymocyte globulin | - | - | - | - | 1件: 51 51 💬
|
1103 | Anti TNF | - | - | - | - | 1件: 96 96 💬
|
1104 | Anti TNF + meth | - | - | - | - | 1件: 46 46 💬
|
1105 | Anti TNF alpha agent | - | - | - | - | 1件: 271 271 💬
|
1106 | Anti TNF alpha therapy | - | - | - | - | 1件: 271 271 💬
|
1107 | Anti TNF humanized antibody FAB fragment-PEG conjugate | - | - | - | - | 1件: 96 96 💬
|
1108 | Anti TNF therapy including infliximab | - | - | - | - | 2件: 96 96, 97 💬
|
1109 | ANTI-(complement C5A) IGG4 chimeric monoclonal antibody | - | - | - | - | 1件: 269 269 💬
|
1110 | ANTI-(misfolded human superoxide dismutase 1) human IGG1m3 monoclonal antibody | - | - | - | - | 1件: 2 2 💬
|
1111 | ANTI-aquaporin-4 antibody | - | - | - | - | 1件: 13 13 💬
|
1112 | ANTI-baffr antibody | - | - | - | - | 1件: 95 95 💬
|
1113 | ANTI-baffr cart | - | - | - | - | 1件: 13 13 💬
|
1114 | ANTI-bcma/CD70-CAR-T cells | - | - | - | - | 1件: 49 49 💬
|
1115 | ANTI-blood dendritic cell antigen 2 | - | - | - | - | 1件: 49 49 💬
|
1116 | ANTI-C5 antibody | - | - | - | - | 4件: 11 11, 14, 62, 109 💬
|
1117 | ANTI-C5AR | - | - | - | - | 1件: 46 46 💬
|
1118 | ANTI-CCP- and ANTI-P.G.-antibodies titers | - | - | - | - | 1件: 46 46 💬
|
1119 | ANTI-CD19 CAR T cell therapy | - | - | - | - | 4件: 49 49, 50, 51, 53 💬
|
1120 | ANTI-CD19 CAR-NK cells | - | - | - | - | 3件: 49 49, 51, 53 💬
|
1121 | ANTI-CD19 CAR-T cells | - | - | - | - | 2件: 51 51, 53 💬
|
1122 | ANTI-CD19 UCAR-T cells | - | - | - | - | 1件: 50 50 💬
|
1123 | ANTI-CD19-CAR-T cells | - | - | - | - | 3件: 49 49, 51, 53 💬
|
1124 | ANTI-CD19-CD3E-CAR-T cells | - | - | - | - | 3件: 49 49, 51, 53 💬
|
1125 | ANTI-CD19/bcma CAR NK cells | - | - | - | - | 1件: 66 66 💬
|
1126 | ANTI-CD20 antibody | - | - | - | - | 2件: 13 13, 64 💬
|
1127 | ANTI-CD20 B cell depletion with truxima | - | - | - | - | 1件: 49 49 💬
|
1128 | ANTI-CD20 MAB | - | - | - | - | 1件: 13 13 💬
|
1129 | ANTI-CD20 monoclonal antibody | - | - | - | - | 1件: 13 13 💬
|
1130 | ANTI-CD20 MS treatment | - | - | - | - | 1件: 13 13 💬
|
1131 | ANTI-CD20 small modular immunopharmaceutical, WYE-400087 | - | - | - | - | 1件: 46 46 💬
|
1132 | ANTI-CD25 humanized monoclonal antibody | - | - | - | - | 1件: 13 13 💬
|
1133 | ANTI-CD28DAB | - | - | - | - | 3件: 49 49, 53, 160 💬
|
1134 | ANTI-CD3 | 1件: Muromonab Muromonab | 1件: Muromonab-CD3
Muromonab-CD3
💬
| 3件: CD3D CD3D, CD3E, CD3G 💬
| 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 1件: 96 96 💬
|
1135 | ANTI-CD3 monoclonal antibody | 1件: Muromonab Muromonab | 1件: Muromonab-CD3
Muromonab-CD3
💬
| 3件: CD3D CD3D, CD3E, CD3G 💬
| 11件: Chagas disease Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | 2件: 96 96, 97 💬
|
1136 | ANTI-CD38 antibody injection | - | - | - | - | 2件: 61 61, 63 💬
|
1137 | ANTI-CD38 monoclonal antibody | - | - | - | - | 1件: 28 28 💬
|
1138 | ANTI-CD40L | 1件: Toralizumab Toralizumab | 1件: Toralizumab
Toralizumab
💬
| 1件: TNFSF5 TNFSF5 💬
| 14件: Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, Lipid and atherosclerosis, Malaria, NF-kappa B signaling pathway, Primary immunodeficiency, Systemic lupus erythematosus, T cell receptor signaling pathway, Toxoplasmosis, Viral myocarditis 💬 | 1件: 63 63 💬
|
1139 | ANTI-CD40ldab | - | - | - | - | 1件: 63 63 💬
|
1140 | ANTI-CD45 | - | - | - | - | 2件: 65 65, 285 💬
|
1141 | ANTI-CD52 monoclonal antibody | - | - | - | - | 1件: 13 13 💬
|
1142 | ANTI-CT51 antigen MAB | - | - | - | - | 1件: 51 51 💬
|
1143 | ANTI-D | - | - | - | - | 1件: 63 63 💬
|
1144 | ANTI-GM-CSF receptor alpha | - | - | - | - | 1件: 46 46 💬
|
1145 | ANTI-human immunoglobulin, equine | - | - | - | - | 1件: 60 60 💬
|
1146 | ANTI-human interleukin-23 monoclonal antibody | - | - | - | - | 1件: 271 271 💬
|
1147 | ANTI-human T-lymphocyte immunoglobulin from horse | - | - | - | - | 1件: 60 60 💬
|
1148 | ANTI-human T-lymphocyte immunoglobulin from rabbits | - | - | - | - | 1件: 51 51 💬
|
1149 | ANTI-human thymocyte immunoglobulin, equine | - | - | - | - | 1件: 60 60 💬
|
1150 | ANTI-human thymocyte immunoglobulin, rabbit | - | - | - | - | 1件: 60 60 💬
|
1151 | ANTI-hypertensive medications | - | - | - | - | 1件: 67 67 💬
|
1152 | ANTI-IL-20 | 1件: Fletikumab Fletikumab | 1件: Fletikumab
Fletikumab
💬
| 1件: IL20 IL20 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 46 46 💬
|
1153 | ANTI-IL-23 monoclonal antibody | - | - | - | - | 1件: 96 96 💬
|
1154 | ANTI-IL-36R monoclonal antibody | - | - | - | - | 1件: 37 37 💬
|
1155 | ANTI-IL-6 MAB | - | - | - | - | 2件: 46 46, 96 💬
|
1156 | ANTI-IL12/23 or ANTI-IL23 - risankizumab | - | - | - | - | 1件: 96 96 💬
|
1157 | ANTI-IL12/23 or ANTI-IL23 - ustekinumab | - | - | - | - | 1件: 96 96 💬
|
1158 | ANTI-IL6 | - | - | - | - | 1件: 46 46 💬
|
1159 | ANTI-inflammatory drugs | - | - | - | - | 1件: 46 46 💬
|
1160 | ANTI-integrin - vedolizumab IV and SC | 1件: Vedolizumab Vedolizumab | 1件: Vedolizumab
Vedolizumab
💬
| 2件: ITGA4 ITGA4, ITGB7 💬
| 16件: Arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬 | 1件: 96 96 💬
|
1161 | ANTI-integrin alphav MAB | - | - | - | - | 1件: 51 51 💬
|
1162 | ANTI-interferon-gamma monoclonal antibody | - | - | - | - | 1件: 96 96 💬
|
1163 | ANTI-interleukin 5 (IL-5) humanized monoclonal | - | - | - | - | 2件: 44 44, 45 💬
|
1164 | ANTI-interleukin-1B monoclonal antibody | - | - | - | - | 1件: 106 106 💬
|
1165 | ANTI-interleukin-23 immunoglobulin G2 (IGG2) human monoclonal antibody | - | - | - | - | 2件: 96 96, 97 💬
|
1166 | ANTI-interleukin-6 monoclonal | - | - | - | - | 1件: 46 46 💬
|
1167 | ANTI-interleukin-6 monoclonal antibody | - | - | - | - | 2件: 46 46, 96 💬
|
1168 | ANTI-IP-10 antibody | - | - | - | - | 1件: 97 97 💬
|
1169 | ANTI-macrophage migration inhibitory factor (ANTI-MIF) antibody | - | - | - | - | 1件: 49 49 💬
|
1170 | ANTI-madcam antibody | - | - | - | - | 2件: 96 96, 97 💬
|
1171 | ANTI-mullerian hormone (AMH) level | - | - | - | - | 1件: 13 13 💬
|
1172 | ANTI-myelin oligodendrocyte glycoprotein | - | - | - | - | 1件: 13 13 💬
|
1173 | ANTI-myostati | - | - | - | - | 1件: 113 113 💬
|
1174 | ANTI-myostatin adnectin | - | - | - | - | 1件: 113 113 💬
|
1175 | ANTI-pandemic H1n1 influenza vaccine | - | - | - | - | 6件: 46 46, 49, 50, 51, 53, 107 💬
|
1176 | ANTI-parkinson medication | - | - | - | - | 5件: 5 5, 6, 7, 8, 17 💬
|
1177 | ANTI-parkinsonian drugs | - | - | - | - | 1件: 6 6 💬
|
1178 | ANTI-pseudomonas IGY gargle | - | - | - | - | 1件: 299 299 💬
|
1179 | ANTI-reflux pharmacotherapy | - | - | - | - | 1件: 299 299 💬
|
1180 | ANTI-sclerostin monoclonal antibody | - | - | - | - | 1件: 274 274 💬
|
1181 | ANTI-thymocyte globulin | - | - | - | - | 18件: 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬
|
1182 | ANTI-thymocyte globulin, rabbit | - | - | - | - | 1件: 51 51 💬
|
1183 | ANTI-TL1A | - | - | - | - | 1件: 97 97 💬
|
1184 | ANTI-TNF | - | - | - | - | 5件: 46 46, 96, 97, 107, 271 💬
|
1185 | ANTI-TNF agents | - | - | - | - | 1件: 271 271 💬
|
1186 | ANTI-TNF biologics therapy | - | - | - | - | 1件: 46 46 💬
|
1187 | ANTI-TNF discontinuation: physiological saline solution | - | - | - | - | 2件: 96 96, 97 💬
|
1188 | ANTI-TNF drug | - | - | - | - | 2件: 96 96, 97 💬
|
1189 | ANTI-TNF humanized antibody FAB fragment - PEG conjugate | - | - | - | - | 1件: 46 46 💬
|
1190 | ANTI-TNF humanized antibody FAB' fragment - PEG conjugate | - | - | - | - | 1件: 46 46 💬
|
1191 | ANTI-TNF suspended perioperatively | - | - | - | - | 1件: 46 46 💬
|
1192 | ANTI-TNF therapy | - | - | - | - | 4件: 46 46, 96, 97, 271 💬
|
1193 | ANTI-TNF-alpha | - | - | - | - | 1件: 46 46 💬
|
1194 | ANTI-tnfa continued perioperatively | - | - | - | - | 1件: 46 46 💬
|
1195 | ANTI-tumor necrosing factor (TNF) therapy | - | - | - | - | 1件: 46 46 💬
|
1196 | ANTI-tumor necrosis factor | - | - | - | - | 1件: 271 271 💬
|
1197 | ANTI-tumor necrosis factor alpha agents | - | - | - | - | 1件: 97 97 💬
|
1198 | ANTI-tumor necrosis factor alpha monoclonal antibody | - | - | - | - | 1件: 107 107 💬
|
1199 | ANTI-tumour necrosis factor A antibodies | - | - | - | - | 1件: 96 96 💬
|
1200 | ANTI-VON willebrand factor nanobody | - | - | - | - | 1件: 64 64 💬
|
1201 | ANTI-VON willebrand factor nanobody, caplacizumab | - | - | - | - | 1件: 64 64 💬
|
1202 | ANTI-VON willebrand factor nanobody, INN = caplacizumab | 1件: Caplacizumab Caplacizumab | 1件: Caplacizumab
Caplacizumab
💬
| 1件: VWF VWF 💬
| 8件: Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation 💬 | 1件: 64 64 💬
|
1203 | Antiarrhythmic drugs | - | - | - | - | 1件: 58 58 💬
|
1204 | Antibiotic | - | - | - | - | 1件: 299 299 💬
|
1205 | Antibiotic cocktail | - | - | - | - | 1件: 97 97 💬
|
1206 | Antibiotic regimen | - | - | - | - | 1件: 84 84 💬
|
1207 | Antibiotics | - | - | - | - | 2件: 96 96, 97 💬
|
1208 | Antibodies TO golimumab | 1件: Golimumab Golimumab | 1件: Golimumab
Golimumab
💬
| 1件: TNF TNF 💬
| 66件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 97 97 💬
|
1209 | Anticholinergic | - | - | - | - | 1件: 118 118 💬
|
1210 | Anticholinergic medication | - | - | - | - | 1件: 13 13 💬
|
1211 | Anticorpo monoclonale antagonista DEL fattore xiia | - | - | - | - | 1件: 85 85 💬
|
1212 | Anticorpo monoclonale anti GM-CSF umano | - | - | - | - | 1件: 46 46 💬
|
1213 | Anticorpo monoclonale anti IL-23 | - | - | - | - | 1件: 96 96 💬
|
1214 | Anticorpo monoclonale ANTI-IL-23 | - | - | - | - | 1件: 96 96 💬
|
1215 | Anticuerpo monoclonal ANTI-lingo-1 humano | - | - | - | - | 1件: 13 13 💬
|
1216 | Antigen (wheat base SOY sauce) spray | - | - | - | - | 1件: 98 98 💬
|
1217 | Antigen-specific T cells cart/CTL and dcvac | - | - | - | - | 1件: 34 34 💬
|
1218 | Antigeno superficie hepatitis B | - | - | - | - | 1件: 97 97 💬
|
1219 | Antihistamine | - | - | - | - | 3件: 13 13, 19, 46 💬
|
1220 | Antihuman granulocyte-macrophage colony-stimulating factor (GM-CSF) monoclonal | - | - | - | - | 1件: 46 46 💬
|
1221 | Antihypertensive drugs | - | - | - | - | 1件: 67 67 💬
|
1222 | Antilymphocyte serum | - | - | - | - | 1件: 60 60 💬
|
1223 | Antimicrobial therapy: CO-trimoxazole or doxycycline | - | - | - | - | 1件: 85 85 💬
|
1224 | Antimycotic | - | - | - | - | 1件: 13 13 💬
|
1225 | Antioxidant cocktail | - | - | - | - | 1件: 299 299 💬
|
1226 | Antioxidant diet | - | - | - | - | 1件: 97 97 💬
|
1227 | Antioxidant plus pregabalin | - | - | - | - | 1件: 298 298 💬
|
1228 | Antioxidant supplement | - | - | - | - | 1件: 299 299 💬
|
1229 | Antioxidants | - | - | - | - | 3件: 90 90, 298, 310 💬
|
1230 | Antiplatelets | - | - | - | - | 1件: 124 124 💬
|
1231 | Antipyretic | - | - | - | - | 2件: 19 19, 257 💬
|
1232 | Antiretroviral/anti HIV | - | - | - | - | 1件: 265 265 💬
|
1233 | Antisense oligonucleotide | - | - | - | - | 1件: 5 5 💬
|
1234 | Antistaminici H1 - H2 | - | - | - | - | 1件: 299 299 💬
|
1235 | Antithymocyte | - | - | - | - | 1件: 13 13 💬
|
1236 | Antithymocyte globulin | - | - | - | - | 3件: 60 60, 65, 284 💬
|
1237 | Antithymocyte immunoglobulin | 1件: Antithymocyte immunoglobulin (rabbit) Antithymocyte immunoglobulin (rabbit) | 1件: Anti-human thymocyte immunoglobulin, rabbit
Anti-human thymocyte immunoglobulin, rabbit
💬
| 11件: CD2 CD2, CD3D, CD3E, CD3G, CD4, CD5, CD7, CD8A, CD8B, IL2RA, ITGAL 💬
| 31件: Antigen processing and presentation Antigen processing and presentation, Cell adhesion molecules, Chagas disease, Cytokine-cytokine receptor interaction, Endocytosis, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Leukocyte transendothelial migration, Malaria, Measles, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral life cycle - HIV-1, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus, Yersinia infection 💬 | 2件: 13 13, 96 💬
|
1238 | Antituberculous therapy along with steroids | - | - | - | - | 1件: 84 84 💬
|
1239 | Antiviral therapy | - | - | - | - | 2件: 28 28, 60 💬
|
1240 | Antivirale AD USO diretto | - | - | - | - | 1件: 107 107 💬
|
1241 | Antox (vers) 1.2 | - | - | - | - | 1件: 298 298 💬
|
1242 | Antox (vers.)1.2 | - | - | - | - | 1件: 298 298 💬
|
1243 | Antox version 1.2 | - | - | - | - | 1件: 298 298 💬
|
1244 | ANVS401 | - | - | - | - | 1件: 6 6 💬
|
1245 | ANX005 | - | - | - | - | 3件: 2 2, 8, 61 💬
|
1246 | Anxiety | - | - | - | - | 1件: 13 13 💬
|
1247 | Anxiety/depression and work and activities | - | - | - | - | 1件: 13 13 💬
|
1248 | Anxiety/depression questionnaires | - | - | - | - | 1件: 97 97 💬
|
1249 | ANY biologic treatment FOR psoriasis | - | - | - | - | 1件: 37 37 💬
|
1250 | ANY other approved antiepileptic drug | - | - | - | - | 1件: 144 144 💬
|
1251 | AOC 1001 | 1件: AOC 1001 AOC 1001 | - | - | - | 1件: 113 113 💬
|
1252 | AOC 1020 | - | - | - | - | 1件: 113 113 💬
|
1253 | AOC 1044 | - | - | - | - | 1件: 113 113 💬
|
1254 | Aortic/ cardiac magnetic resonance imaging | - | - | - | - | 1件: 41 41 💬
|
1255 | AP-101 | 1件: AP-101 AP-101 | - | - | - | 1件: 2 2 💬
|
1256 | AP-CD/LD | - | - | - | - | 1件: 6 6 💬
|
1257 | AP-PA02 | - | - | - | - | 1件: 299 299 💬
|
1258 | AP01 | - | - | - | - | 1件: 85 85 💬
|
1259 | AP09004 | - | - | - | - | 1件: 6 6 💬
|
1260 | AP1189 | - | - | - | - | 2件: 46 46, 222 💬
|
1261 | AP1189 tablet | - | - | - | - | 1件: 46 46 💬
|
1262 | AP1189, 100 MG | - | - | - | - | 1件: 46 46 💬
|
1263 | AP1189, 40 MG | - | - | - | - | 1件: 46 46 💬
|
1264 | AP1189, 60 MG | - | - | - | - | 1件: 46 46 💬
|
1265 | AP1189, 70 MG | - | - | - | - | 1件: 46 46 💬
|
1266 | AP1189, 80 MG | - | - | - | - | 1件: 46 46 💬
|
1267 | AP1903 | - | - | - | - | 4件: 60 60, 65, 285, 326 💬
|
1268 | Apabetalone | 1件: Apabetalone Apabetalone | 1件: Apabetalone
Apabetalone
💬
| - | - | 1件: 86 86 💬
|
1269 | Apadamtase alfa | 1件: Apadamtase alfa Apadamtase alfa | 2件: Apadamtase alfa
Apadamtase alfa
,
Apadamtase alfa and cinaxadamtase alfa
💬
| 1件: ADAMTS13 ADAMTS13 💬
| 1件: Platelet activation Platelet activation 💬 | 1件: 64 64 💬
|
1270 | Apademtase alfa | - | - | - | - | 1件: 64 64 💬
|
1271 | Apcc, apcc + TXA | - | - | - | - | 1件: 288 288 💬
|
1272 | APD334 | - | - | - | - | 5件: 93 93, 96, 97, 98, 269 💬
|
1273 | APD334 L-arginine | - | - | - | - | 1件: 97 97 💬
|
1274 | APD371 | - | - | - | - | 1件: 96 96 💬
|
1275 | APD421 | - | - | - | - | 1件: 107 107 💬
|
1276 | APD811 | - | - | - | - | 1件: 86 86 💬
|
1277 | Apelin | 1件: Apelin Apelin | - | - | - | 1件: 86 86 💬
|
1278 | APG-115 | - | - | - | - | 1件: 34 34 💬
|
1279 | APG-2575 | - | - | - | - | 1件: 49 49 💬
|
1280 | Apheresis | - | - | - | - | 1件: 60 60 💬
|
1281 | Apheresis catheter placement | - | - | - | - | 1件: 96 96 💬
|
1282 | API-AAT, AD00370, ARC-AAT, API drug substance | - | - | - | - | 1件: 231 231 💬
|
1283 | Apigenin | 1件: Apigenin Apigenin | - | - | - | 1件: 97 97 💬
|
1284 | Apigenin and glycyrrhizin | 2件: Apigenin Apigenin, Glycyrrhizic acid | 2件: Glycyrrhizin
Glycyrrhizin
,
Dipotassium glycyrrhizinate
💬
| 1件: HSD11B1 HSD11B1 💬
| 3件: Chemical carcinogenesis - DNA adducts Chemical carcinogenesis - DNA adducts, Metabolism of xenobiotics by cytochrome P450, Steroid hormone biosynthesis 💬 | 1件: 46 46 💬
|
1285 | Apitegromab | 1件: Apitegromab Apitegromab | 1件: Apitegromab
Apitegromab
💬
| 1件: MSTN MSTN 💬
| 1件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | 1件: 3 3 💬
|
1286 | Apitox - pure honeybee toxin | - | - | - | - | 1件: 13 13 💬
|
1287 | Apixaban | 1件: Apixaban Apixaban | 1件: Apixaban
Apixaban
💬
| 1件: F10 F10 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 222 222, 279 💬
|
1288 | Apixaban 2.5 milligram | 1件: Apixaban Apixaban | 1件: Apixaban
Apixaban
💬
| 1件: F10 F10 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 2件: 96 96, 97 💬
|
1289 | Apixaban 5 MG | 1件: Apixaban Apixaban | 1件: Apixaban
Apixaban
💬
| 1件: F10 F10 💬
| 1件: Complement and coagulation cascades Complement and coagulation cascades 💬 | 1件: 222 222 💬
|
1290 | APL-130277 | - | - | - | - | 1件: 6 6 💬
|
1291 | APL-1401 | - | - | - | - | 1件: 97 97 💬
|
1292 | APL-2 | - | - | - | - | 5件: 2 2, 61, 62, 66, 222 💬
|
1293 | APL-9796 | - | - | - | - | 1件: 86 86 💬
|
1294 | APLA12 | - | - | - | - | 1件: 46 46 💬
|
1295 | Aplindore | 1件: Aplindore Aplindore | 1件: Aplindore fumarate
Aplindore fumarate
💬
| 2件: DRD2 DRD2, DRD3 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1296 | Aplindore MR tablets | 1件: Aplindore Aplindore | 1件: Aplindore fumarate
Aplindore fumarate
💬
| 2件: DRD2 DRD2, DRD3 💬
| 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1297 | APO-GO | - | - | - | - | 1件: 6 6 💬
|
1298 | APO-P001 | - | - | - | - | 1件: 2 2 💬
|
1299 | Apoe genotype | - | - | - | - | 1件: 6 6 💬
|
1300 | Apokinon | - | - | - | - | 1件: 6 6 💬
|
1301 | Apokyn | - | - | - | - | 1件: 6 6 💬
|
1302 | Apolipoprotein E genetic test | - | - | - | - | 1件: 127 127 💬
|
1303 | Apomor | - | - | - | - | 1件: 6 6 💬
|
1304 | Apomorfina cloridrato | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1305 | Apomorp | - | - | - | - | 1件: 6 6 💬
|
1306 | Apomorphine | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 5 5, 6, 7 💬
|
1307 | Apomorphine cartridge | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1308 | Apomorphine HCL injection | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1309 | Apomorphine hydrochloride | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1310 | Apomorphine hydrochloride 1.8MG inhalation powder, PRE-dispensed | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1311 | Apomorphine hydrochloride 2.8MG inhalation powder, PRE-dispensed | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1312 | Apomorphine hydrochloride 4.0 MG inhalation powder, PRE-dispensed | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1313 | Apomorphine hydrochloride 5.8 MG inhalation powder, PRE-dispensed | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1314 | Apomorphine hydrochloride hemihydrate | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1315 | Apomorphine hydrocloride hemihydrate | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1316 | Apomorphine infusion | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1317 | Apomorphine injectable solution | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1318 | Apomorphine nasal powder | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1319 | Apomorphine pump | 1件: Apomorphine Apomorphine | 2件: Apomorphine hydrochloride
Apomorphine hydrochloride
,
Apomorphine
💬
| 2件: DRD1 DRD1, DRD2 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 💬
|
1320 | Aporon | - | - | - | - | 1件: 6 6 💬
|
1321 | Apotamox 10MG | - | - | - | - | 1件: 111 111 💬
|
1322 | Appendectomy | - | - | - | - | 1件: 97 97 💬
|
1323 | Apple smart watch single lead ECG | 1件: Apple Apple | - | - | - | 1件: 58 58 💬
|
1324 | Apple watch and APP | 1件: Apple Apple | - | - | - | 1件: 70 70 💬
|
1325 | Application OF adalimumab | - | - | - | - | 1件: 96 96 💬
|
1326 | Apply veregen ® 10 % ON A randomized area and THE moisturizing cream OF THE other side | - | - | - | - | 1件: 160 160 💬
|
1327 | Approved hypertrophic cardiomyopathy drug treatments | - | - | - | - | 1件: 58 58 💬
|
1328 | Apraclonidine HCL 0.5% OPH soln | 1件: Apraclonidine Apraclonidine | 2件: Apraclonidine hydrochloride
Apraclonidine hydrochloride
,
Apraclonidine
💬
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬
| 4件: Hormone signaling Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 11 11 💬
|
1329 | Apratastat | 1件: Apratastat Apratastat | 1件: Apratastat
Apratastat
💬
| 2件: ADAM17 ADAM17, MMP13 💬
| 9件: Alzheimer disease Alzheimer disease, Coronavirus disease - COVID-19, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, IL-17 signaling pathway, Notch signaling pathway, Parathyroid hormone synthesis, secretion and action, Relaxin signaling pathway, TNF signaling pathway 💬 | 1件: 46 46 💬
|
1330 | Apremilast | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 7件: 46 46, 50, 56, 97, 107, 162, 271 💬
|
1331 | Apremilast 10 MG | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 2件: 56 56, 107 💬
|
1332 | Apremilast 20 MG | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 3件: 46 46, 56, 107 💬
|
1333 | Apremilast 30 MG | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 3件: 46 46, 56, 107 💬
|
1334 | Apremilast 30MG | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 50 50 💬
|
1335 | Apremilast tablet 20 MG | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 271 271 💬
|
1336 | Apremilast tablet 30 MG BID | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 271 271 💬
|
1337 | Apremilast treatment | 1件: Apremilast Apremilast | 1件: Apremilast
Apremilast
💬
| 4件: PDE4 PDE4, PDE4, PDE4, PDE4 💬
| 4件: Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | 1件: 36 36 💬
|
1338 | Aprinox | - | - | - | - | 1件: 67 67 💬
|
1339 | Apriso 0.375G ER CAP | - | - | - | - | 1件: 97 97 💬
|
1340 | Apriso 375 MG extended-release capsules | - | - | - | - | 1件: 97 97 💬
|
1341 | Aprokam | - | - | - | - | 1件: 90 90 💬
|
1342 | Aprotinin | 1件: Aprotinin Aprotinin | 1件: Aprotinin
Aprotinin
💬
| - | - | 1件: 28 28 💬
|
1343 | Aprovel | 1件: Irbesartan Irbesartan | 1件: Irbesartan
Irbesartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬
|
1344 | Aprovel 150 MG tablets | 1件: Irbesartan Irbesartan | 1件: Irbesartan
Irbesartan
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 222 222 💬
|
1345 | APT-1011 | - | - | - | - | 1件: 98 98 💬
|
1346 | APT-1011 - 3 MG | - | - | - | - | 1件: 98 98 💬
|
1347 | APT-1011 3 MG HS | - | - | - | - | 1件: 98 98 💬
|
1348 | APVO210 | - | - | - | - | 1件: 97 97 💬
|
1349 | AQ280 | - | - | - | - | 1件: 98 98 💬
|
1350 | Aquadek | - | - | - | - | 1件: 299 299 💬
|
1351 | Aquadeks-2 | - | - | - | - | 1件: 299 299 💬
|
1352 | Aquamin | - | - | - | - | 1件: 97 97 💬
|
1353 | AQW051 | - | - | - | - | 1件: 6 6 💬
|
1354 | AQX-1125 | 1件: AQX-1125 AQX-1125 | - | - | - | 1件: 226 226 💬
|
1355 | AQX-1125 100 MG | 1件: AQX-1125 AQX-1125 | - | - | - | 1件: 226 226 💬
|
1356 | AQX-1125 200 MG | 1件: AQX-1125 AQX-1125 | - | - | - | 1件: 226 226 💬
|
1357 | AR-42 | 1件: AR-42 AR-42 | - | - | - | 1件: 34 34 💬
|
1358 | AR101 | - | - | - | - | 1件: 168 168 💬
|
1359 | AR392830 | - | - | - | - | 1件: 86 86 💬
|
1360 | AR401959 L-arginine | - | - | - | - | 3件: 96 96, 97, 98 💬
|
1361 | ARA 290 | - | - | - | - | 1件: 84 84 💬
|
1362 | ARA-C | - | - | - | - | 1件: 65 65 💬
|
1363 | ARA290 | - | - | - | - | 1件: 46 46 💬
|
1364 | Aramchol | 1件: Aramchol Aramchol | - | - | - | 1件: 265 265 💬
|
1365 | Aramchol meglumine | 1件: Aramchol Aramchol | - | - | - | 1件: 94 94 💬
|
1366 | Arava | 1件: Leflunomide Leflunomide | 1件: Leflunomide
Leflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 4件: 46 46, 53, 54, 162 💬
|
1367 | Arava 20 MG filmdrasjerte tabletter | - | - | - | - | 1件: 46 46 💬
|
1368 | ARB | - | - | - | - | 1件: 66 66 💬
|
1369 | ARB /angiotensin receptor blocker | - | - | - | - | 1件: 234 234 💬
|
1370 | Arbaclofen | 1件: Arbaclofen Arbaclofen | 1件: Arbaclofen
Arbaclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 2件: 13 13, 206 💬
|
1371 | Arbaclofen ER tablets | 1件: Arbaclofen Arbaclofen | 1件: Arbaclofen
Arbaclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
1372 | Arbaclofen extended release tablets | 1件: Arbaclofen Arbaclofen | 1件: Arbaclofen
Arbaclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
1373 | Arbaclofen placarbil | 2件: Arbaclofen Arbaclofen, Arbaclofen Placarbil | 2件: Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
1374 | Arbaclofen placarbil 15 MG BID | 2件: Arbaclofen Arbaclofen, Arbaclofen Placarbil | 2件: Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
1375 | Arbaclofen placarbil 30 MG BID | 2件: Arbaclofen Arbaclofen, Arbaclofen Placarbil | 2件: Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
1376 | Arbaclofen placarbil 45 MG BID | 2件: Arbaclofen Arbaclofen, Arbaclofen Placarbil | 2件: Arbaclofen placarbil
Arbaclofen placarbil
,
Arbaclofen
💬
| 2件: GABBR GABBR, GABBR 💬
| 8件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 13 13 💬
|
1377 | ARC 1779 | - | - | - | - | 2件: 64 64, 288 💬
|
1378 | ARC-AAT injection | - | - | - | - | 1件: 231 231 💬
|
1379 | ARC1779 | - | - | - | - | 2件: 64 64, 288 💬
|
1380 | ARC1779 injection | - | - | - | - | 2件: 64 64, 288 💬
|
1381 | ARC1905 | - | - | - | - | 1件: 301 301 💬
|
1382 | ARC1905 20 MG/ML | - | - | - | - | 1件: 301 301 💬
|
1383 | Arcoxia | - | - | - | - | 2件: 46 46, 271 💬
|
1384 | Arcoxia 90 MG comprimidos recubiertos CON PELícula | - | - | - | - | 1件: 271 271 💬
|
1385 | ARCT-032 | - | - | - | - | 1件: 299 299 💬
|
1386 | ARCT-810 | 1件: ARCT-810 ARCT-810 | - | - | - | 1件: 251 251 💬
|
1387 | ARD-101 | - | - | - | - | 1件: 193 193 💬
|
1388 | ARD-3150 | - | - | - | - | 1件: 299 299 💬
|
1389 | Arginine | 1件: Arginine Arginine | 3件: Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | 3件: 72 72, 225, 251 💬
|
1390 | Arginine and citrulline supplementations | 1件: Arginine Arginine | 3件: Arginine hydrochloride
Arginine hydrochloride
,
Arginine
,
Arginine hydrochloride
💬
| - | - | 1件: 21 21 💬
|
1391 | Argininhydrochlorid | - | - | - | - | 1件: 65 65 💬
|
1392 | ARGX-113 | - | - | - | - | 5件: 11 11, 14, 35, 53, 63 💬
|
1393 | ARGX-117 | - | - | - | - | 1件: 14 14 💬
|
1394 | ARGX-117 IV | - | - | - | - | 1件: 14 14 💬
|
1395 | ARGX-119 | 1件: ARGX-119 ARGX-119 | - | - | - | 2件: 2 2, 12 💬
|
1396 | Aricept | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 3件: 6 6, 13, 124 💬
|
1397 | Aricept 10 MG filmdragerade tabletter | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 13 13 💬
|
1398 | Aricept 5 MG filmdragerade tabletter | 1件: Donepezil Donepezil | 2件: Donepezil hydrochloride
Donepezil hydrochloride
,
Donepezil
💬
| 1件: ACHE ACHE 💬
| 3件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | 1件: 13 13 💬
|
1399 | Aricept 5 MG-filmtabletten | - | - | - | - | 1件: 6 6 💬
|
1400 | Aricept 5MG-filmtabletten | - | - | - | - | 1件: 6 6 💬
|
1401 | Aridol or osmohale | 1件: Mannitol Mannitol | 1件: Mannitol
Mannitol
💬
| - | - | 1件: 299 299 💬
|
1402 | Arikayce™ 140 MG | - | - | - | - | 1件: 299 299 💬
|
1403 | Arikayce™ 560 MG | - | - | - | - | 1件: 299 299 💬
|
1404 | Arikayce™ 70 MG | - | - | - | - | 1件: 299 299 💬
|
1405 | Arimidex | 1件: Anastrozole Anastrozole | 1件: Anastrozole
Anastrozole
💬
| 1件: CYP19A CYP19A 💬
| 2件: Ovarian steroidogenesis Ovarian steroidogenesis, Steroid hormone biosynthesis 💬 | 1件: 78 78 💬
|
1406 | Arimoclomol | 1件: Arimoclomol Arimoclomol | 2件: Arimoclomol
Arimoclomol
,
Arimoclomol citrate
💬
| - | - | 3件: 2 2, 15, 19 💬
|
1407 | Arimoclomol citrate | 1件: Arimoclomol Arimoclomol | 2件: Arimoclomol
Arimoclomol
,
Arimoclomol citrate
💬
| - | - | 2件: 15 15, 19 💬
|
1408 | Arina-1 | - | - | - | - | 2件: 228 228, 299 💬
|
1409 | Aripiprazole | 1件: Aripiprazole Aripiprazole | 1件: Aripiprazole
Aripiprazole
💬
| 4件: DRD2 DRD2, DRD3, HTR1, HTR2 💬
| 14件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 206 💬
|
1410 | ARM 1 - GEH120714 (18F) injection | - | - | - | - | 1件: 13 13 💬
|
1411 | ARM 2 | - | - | - | - | 1件: 97 97 💬
|
1412 | ARM B- standard OF care | - | - | - | - | 1件: 97 97 💬
|
1413 | ARM1 | - | - | - | - | 1件: 97 97 💬
|
1414 | Armodafinil | 1件: Armodafinil Armodafinil | 1件: Armodafinil
Armodafinil
💬
| 1件: SLC6A3 SLC6A3 💬
| 8件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 84 💬
|
1415 | ARN-6039 | - | - | - | - | 1件: 13 13 💬
|
1416 | ARO-AAT | 1件: Fazirsiran Fazirsiran | - | - | - | 1件: 231 231 💬
|
1417 | ARO-AAT injection | 1件: Fazirsiran Fazirsiran | - | - | - | 1件: 231 231 💬
|
1418 | ARO-ANG 3 injection | - | - | - | - | 1件: 79 79 💬
|
1419 | ARO-C3 | - | - | - | - | 1件: 66 66 💬
|
1420 | ARO-CFB | - | - | - | - | 1件: 66 66 💬
|
1421 | ARO-DM1 FOR injection | - | - | - | - | 1件: 113 113 💬
|
1422 | ARO-DUX4 FOR injection | - | - | - | - | 1件: 113 113 💬
|
1423 | ARO-enac | - | - | - | - | 1件: 299 299 💬
|
1424 | ARO-MMP7 inhalation solution | - | - | - | - | 1件: 85 85 💬
|
1425 | ARO-SOD1 injection | - | - | - | - | 1件: 2 2 💬
|
1426 | ARRY-371797 | - | - | - | - | 1件: 271 271 💬
|
1427 | ARRY-371797, P38 inhibitor | - | - | - | - | 2件: 46 46, 271 💬
|
1428 | ARRY-438162 | - | - | - | - | 1件: 46 46 💬
|
1429 | ARRY-438162, MEK inhibitor | - | - | - | - | 1件: 46 46 💬
|
1430 | ART-123 | - | - | - | - | 1件: 85 85 💬
|
1431 | ART-I02 | - | - | - | - | 1件: 46 46 💬
|
1432 | ART621 | - | - | - | - | 1件: 46 46 💬
|
1433 | Artamin 150 MG | - | - | - | - | 1件: 171 171 💬
|
1434 | Artamin 250 MG | - | - | - | - | 1件: 171 171 💬
|
1435 | Artesunate | 1件: Artesunate Artesunate | 1件: Artesunate
Artesunate
💬
| - | - | 4件: 18 18, 66, 86, 96 💬
|
1436 | Artesunate oral product | 1件: Artesunate Artesunate | 1件: Artesunate
Artesunate
💬
| - | - | 2件: 18 18, 85 💬
|
1437 | Arthroscopic synovectomy OF THE wrist | - | - | - | - | 1件: 46 46 💬
|
1438 | Arthroscopic synovial tissue biopsy | - | - | - | - | 1件: 46 46 💬
|
1439 | Arthroscopy & saline irrigation alone | - | - | - | - | 1件: 46 46 💬
|
1440 | Artificial saliva | - | - | - | - | 1件: 53 53 💬
|
1441 | Artilog | - | - | - | - | 1件: 46 46 💬
|
1442 | Arundic acid | 1件: Arundic acid Arundic acid | 1件: Arundic acid
Arundic acid
💬
| - | - | 1件: 2 2 💬
|
1443 | Arylsulfatase A | - | - | - | - | 1件: 19 19 💬
|
1444 | Arzerra | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
1445 | Arzerra - 100 MG - concentrato PER soluzione PER infusione - USO endovenoso - flacone(vetro) - 5 ML(20MG/ML) 3 flaconi | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
1446 | Arzerra - 1000 MG - concentrato PER soluzione PER infusione - USO endovenoso - flaconcino (vetro) - 50 ML (20 MG/ML) 1 flaconcino + 2 KIT DI prolunga | 1件: Ofatumumab Ofatumumab | 1件: Ofatumumab
Ofatumumab
💬
| 1件: MS4A1 MS4A1 💬
| 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 1件: 13 13 💬
|
1447 | AS2 | - | - | - | - | 1件: 6 6 💬
|
1448 | ASA | - | - | - | - | 1件: 13 13 💬
|
1449 | Asacol | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1450 | Asacol (mesalamine) delayed-release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1451 | Asacol 400 MG | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1452 | Asacol 400 MG tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1453 | Asacol 400MG tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1454 | Asacol 800 MG tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1455 | Asacol 800MG tablet | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1456 | Asacol delayed release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1457 | Asacol delayed-release tablets | 1件: Mesalazine Mesalazine | 1件: Mesalamine
Mesalamine
💬
| - | - | 1件: 97 97 💬
|
1458 | Asacol® 400 MG | - | - | - | - | 1件: 97 97 💬
|
1459 | Asasantin retard | - | - | - | - | 1件: 51 51 💬
|
1460 | ASB-683699 | - | - | - | - | 1件: 13 13 💬
|
1461 | ASC | - | - | - | - | 1件: 97 97 💬
|
1462 | ASC42 10 MG | - | - | - | - | 1件: 93 93 💬
|
1463 | ASC42 15 MG | - | - | - | - | 1件: 93 93 💬
|
1464 | ASC42 5 MG | - | - | - | - | 1件: 93 93 💬
|
1465 | Ascal(R) / carbasalate calcium | - | - | - | - | 1件: 46 46 💬
|
1466 | Asclera | - | - | - | - | 1件: 34 34 💬
|
1467 | Ascorbic acid | 1件: Ascorbic acid Ascorbic acid | 1件: Ascorbic acid
Ascorbic acid
💬
| - | - | 4件: 10 10, 97, 206, 298 💬
|
1468 | Ascs | - | - | - | - | 2件: 53 53, 97 💬
|
1469 | Ascs: adipose derived stem cells | - | - | - | - | 1件: 96 96 💬
|
1470 | Ascs:adipose derived stem cells | - | - | - | - | 1件: 97 97 💬
|
1471 | Asendis 50 MG | - | - | - | - | 1件: 46 46 💬
|
1472 | Asfotas alfa | - | - | - | - | 1件: 172 172 💬
|
1473 | Asfotase alfa | 1件: Asfotase alfa Asfotase alfa | 1件: Asfotase alfa
Asfotase alfa
💬
| 1件: E3.1.3.1 E3.1.3.1 💬
| 2件: Folate biosynthesis Folate biosynthesis, Thiamine metabolism 💬 | 1件: 172 172 💬
|
1474 | ASK NR. 21972 | - | - | - | - | 1件: 5 5 💬
|
1475 | ASK8007 | - | - | - | - | 1件: 46 46 💬
|
1476 | ASP015K | - | - | - | - | 2件: 46 46, 97 💬
|
1477 | ASP015K hydrobromide, AS1940150-BR, JKT-201A, 4-{[(1R,2S,3S,5S,7S)-5-hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-B]pyridine-5-carboxamide monohydrobromide | - | - | - | - | 1件: 46 46 💬
|
1478 | ASP1707 | - | - | - | - | 1件: 46 46 💬
|
1479 | ASP2016 | - | - | - | - | 1件: 18 18 💬
|
1480 | ASP2408 | - | - | - | - | 1件: 46 46 💬
|
1481 | ASP2409 | - | - | - | - | 1件: 46 46 💬
|
1482 | ASP3291 | - | - | - | - | 1件: 97 97 💬
|
1483 | ASP3652 | - | - | - | - | 1件: 226 226 💬
|
1484 | ASP5094 | - | - | - | - | 1件: 46 46 💬
|
1485 | ASP5502 | - | - | - | - | 1件: 53 53 💬
|
1486 | ASP6294 | - | - | - | - | 1件: 226 226 💬
|
1487 | Aspaveli | 1件: Pegcetacoplan Pegcetacoplan | 1件: Pegcetacoplan
Pegcetacoplan
💬
| 1件: C3 C3 💬
| 17件: Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | 4件: 2 2, 61, 62, 222 💬
|
1488 | Aspergillus oryzae | 1件: Aspergillus oryzae Aspergillus oryzae | - | - | - | 1件: 97 97 💬
|
1489 | Aspirin | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 12件: 13 13, 22, 34, 46, 49, 51, 86, 113, 158, 210, 231, 271 💬
|
1490 | Aspirin 650MG oral capsule | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 13 13 💬
|
1491 | Aspirin 81MG EC TAB | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 96 96, 97 💬
|
1492 | Aspirin 81MG tablet | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
1493 | Aspirin and meloxicam | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 49 49 💬
|
1494 | Aspirin tablet | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 64 64 💬
|
1495 | Aspirin tablets | 1件: Acetylsalicylic acid Acetylsalicylic acid | 1件: Aspirin
Aspirin
💬
| 2件: PTGS1 PTGS1, PTGS2 💬
| 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 46 46 💬
|
1496 | Assessment during THE transition between OFF-levodopa (I.E. withdrawal OF levodopa phase) and ON-levodopa (I.E. effect OF levodopa phase)states | - | - | - | - | 1件: 6 6 💬
|
1497 | Assessment OF activity and muscle fatigue | - | - | - | - | 1件: 3 3 💬
|
1498 | Assessment OF arterial stiffness using THE vasera VS-1500N | - | - | - | - | 2件: 89 89, 299 💬
|
1499 | Assessment OF biological factors | - | - | - | - | 1件: 97 97 💬
|
1500 | Assessment OF bulbar function | - | - | - | - | 1件: 3 3 💬
|
1501 | Assessment OF cognition | - | - | - | - | 1件: 6 6 💬
|
1502 | Assessment OF depression | - | - | - | - | 1件: 6 6 💬
|
1503 | Assessment OF disability | - | - | - | - | 1件: 13 13 💬
|
1504 | Assessment OF genetics | - | - | - | - | 1件: 97 97 💬
|
1505 | Assessment OF impact OF MS ON cognition | - | - | - | - | 1件: 13 13 💬
|
1506 | Assessment OF medication compliance | - | - | - | - | 1件: 98 98 💬
|
1507 | Assessment OF motor and NON-motors symptoms OF PD evaluation OF hyper- and hypodopaminergic behaviors | - | - | - | - | 1件: 6 6 💬
|
1508 | Assessment OF psychophysiological factors | - | - | - | - | 1件: 97 97 💬
|
1509 | Assessment OF quality OF life | - | - | - | - | 2件: 6 6, 97 💬
|
1510 | Assessment OF severity OF parkinson disease | - | - | - | - | 1件: 6 6 💬
|
1511 | Assessment OF therapy complications | - | - | - | - | 1件: 60 60 💬
|
1512 | Assessments IN ON and OFF levodopa state | - | - | - | - | 1件: 6 6 💬
|
1513 | Assigned interventions CD19/bcma CAR T-cells | - | - | - | - | 3件: 49 49, 51, 53 💬
|
1514 | Assigned pulmonary hypertension medication | - | - | - | - | 1件: 86 86 💬
|
1515 | AST-120 | - | - | - | - | 2件: 96 96, 97 💬
|
1516 | Astaxanthin | 1件: Astaxanthin Astaxanthin | - | - | - | 1件: 2 2 💬
|
1517 | Asthma patients | - | - | - | - | 1件: 299 299 💬
|
1518 | Astrorx | - | - | - | - | 1件: 2 2 💬
|
1519 | Asyn MAB | - | - | - | - | 1件: 6 6 💬
|
1520 | AT-02 | - | - | - | - | 1件: 28 28 💬
|
1521 | AT-1501 | - | - | - | - | 1件: 66 66 💬
|
1522 | AT-GTX-501 | - | - | - | - | 1件: 19 19 💬
|
1523 | AT-home natalizumab treated MS patient | - | - | - | - | 1件: 13 13 💬
|
1524 | AT02 | - | - | - | - | 1件: 28 28 💬
|
1525 | AT1001 | - | - | - | - | 1件: 19 19 💬
|
1526 | AT1001 150 MG | - | - | - | - | 1件: 19 19 💬
|
1527 | AT132 | - | - | - | - | 1件: 111 111 💬
|
1528 | AT2101 | - | - | - | - | 1件: 19 19 💬
|
1529 | AT2220 | 1件: AT2220 AT2220 | - | - | - | 1件: 256 256 💬
|
1530 | AT2221 | 1件: Miglustat Miglustat | 1件: Miglustat
Miglustat
💬
| 1件: UGCG UGCG 💬
| 2件: Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | 1件: 256 256 💬
|
1531 | AT2221 65 MG formulated capsules | 1件: Miglustat Miglustat | 1件: Miglustat
Miglustat
💬
| 1件: UGCG UGCG 💬
| 2件: Cornified envelope formation Cornified envelope formation, Sphingolipid metabolism 💬 | 1件: 256 256 💬
|
1532 | AT845 | 1件: AT845 AT845 | - | - | - | 1件: 256 256 💬
|
1533 | ATA-200 | - | - | - | - | 1件: 113 113 💬
|
1534 | ATA188 | - | - | - | - | 1件: 13 13 💬
|
1535 | ATA3219 | - | - | - | - | 1件: 49 49 💬
|
1536 | Atacicept | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 5件: 13 13, 46, 49, 66, 222 💬
|
1537 | Atacicept 150 MG | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 13 13, 49, 66 💬
|
1538 | Atacicept 25 MG | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 2件: 13 13, 66 💬
|
1539 | Atacicept 75 MG | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 3件: 13 13, 49, 66 💬
|
1540 | Atacicept: with loading dose | 1件: Atacicept Atacicept | 1件: Atacicept
Atacicept
💬
| 2件: TNFSF13 TNFSF13, TNFSF13B 💬
| 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | 1件: 46 46 💬
|
1541 | Ataluren | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 6件: 19 19, 113, 140, 246, 299, 329 💬
|
1542 | Ataluren 1000 MG | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
1543 | Ataluren 1000MG | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 246 246 💬
|
1544 | Ataluren 125 MG | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
1545 | Ataluren 125MG | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 246 246 💬
|
1546 | Ataluren 250 MG | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 113 113 💬
|
1547 | Ataluren 250MG | 1件: Ataluren Ataluren | 1件: Ataluren
Ataluren
💬
| - | - | 1件: 246 246 💬
|
1548 | Atazanavir | 1件: Atazanavir Atazanavir | 2件: Atazanavir sulfate
Atazanavir sulfate
,
Atazanavir
💬
| - | - | 1件: 265 265 💬
|
1549 | Atazanavir/ritonavir | 1件: Atazanavir Atazanavir | 2件: Atazanavir sulfate
Atazanavir sulfate
,
Atazanavir
💬
| - | - | 1件: 265 265 💬
|
1550 | ATB200 | - | - | - | - | 1件: 256 256 💬
|
1551 | Atenolol | 1件: Atenolol Atenolol | 1件: Atenolol
Atenolol
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬
|
1552 | Atenolol or propranolol | 1件: Atenolol Atenolol | 1件: Atenolol
Atenolol
💬
| 1件: ADRB1 ADRB1 💬
| 13件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 167 167 💬
|
1553 | Atezolizumab | 1件: Atezolizumab Atezolizumab | 1件: Atezolizumab
Atezolizumab
💬
| 1件: PDL1 PDL1 💬
| 2件: Cell adhesion molecules Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 | 1件: 85 85 💬
|
1554 | ATG | - | - | - | - | 6件: 13 13, 19, 60, 96, 222, 285 💬
|
1555 | ATG+cyclosporine | - | - | - | - | 1件: 60 60 💬
|
1556 | ATG+rapamune+cyclosporine | - | - | - | - | 1件: 60 60 💬
|
1557 | ATG-F | - | - | - | - | 1件: 66 66 💬
|
1558 | ATG-fresenius | - | - | - | - | 1件: 60 60 💬
|
1559 | Atgam | - | - | - | - | 1件: 60 60 💬
|
1560 | Atgam 50 MG/ML, solution à diluer pour perfusion | 1件: Antilymphocyte immunoglobulin (horse) Antilymphocyte immunoglobulin (horse) | 1件: Anti-human thymocyte immunoglobulin, equine
Anti-human thymocyte immunoglobulin, equine
💬
| - | - | 1件: 60 60 💬
|
1561 | Atgam plus CSA with or without eltrombopag | - | - | - | - | 1件: 60 60 💬
|
1562 | ATH-063 | - | - | - | - | 2件: 96 96, 97 💬
|
1563 | ATH-1017 | - | - | - | - | 1件: 6 6 💬
|
1564 | ATH434 | - | - | - | - | 1件: 17 17 💬
|
1565 | ATH434 dose level 1 | - | - | - | - | 1件: 17 17 💬
|
1566 | ATH434 dose level 2 | - | - | - | - | 1件: 17 17 💬
|
1567 | ATH434 mesylate | - | - | - | - | 1件: 17 17 💬
|
1568 | Athena CAR-T | - | - | - | - | 1件: 49 49 💬
|
1569 | ATI-450 | - | - | - | - | 2件: 46 46, 106 💬
|
1570 | ATI-450 20 MG oral tablet BID | - | - | - | - | 1件: 46 46 💬
|
1571 | ATI-450 50 MG oral tablet BID | - | - | - | - | 1件: 46 46 💬
|
1572 | ATL 1102 | - | - | - | - | 1件: 113 113 💬
|
1573 | ATL-2502 | 1件: ATL-2502 ATL-2502 | - | - | - | 1件: 97 97 💬
|
1574 | ATL1102 | 1件: ATL1102 ATL1102 | - | - | - | 2件: 13 13, 113 💬
|
1575 | ATL1102 25MG | 1件: ATL1102 ATL1102 | - | - | - | 1件: 113 113 💬
|
1576 | ATL1102 50MG | 1件: ATL1102 ATL1102 | - | - | - | 1件: 113 113 💬
|
1577 | ATL1103 | - | - | - | - | 1件: 77 77 💬
|
1578 | ATM FOG IN PD | - | - | - | - | 1件: 6 6 💬
|
1579 | ATN-103 | - | - | - | - | 1件: 46 46 💬
|
1580 | ATN-103 10 MG Q4WKS | - | - | - | - | 1件: 46 46 💬
|
1581 | ATN-103 10 MG Q8WKS | - | - | - | - | 1件: 46 46 💬
|
1582 | ATN-103 30 MG Q4WKS | - | - | - | - | 1件: 46 46 💬
|
1583 | ATN-103 80 MG Q4WKS | - | - | - | - | 1件: 46 46 💬
|
1584 | ATN-103 80 MG Q8WKS | - | - | - | - | 1件: 46 46 💬
|
1585 | Atogepant | 1件: Atogepant Atogepant | 1件: Atogepant
Atogepant
💬
| 1件: CALCRL CALCRL 💬
| 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction 💬 | 1件: 226 226 💬
|
1586 | Atomexetine | - | - | - | - | 1件: 17 17 💬
|
1587 | Atomoxetina | 1件: Atomoxetine Atomoxetine | 2件: Atomoxetine hydrochloride
Atomoxetine hydrochloride
,
Atomoxetine
💬
| 1件: SLC6A2 SLC6A2 💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle 💬 | 1件: 230 230 💬
|
1588 | Atomoxetine | 1件: Atomoxetine Atomoxetine | 2件: Atomoxetine hydrochloride
Atomoxetine hydrochloride
,
Atomoxetine
💬
| 1件: SLC6A2 SLC6A2 💬
| 2件: Neuroactive ligand signaling Neuroactive ligand signaling, Synaptic vesicle cycle 💬 | 3件: 6 6, 8, 13 💬
|
1589 | Atorvastatin | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 17件: 13 13, 22, 46, 49, 51, 58, 79, 84, 88, 93, 96, 97, 160, 225, 271, 297, 299 💬
|
1590 | Atorvastatin 10MG | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 63 63 💬
|
1591 | Atorvastatin 20 MG oral tablet | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 67 67 💬
|
1592 | Atorvastatin 20MG | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 63 63 💬
|
1593 | Atorvastatin 40 MG oral tablet + N-acetylcysteine 400 MG oral tablet | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 63 63 💬
|
1594 | Atorvastatin 80MG | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 97 97 💬
|
1595 | Atorvastatin calcium | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 2件: 97 97, 265 💬
|
1596 | Atorvastatin tablet 20 MG | 1件: Atorvastatin Atorvastatin | 2件: Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| 1件: HMGCR HMGCR 💬
| 3件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | 1件: 46 46 💬
|
1597 | Atosiban | 1件: Atosiban Atosiban | 2件: Atosiban
Atosiban
,
Atosiban acetate
💬
| 1件: OXTR OXTR 💬
| 5件: Calcium signaling pathway Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 1件: 118 118 💬
|
1598 | Atovaquone | 1件: Atovaquone Atovaquone | 1件: Atovaquone
Atovaquone
💬
| - | - | 1件: 61 61 💬
|
1599 | ATR-101 | - | - | - | - | 2件: 75 75, 81 💬
|
1600 | ATR12-351 | - | - | - | - | 1件: 160 160 💬
|
1601 | Atra | 1件: Tretinoin Tretinoin | 1件: Tretinoin
Tretinoin
💬
| 3件: PML PML, RARA, RARB 💬
| 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 2件: 63 63, 94 💬
|
1602 | Atrasentan | 1件: Atrasentan Atrasentan | 1件: Atrasentan hydrochloride
Atrasentan hydrochloride
💬
| 1件: EDNRA EDNRA 💬
| 7件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 3件: 66 66, 218, 222 💬
|
1603 | Atropina | 1件: Atropine Atropine | 2件: Atropine
Atropine
,
Atropine sulfate
💬
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬
| 14件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 299 299 💬
|
1604 | Atumelnant | - | - | - | - | 1件: 75 75 💬
|
1605 | ATV | - | - | - | - | 1件: 265 265 💬
|
1606 | ATX-01 | 1件: ATX-01 ATX-01 | - | - | - | 1件: 113 113 💬
|
1607 | ATX-MS-1467 | - | - | - | - | 1件: 13 13 💬
|
1608 | Atypical antipsychotics | - | - | - | - | 1件: 6 6 💬
|
1609 | ATYR1923 | - | - | - | - | 1件: 84 84 💬
|
1610 | ATYR1923 1.0 MG/KG | - | - | - | - | 1件: 84 84 💬
|
1611 | ATYR1923 3.0 MG/KG | - | - | - | - | 1件: 84 84 💬
|
1612 | ATYR1923 5.0 MG/KG | - | - | - | - | 1件: 84 84 💬
|
1613 | ATYR1940 | 1件: ATYR-1940 ATYR-1940 | - | - | - | 1件: 113 113 💬
|
1614 | Aubagio | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
1615 | Aubagio - 14 MG - compressa rivestita CON film - USO orale - bister (ALU/ALU) perforato monodose - 10 X 1 compressa | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
1616 | Aubagio - 14 MG - compressa rivestita CON film - USO orale - blister (ALU/ALU) - 28 compresse | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
1617 | Aubagio 14 MG FILM-coated tablets | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
1618 | Aubagio 14MG TBL FLM | 1件: Teriflunomide Teriflunomide | 1件: Teriflunomide
Teriflunomide
💬
| 1件: DHODH DHODH 💬
| 1件: Pyrimidine metabolism Pyrimidine metabolism 💬 | 1件: 13 13 💬
|
1619 | AUC OF MPA measure | - | - | - | - | 1件: 51 51 💬
|
1620 | Audiology assessment with ABR | - | - | - | - | 1件: 19 19 💬
|
1621 | Augmentin | 2件: Amoxicillin Amoxicillin, Clavulanic acid | 5件: Amoxicillin
Amoxicillin
,
Clavulanate potassium
,
Amoxicillin sodium
,
Amoxicillin
,
Clavulanic acid
💬
| - | - | 1件: 299 299 💬
|
1622 | AUTO-titrating oxygen system | - | - | - | - | 1件: 85 85 💬
|
1623 | Autoantibody reductive therapy | - | - | - | - | 1件: 85 85 💬
|
1624 | Autofluorescent detection + injection OF indocyanine green | - | - | - | - | 1件: 235 235 💬
|
1625 | Autogenic drainage | - | - | - | - | 1件: 299 299 💬
|
1626 | Autoinjector | - | - | - | - | 1件: 46 46 💬
|
1627 | Autologous (self) mononuclear cells derived from umbilical cord blood | - | - | - | - | 1件: 211 211 💬
|
1628 | Autologous adipose derived mesenchymal cells | - | - | - | - | 1件: 13 13 💬
|
1629 | Autologous adipose derived stem cells | - | - | - | - | 1件: 46 46 💬
|
1630 | Autologous adipose derived stromal vascular fraction | - | - | - | - | 1件: 96 96 💬
|
1631 | Autologous adipose mesenchymal stem cell implantation | - | - | - | - | 1件: 17 17 💬
|
1632 | Autologous adipose-derived mesenchymal stromal cells | - | - | - | - | 1件: 2 2 💬
|
1633 | Autologous adult bone marrow mononuclear cells (BM-MNC) unexpanded | - | - | - | - | 1件: 2 2 💬
|
1634 | Autologous adult bone marrow mononuclear cells unexpanded | - | - | - | - | 1件: 2 2 💬
|
1635 | Autologous adult mesenchymal stem cells from bone marrow expanded and cryopreserved | - | - | - | - | 1件: 13 13 💬
|
1636 | Autologous apoptotic cells injection | - | - | - | - | 1件: 46 46 💬
|
1637 | Autologous ASC | - | - | - | - | 1件: 51 51 💬
|
1638 | Autologous bone marrow mononuclear cell transplantation | - | - | - | - | 1件: 113 113 💬
|
1639 | Autologous bone marrow mononucleated cells | - | - | - | - | 1件: 2 2 💬
|
1640 | Autologous bone marrow transplantation | - | - | - | - | 2件: 13 13, 28 💬
|
1641 | Autologous bone marrow-derived mononuclear stem cells | - | - | - | - | 1件: 13 13 💬
|
1642 | Autologous bone marrow-derived stem cells | - | - | - | - | 1件: 2 2 💬
|
1643 | Autologous CD34 positive cells transduced with A lentiviral vector containing human WAS gene | - | - | - | - | 1件: 65 65 💬
|
1644 | Autologous CD34+ cells transduced EX-vivo with THE pcclchimgp91/vsvg lentiviral vector | - | - | - | - | 1件: 65 65 💬
|
1645 | Autologous CD34+ cells transduced with A lentiviral vector containing THE human sgsh gene | - | - | - | - | 1件: 19 19 💬
|
1646 | Autologous CD34+ cells transduced with A lentiviral vector encoding THE arsa cdna | - | - | - | - | 1件: 19 19 💬
|
1647 | Autologous CD34+ cells transduced with lenti-D vector encoding ABCD1 cdna | 1件: Elivaldogene tavalentivec Elivaldogene tavalentivec | - | - | - | 1件: 20 20 💬
|
1648 | Autologous CD34+ cells transduced with THE G1xcgd lentiviral vector | - | - | - | - | 1件: 65 65 💬
|
1649 | Autologous CD34+ cells transduced with THE lentiviral vector containing THE human wiskott aldrich SY | - | - | - | - | 1件: 65 65 💬
|
1650 | Autologous CD34+ cells transduced with wasp lentiviral vector | - | - | - | - | 1件: 65 65 💬
|
1651 | Autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with lentiviral vector that encodes FOR THE human wiskott aldrich syndrome (WAS) cdna sequence | - | - | - | - | 1件: 65 65 💬
|
1652 | Autologous CD34+ hscs transduced EX vivo with CD11B LV encoding human IDS tagged with apoeii | - | - | - | - | 1件: 19 19 💬
|
1653 | Autologous CD34+ hscs transduced EX vivo with EFS lentiviral vector encoding FOR THE human ADA gene | - | - | - | - | 1件: 65 65 💬
|
1654 | Autologous CD34+cells transduced with THE W1.6_hwasp_wpre (vsvg) lentiviral vector | - | - | - | - | 1件: 65 65 💬
|
1655 | Autologous CD34-selected peripheral blood stem cells transplant | - | - | - | - | 1件: 96 96 💬
|
1656 | Autologous CD4+T cells stimulated and expanded EX vivo BY A MOG peptide modified BY THE introduction OF A thioreductase motif into THE flanking residues OF THE T cell epitope | - | - | - | - | 1件: 13 13 💬
|
1657 | Autologous CELL-based delivery | - | - | - | - | 1件: 211 211 💬
|
1658 | Autologous dopaminergic cell implantation | - | - | - | - | 1件: 6 6 💬
|
1659 | Autologous EBV specific CTL infusion | - | - | - | - | 1件: 49 49 💬
|
1660 | Autologous haematopoietic stem cells transduced with lentiviral vector lenti-D encoding THE human ABCD1 cdna | 1件: Elivaldogene tavalentivec Elivaldogene tavalentivec | - | - | - | 1件: 20 20 💬
|
1661 | Autologous HB-admscs | - | - | - | - | 1件: 13 13 💬
|
1662 | Autologous hematopoietic stem cell | - | - | - | - | 1件: 13 13 💬
|
1663 | Autologous hematopoietic stem cell transplant | - | - | - | - | 1件: 13 13 💬
|
1664 | Autologous hematopoietic stem cell transplantation | - | - | - | - | 7件: 11 11, 13, 14, 28, 49, 51, 84 💬
|
1665 | Autologous hematopoietic stem cells | - | - | - | - | 1件: 13 13 💬
|
1666 | Autologous induced neural stem CELL-derived DA precursor cells | - | - | - | - | 1件: 6 6 💬
|
1667 | Autologous mature tolerogenic monocyte-derived dendritic cells loaded with THE B29 peptide OF HSP70 | - | - | - | - | 1件: 46 46 💬
|
1668 | Autologous mesenchymal cell product | - | - | - | - | 1件: 13 13 💬
|
1669 | Autologous mesenchymal stem cell transplantation | - | - | - | - | 1件: 13 13 💬
|
1670 | Autologous mesenchymal stem cells | - | - | - | - | 5件: 2 2, 6, 13, 17, 46 💬
|
1671 | Autologous mesenchymal stem cells derived from bone marrow | - | - | - | - | 1件: 85 85 💬
|
1672 | Autologous mesenchymal stromal cell | - | - | - | - | 2件: 96 96, 298 💬
|
1673 | Autologous midbrain dopamine neurons | - | - | - | - | 1件: 6 6 💬
|
1674 | Autologous MSC-NTF cells | 1件: Debamestrocel Debamestrocel | - | - | - | 1件: 2 2 💬
|
1675 | Autologous myelin-derived peptide-pulsed tolerogenic dendritic cells | - | - | - | - | 1件: 13 13 💬
|
1676 | Autologous ovalbumin-specific type 1 regulatory T lymphocytes expanded population | - | - | - | - | 1件: 96 96 💬
|
1677 | Autologous peripheral blood stem cell transplantation | - | - | - | - | 8件: 28 28, 40, 41, 42, 45, 46, 49, 283 💬
|
1678 | Autologous plasmablasts | - | - | - | - | 1件: 19 19 💬
|
1679 | Autologous platelet rich plasma | - | - | - | - | 1件: 35 35 💬
|
1680 | Autologous platelet-poor plasma (PPP) and thrombin coagulum treatment | - | - | - | - | 1件: 97 97 💬
|
1681 | Autologous platelet-rich plasma (PRP) and thrombin coagulum treatment | - | - | - | - | 1件: 97 97 💬
|
1682 | Autologous regulatory ?-cells | - | - | - | - | 1件: 51 51 💬
|
1683 | Autologous serum | - | - | - | - | 1件: 53 53 💬
|
1684 | Autologous serum tears combined with 0.05% cyclosporin EYE drop | - | - | - | - | 1件: 53 53 💬
|
1685 | Autologous stem cell | - | - | - | - | 1件: 8 8 💬
|
1686 | Autologous stem cell transplant | - | - | - | - | 4件: 28 28, 53, 56, 96 💬
|
1687 | Autologous stem cell transplantation | - | - | - | - | 4件: 13 13, 28, 56, 96 💬
|
1688 | Autologous stem cells | - | - | - | - | 2件: 13 13, 51 💬
|
1689 | Autologous stemcell transplantation with CD (cluster OF differentiation) 34 selected stem cells | - | - | - | - | 1件: 51 51 💬
|
1690 | Autologous stromal vascular fraction cells | - | - | - | - | 1件: 46 46 💬
|
1691 | Autologous T-lymphocytes | - | - | - | - | 1件: 13 13 💬
|
1692 | Autologous T-regulatory lymphocytes | - | - | - | - | 1件: 2 2 💬
|
1693 | Autologous tissue-engineered vascular graft | - | - | - | - | 1件: 210 210 💬
|
1694 | Autologous umbilical cord blood | 1件: Autologous cord blood Autologous cord blood | - | - | - | 2件: 211 211, 294 💬
|
1695 | Autologous-autologous tandem hematopoietic stem cell transplantation | - | - | - | - | 1件: 28 28 💬
|
1696 | Automated abdominal binder | - | - | - | - | 1件: 17 17 💬
|
1697 | Autonomic testing ON and OFF levodopa | - | - | - | - | 1件: 6 6 💬
|
1698 | AV-101 | 1件: AV-101 AV-101 | - | - | - | 2件: 6 6, 86 💬
|
1699 | AV1451 TAU | - | - | - | - | 3件: 6 6, 17, 127 💬
|
1700 | AV605 | - | - | - | - | 1件: 13 13 💬
|
1701 | Avacincaptad pegol | 1件: Avacincaptad pegol Avacincaptad pegol | 1件: Avacincaptad pegol sodium
Avacincaptad pegol sodium
💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 301 301 💬
|
1702 | Avacopan | 1件: Avacopan Avacopan | 1件: Avacopan
Avacopan
💬
| 1件: C5AR1 C5AR1 💬
| 6件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Staphylococcus aureus infection 💬 | 4件: 43 43, 44, 66, 222 💬
|
1703 | Avalglucosidase alfa | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
1704 | Avalglucosidase ALFA-ngpt (GZ402666) IV | 1件: Avalglucosidase alfa Avalglucosidase alfa | 1件: Avalglucosidase alfa
Avalglucosidase alfa
💬
| 1件: GAA GAA 💬
| 3件: Galactose metabolism Galactose metabolism, Lysosome, Starch and sucrose metabolism 💬 | 1件: 256 256 💬
|
1705 | Avalglucosidasi alfa | - | - | - | - | 1件: 256 256 💬
|
1706 | Avalotcagene ontaparvovec | 1件: Avalotcagene ontaparvovec Avalotcagene ontaparvovec | - | - | - | 1件: 251 251 💬
|
1707 | Avandia administration FOR 6-12 weeks | - | - | - | - | 1件: 265 265 💬
|
1708 | Avandia*28CPR RIV 4MG | 1件: Rosiglitazone Rosiglitazone | 2件: Rosiglitazone maleate
Rosiglitazone maleate
,
Rosiglitazone
💬
| 1件: NR1C3 NR1C3 💬
| 12件: AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 77 77 💬
|
1709 | Avastin | 1件: Bevacizumab Bevacizumab | 1件: Bevacizumab
Bevacizumab
💬
| 1件: VEGFA VEGFA 💬
| 23件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 1件: 227 227 💬
|
1710 | Avastin 25 MG/ML - konzentrat ZUR herstellung einer infusionsloesung | 1件: Bevacizumab Bevacizumab | 1件: Bevacizumab
Bevacizumab
💬
| 1件: VEGFA VEGFA 💬
| 23件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬 | 1件: 227 227 💬
|
1711 | Avatrombopag | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 2件: 60 60, 63 💬
|
1712 | Avatrombopag +rhtpo | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 60 60 💬
|
1713 | Avatrombopag 20 MG | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 60 60 💬
|
1714 | Avatrombopag 20 MG oral tablet | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 60 60 💬
|
1715 | Avatrombopag maleate | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
1716 | Avatrombopag tablets | 1件: Avatrombopag Avatrombopag | 2件: Avatrombopag
Avatrombopag
,
Avatrombopag maleate
💬
| 1件: TPOR TPOR 💬
| 3件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hormone signaling, JAK-STAT signaling pathway 💬 | 1件: 63 63 💬
|
1717 | AVB-101 | 1件: AVB-101 AVB-101 | - | - | - | 1件: 127 127 💬
|
1718 | AVB-114 | - | - | - | - | 1件: 96 96 💬
|
1719 | AVB-S6-500 | 1件: Batiraxcept Batiraxcept | 1件: Batiraxcept
Batiraxcept
💬
| 1件: AXL AXL 💬
| 1件: Efferocytosis Efferocytosis 💬 | 1件: 66 66 💬
|
1720 | Avdoralimab | 1件: Avdoralimab Avdoralimab | - | - | - | 1件: 162 162 💬
|
1721 | AVE8112 | - | - | - | - | 1件: 6 6 💬
|
1722 | Avelox- moxifloxacin | 1件: Moxifloxacin Moxifloxacin | 3件: Moxifloxacin hydrochloride
Moxifloxacin hydrochloride
,
Moxifloxacin
,
Moxifloxacin hydrochloride monohydrate
💬
| - | - | 1件: 46 46 💬
|
1723 | Avenciguat | 1件: Avenciguat Avenciguat | 1件: Avenciguat
Avenciguat
💬
| 3件: GUCY1A GUCY1A, GUCY1A, GUCY1B 💬
| 10件: Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 51 51 💬
|
1724 | AVI-4658 | - | - | - | - | 1件: 113 113 💬
|
1725 | AVI-4658 FOR injection | - | - | - | - | 1件: 113 113 💬
|
1726 | Avian polyclonal IGY antibody against PA | - | - | - | - | 1件: 299 299 💬
|
1727 | AVID200 | - | - | - | - | 1件: 51 51 💬
|
1728 | Aviptadil | 1件: Aviptadil Aviptadil | 1件: Aviptadil
Aviptadil
💬
| - | - | 4件: 49 49, 51, 84, 86 💬
|
1729 | Avonex | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 2件: 13 13, 97 💬
|
1730 | Avonex (interferon BETA-1A), biogen idec LTD | 2件: Human interferon beta Human interferon beta, Interferon beta-1a | 2件: Interferon beta
Interferon beta
,
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
1731 | Avonex - 30 MCG (6 milioni UI) polvere E solvente PER soluzione iniettabile 4 flaconi CON dispositivo bioset + 4 siringhe preriempite USO intramuscolare | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
1732 | Avonex 30 microgram/0.5 ML solution FOR injection | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
1733 | Avonex 30 microgramos/0,5 ML (interferóN beta - 1A) solucióN inyectable | - | - | - | - | 1件: 13 13 💬
|
1734 | Avonex 30 microgramos/0.5 ML solucióN para inyeccióN | - | - | - | - | 1件: 13 13 💬
|
1735 | Avonex 30 µG/0,5 ML solution FOR injection | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
1736 | Avonex and topamax | - | - | - | - | 1件: 13 13 💬
|
1737 | Avonex IM 4SIR 30MCG/0,5ML 4AG | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
1738 | Avonex prefilled syringe VIA manual IM injection | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
1739 | Avonex*IM 4SIR 30MCG/0,5ML+4AG | 1件: Interferon beta-1a Interferon beta-1a | 1件: Interferon beta-1a
Interferon beta-1a
💬
| 2件: IFNAR1 IFNAR1, IFNAR2 💬
| 18件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | 1件: 13 13 💬
|
1740 | Avonex/betaseron/copaxone/rebif | - | - | - | - | 1件: 13 13 💬
|
1741 | Avonex/zocor | - | - | - | - | 1件: 13 13 💬
|
1742 | Avoralstat | 1件: Avoralstat Avoralstat | - | - | - | 1件: 65 65 💬
|
1743 | AVP-923 | - | - | - | - | 3件: 2 2, 6, 13 💬
|
1744 | AVP-923-45 | - | - | - | - | 1件: 6 6 💬
|
1745 | AVR-RD-01 | 1件: AVR-RD-01 AVR-RD-01 | - | - | - | 1件: 19 19 💬
|
1746 | AVR-RD-02 | 1件: AVR-RD-02 AVR-RD-02 | - | - | - | 1件: 19 19 💬
|
1747 | AVT05 | - | - | - | - | 1件: 46 46 💬
|
1748 | AVT16 | - | - | - | - | 1件: 97 97 💬
|
1749 | AVTX-803 | - | - | - | - | 1件: 65 65 💬
|
1750 | AVX 470 | - | - | - | - | 1件: 97 97 💬
|
1751 | AVXS-101 | - | - | - | - | 1件: 3 3 💬
|
1752 | AX 250 | - | - | - | - | 1件: 19 19 💬
|
1753 | Axatilimab | 1件: Axatilimab Axatilimab | 1件: Axatilimab
Axatilimab
💬
| 1件: CSF1R CSF1R 💬
| 11件: Acute myeloid leukemia Acute myeloid leukemia, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, MAPK signaling pathway, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Rap1 signaling pathway, Ras signaling pathway, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 85 85 💬
|
1754 | Axitinib | 1件: Axitinib Axitinib | 1件: Axitinib
Axitinib
💬
| 3件: FLT1 FLT1, FLT4, KDR 💬
| 14件: Breast cancer Breast cancer, Calcium signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Rheumatoid arthritis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | 1件: 34 34 💬
|
1755 | AXO-AAV-GM2 | 1件: Cobnabexagene anvuparvovec Cobnabexagene anvuparvovec | - | - | - | 1件: 19 19 💬
|
1756 | AXO-AAV-GM2 high dose | 1件: Cobnabexagene anvuparvovec Cobnabexagene anvuparvovec | - | - | - | 1件: 19 19 💬
|
1757 | AXO-AAV-GM2 LOW dose | 1件: Cobnabexagene anvuparvovec Cobnabexagene anvuparvovec | - | - | - | 1件: 19 19 💬
|
1758 | AXO-AAV-GM2 middle dose | 1件: Cobnabexagene anvuparvovec Cobnabexagene anvuparvovec | - | - | - | 1件: 19 19 💬
|
1759 | AXO-AAV-GM2 starting dose | 1件: Cobnabexagene anvuparvovec Cobnabexagene anvuparvovec | - | - | - | 1件: 19 19 💬
|
1760 | AZ-3102 | 1件: AZ-3102 AZ-3102 | - | - | - | 1件: 19 19 💬
|
1761 | AZA | - | - | - | - | 4件: 11 11, 40, 96, 97 💬
|
1762 | AZA capsules | - | - | - | - | 1件: 96 96 💬
|
1763 | Azacitidine | 1件: Azacitidine Azacitidine | 1件: Azacitidine
Azacitidine
💬
| 3件: DNMT1 DNMT1, DNMT3A, DNMT3B 💬
| 3件: Cysteine and methionine metabolism Cysteine and methionine metabolism, Efferocytosis, MicroRNAs in cancer 💬 | 1件: 34 34 💬
|
1764 | Azafol | - | - | - | - | 1件: 41 41 💬
|
1765 | Azafor - 50 MG compresse rivestite CON film 50 compresse IN blister PVC/pvdc/AL | - | - | - | - | 1件: 97 97 💬
|
1766 | Azafor 50MG | - | - | - | - | 1件: 97 97 💬
|
1767 | Azapred | - | - | - | - | 1件: 85 85 💬
|
1768 | Azathioprin | - | - | - | - | 3件: 46 46, 54, 96 💬
|
1769 | Azathioprin-ratiopharm 25 MG | - | - | - | - | 1件: 96 96 💬
|
1770 | Azathioprin-ratiopharm® 25 MG filmtabletten | - | - | - | - | 1件: 44 44 💬
|
1771 | Azathioprine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 22件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 55, 63, 65, 66, 84, 85, 94, 95, 96, 97, 162 💬
|
1772 | Azathioprine (AZA) caps | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
1773 | Azathioprine (imuran) 50 MG overencapsulated tablet | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 97 97 💬
|
1774 | Azathioprine + infliximab | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
1775 | Azathioprine + prednisolone | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 95 95 💬
|
1776 | Azathioprine - ratiopharm 50 MG | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
1777 | Azathioprine / 6 mercaptopurine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
1778 | Azathioprine / allopurinol | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 97 97 💬
|
1779 | Azathioprine 25 MG | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 44 44 💬
|
1780 | Azathioprine and allopurinol | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 97 97 💬
|
1781 | Azathioprine BP | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 97 97 💬
|
1782 | Azathioprine IN case OF endoscopic recurrence | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
1783 | Azathioprine individualised dose | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
1784 | Azathioprine or adalimumab and infliximab | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
1785 | Azathioprine or mesalazine | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
1786 | Azathioprine or methotrexate | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
1787 | Azathioprine or mycophenolate mofetil | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 162 162 💬
|
1788 | Azathioprine weight-based dose | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
1789 | Azathioprine+enteral nutrition | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
1790 | Azathioprine/prednisone | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 85 85 💬
|
1791 | Azatioprina | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 2件: 96 96, 97 💬
|
1792 | Azatioprina aspen - 50 compresse | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 96 96 💬
|
1793 | Azatioprina HEX. 50CPR 50MG BL | 1件: Azathioprine Azathioprine | 2件: Azathioprine
Azathioprine
,
Azathioprine sodium
💬
| - | - | 1件: 13 13 💬
|
1794 | AZD0120 | - | - | - | - | 1件: 49 49 💬
|
1795 | AZD0328 | - | - | - | - | 1件: 6 6 💬
|
1796 | AZD0530 | - | - | - | - | 1件: 272 272 💬
|
1797 | AZD0530 difumarate | - | - | - | - | 1件: 272 272 💬
|
1798 | AZD1236 | - | - | - | - | 1件: 299 299 💬
|
1799 | AZD2014 | - | - | - | - | 1件: 34 34 💬
|
1800 | AZD3241 | - | - | - | - | 1件: 17 17 💬
|
1801 | AZD3241 100MG | - | - | - | - | 1件: 17 17 💬
|
1802 | AZD3241 300 MG BID | - | - | - | - | 1件: 6 6 💬
|
1803 | AZD3241 300MG | - | - | - | - | 1件: 17 17 💬
|
1804 | AZD3241 600 MG BID | - | - | - | - | 1件: 6 6 💬
|
1805 | AZD3241 alternative titration scheme with formulation 1 or 2 | - | - | - | - | 1件: 6 6 💬
|
1806 | AZD3241 ER formulation 1 | - | - | - | - | 1件: 6 6 💬
|
1807 | AZD3241 extended release tablets 100 MG | - | - | - | - | 1件: 6 6 💬
|
1808 | AZD3241 extended release tablets 25 MG | - | - | - | - | 1件: 6 6 💬
|
1809 | AZD4017 | - | - | - | - | 1件: 75 75 💬
|
1810 | AZD4017 and prednisolone | - | - | - | - | 1件: 75 75 💬
|
1811 | AZD4522 | - | - | - | - | 1件: 79 79 💬
|
1812 | AZD4831 | - | - | - | - | 1件: 86 86 💬
|
1813 | AZD5055 | - | - | - | - | 1件: 85 85 💬
|
1814 | AZD5492 | - | - | - | - | 1件: 49 49 💬
|
1815 | AZD5634 | - | - | - | - | 1件: 299 299 💬
|
1816 | AZD5634 FOR infusion | - | - | - | - | 1件: 299 299 💬
|
1817 | AZD5634 FOR inhalation | - | - | - | - | 1件: 299 299 💬
|
1818 | AZD5672 | - | - | - | - | 1件: 46 46 💬
|
1819 | AZD6244 | - | - | - | - | 1件: 34 34 💬
|
1820 | AZD6912 | - | - | - | - | 1件: 46 46 💬
|
1821 | AZD7325 | - | - | - | - | 1件: 206 206 💬
|
1822 | AZD7798 | - | - | - | - | 1件: 96 96 💬
|
1823 | AZD7986 | - | - | - | - | 2件: 44 44, 299 💬
|
1824 | AZD9056 | - | - | - | - | 2件: 46 46, 96 💬
|
1825 | AZD9056 hydrochloride | - | - | - | - | 1件: 46 46 💬
|
1826 | AZD9567 | - | - | - | - | 1件: 46 46 💬
|
1827 | AZD9567 10 MG | - | - | - | - | 1件: 46 46 💬
|
1828 | AZD9567 125 MG | - | - | - | - | 1件: 46 46 💬
|
1829 | AZD9567 155 MG | - | - | - | - | 1件: 46 46 💬
|
1830 | AZD9567 20 MG | - | - | - | - | 1件: 46 46 💬
|
1831 | AZD9567 40 MG | - | - | - | - | 1件: 46 46 💬
|
1832 | AZD9567 80 MG | - | - | - | - | 1件: 46 46 💬
|
1833 | AZD9567 monohydrat | - | - | - | - | 1件: 46 46 💬
|
1834 | AZD9567 monohydrate | - | - | - | - | 1件: 46 46 💬
|
1835 | AZD9668 | - | - | - | - | 1件: 299 299 💬
|
1836 | Azilect | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 3件: 5 5, 6, 17 💬
|
1837 | Azilect 1 MG comprimidos | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 💬
|
1838 | Azilect 1MG | - | - | - | - | 1件: 6 6 💬
|
1839 | Azilect® 1 MG tabletten | 1件: Rasagiline Rasagiline | 3件: Rasagiline mesylate
Rasagiline mesylate
,
Rasagiline
,
Rasagiline tartrate
💬
| 1件: MAO MAO 💬
| 13件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 2 2 💬
|
1840 | Azilsartan | 1件: Azilsartan medoxomil Azilsartan medoxomil | 3件: Azilsartan medoxomil
Azilsartan medoxomil
,
Azilsartan
,
Azilsartan kamedoxomil
💬
| 1件: AGTR1 AGTR1 💬
| 17件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 66 66 💬
|
1841 | Azithromycin | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 6件: 13 13, 84, 85, 96, 228, 299 💬
|
1842 | Azithromycin + metronidazole | 2件: Azithromycin Azithromycin, Metronidazole | 5件: Metronidazole
Metronidazole
,
Azithromycin hydrate
,
Metronidazole hydrochloride
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 96 96 💬
|
1843 | Azithromycin + N-acetylcystein + inhaled corticosteroid | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 228 228 💬
|
1844 | Azithromycin 250 MG tablets | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 299 299 💬
|
1845 | Azithromycin 250MG capsule | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 84 84 💬
|
1846 | Azithromycin 500 MG FILM-coated tablet | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 299 299 💬
|
1847 | Azithromycin dihydrate | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 2件: 228 228, 299 💬
|
1848 | Azithromycin monohydrate | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 2件: 84 84, 340 💬
|
1849 | Azithromycin pill | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 96 96 💬
|
1850 | Azithromycine 250 MG | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 228 228 💬
|
1851 | Azithromycine CF 250 MG | 1件: Azithromycin Azithromycin | 3件: Azithromycin hydrate
Azithromycin hydrate
,
Azithromycin
,
Azithromycin
💬
| - | - | 1件: 340 340 💬
|
1852 | Azitromycine CF 250 MG | - | - | - | - | 1件: 340 340 💬
|
1853 | Azli | - | - | - | - | 1件: 299 299 💬
|
1854 | AZM | - | - | - | - | 1件: 228 228 💬
|
1855 | AZP-3601 | - | - | - | - | 1件: 235 235 💬
|
1856 | AZP-531 | - | - | - | - | 1件: 193 193 💬
|
1857 | AZP2006 oral solution | - | - | - | - | 1件: 5 5 💬
|
1858 | AZT | - | - | - | - | 3件: 94 94, 265, 325 💬
|
1859 | AZT/3TC | - | - | - | - | 1件: 265 265 💬
|
1860 | Aztreonam | 1件: Aztreonam Aztreonam | 2件: Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | 2件: 228 228, 299 💬
|
1861 | Aztreonam FOR inhalation solution | 1件: Aztreonam Aztreonam | 2件: Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | 1件: 299 299 💬
|
1862 | Aztreonam lysine | 1件: Aztreonam Aztreonam | 2件: Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | 1件: 299 299 💬
|
1863 | Aztreonam lysine FOR inhalation | 1件: Aztreonam Aztreonam | 2件: Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | 1件: 299 299 💬
|
1864 | Aztreonam solucióN para inhalacióN | 1件: Aztreonam Aztreonam | 2件: Aztreonam
Aztreonam
,
Aztreonam lysine
💬
| - | - | 1件: 299 299 💬
|
1865 | Aztreonan lysine | - | - | - | - | 1件: 299 299 💬
|
1866 | AúN NO establecido | - | - | - | - | 1件: 53 53 💬
|